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ABSTRACT
This thesis consists of 2 major parts - Part A on whole-body 
protein turnover in humans, and Part B on energy metabolism.
The method primarily used for measurement of whole-body protein
turnover in this thesis has been with the constant infusion of 
14(1- C)leucine, and this method is tested, analysed, and developed 
for extended 24 - 40 hour continuous protein turnover measurements. 
Using this method, it was found that protein intake has a dramatic 
and controlling influence on protein synthesis. This is initially 
established in Section 3.
In Section 4, it is shown that protein synthesis, breakdown, 
and oxidation are acutely responsive to protein intake, with large 
diurnal fluctuations resulting from feeding/fasting patterns. Protein 
turnover is compared in obese and lean humans, amino acid pool changes
and the question of circadian rhythms examined.
14Section 5 compares results from the (1- C)leucine method with 
those of (^5N)glycine, and long term changes in protein turnover are 
monitored. Section 6 shows how remarkable adaptive changes occur in 
protein synthesis and breakdown, resulting from a prolonged absence 
of protein intake.
Thus the relationship between whole-body protein turnover and 
protein intake is examined and established.
14In Part B, techniques developed for the (1- C) leucine method are 
exploited to measure by indirect calorimetry acute changes in the net 
synthesis and utilisation of glucose and fat. It is suggested that 
traditional methodology and restrictive current concepts concerning the 
use of indirect calorimetry have limited its development. Formulae
tt
are derived, which allow calculation of net fuel transfers under most
14conditions, and these formulae and (1- C)leucine techniques are 
combined to measure the body's response to different levels of 
carbohydrate intake, in both obese and non-obese humans.
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21.1. WHOLE-BODY PROTEIN TURNOVER AND ITS MEASUREMENT
Two basic aims underlie the work in this thesis - the development 
of a specific method for estimating whole-body protein turnover in 
humans, and the measurement of absolute values and patterns of change 
in whole body protein synthesis and breakdown.
The concept that all body proteins are in a dynamic state of 
turnover, with their own individual patterns of continuous breakdown 
and renewal, has only been recognised in the last few decades, and 
indicates even further the awesome complexity of protein metabolism.
Nitrogen balance studies have been the traditional method for assessing 
the state of whole-body protein metabolism in man, measuring differences 
between nitrogen intake and excretion under different conditions of 
health and dietary intake, and then attempting to deduce the metabolic 
significance in terms of net protein anabolism or catabolism. Useful 
as this method has been, it can only measure the end-result and net 
balance between whole-body protein synthesis and breakdown, yet it is 
the dynamics of these protein turnover processes that are ultimately 
responsible for growth in children, the wasting seen in malnutrition and 
disease states and changes in lean body mass resulting from a wide 
spectrum of dietary conditions. Therefore the recent development of 
methods for measurement of whole-body protein synthesis and breakdown 
offers the opportunity for a 'great leap forwards' in our understanding 
of human protein metabolism.
These methods involve the administration of isotopically labelled 
amino acids. In animals this has meant the ability to measure protein 
synthesis and breakdown in most tissues and under many different conditions, 
essentially by measuring the rate of incorporation of label into the 
protein of a particular tissue to determine its synthesis rate, or by
3measuring its subsequent rate of loss from the tissue to determine 
both breakdown and synthesis.
In man, because it is rarely possible to obtain tissue samples, 
efforts have largely concentrated on the measurement of whole-body 
protein turnover. This quantity is comprised of the sum of turnover 
rates of all individual body proteins, and Waterlow (1969) has 
pointed out the analogy with basal metabolic rate, which is the sum 
of the oxygen turnover rates of all cells in the body.
Whole-body protein turnover research can be seen to have developed 
along two distinct but related paths - the refinement of measurement 
techniques, and investigation of actual rates of whole body protein 
synthesis and breakdown especially in relation to growth, malnutrition 
and pathological conditions. In a very miniaturised way, the work in 
this thesis involves both those pathways. The underlying principles 
of whole body protein turnover and its measurement are outlined below, 
particularly those applicable to the methods used in this thesis.
Since the first attempt to obtain quantitative measurements of 
whole-body protein turnover in man (Sprinson «. Rittenbcrg, 1949) 
using a single dose of (15N)glycine, much research has been put into 
developing methods and techniques that might improve accuracy, precision 
and validity of protein turnover measurements. This has led to the 
use of amino acids with stable or radioactive labelling, different 
methods of sample collection, and often very complicated analysis models 
derived from alternative approaches to the calculation of results.
The simplest model representing whole body protein metabolism, 
used for calculating whole body protein synthesis and breakdown when 
labelled amino acids are given, is shown in Figure 1.
FIGURE 1.1. The 2-pool model
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The underlying assumptions in the use of this model are:
(i) the synthesis and breakdown of all body proteins occur
from one homogeneous precursor pool (the 'metabolic pool');
(ii) that a labelled amino acid introduced into that pool 
mixes completely and reflects the metabolism of all 
amino acids;
(iii) that protein synthesis and amino acid oxidation are the only 
significant pathways out of the metabolic pool, and protein 
breakdown and dietary intake the only significant pathways in;
5(iv) that while measurements are being made the pool size 
remains constant so that -
Z + E  = I + B  = Q ("flux"),-
(v) that no recycling of labelled amino acid occurs from 
the protein pool.
All these assumptions introduce some errors, and different measurement 
and calculation techniques have attempted to minimise these.
The aim of most methods of measurement of whole-body protein turnover 
is to estimate flux (Q), the rate of total amino acid flow through 
the free amino acid metabolic pool. However, there are two basically 
different approaches in the methods which attempt to estimate flux:
(1) Measurements on plasma.
(2) Measurements on excreted end-products.
Both approaches involve their own set of assumptions, error sources,
advantages and disadvantages, but nevertheless flux can be calculated
from the same fundamental equation (Equation 1) .
14 15When a labelled amino acid (eg. C- or N- labelled) is introduced 
at a constant rate (i) into the metabolic pool, the specific activity 
of the free amino acid (or relative abundance of 1&N) rices to a constant 
plateau value (S). The flux (Q) is then calculated from an equation 
which reflects the fact that the amount of isotope entering the metabolic 
pool (ie. by infusion) must equal the amount leaving.
1 = Q . S  Equation 1
Both plasma and end-product approaches attempt to measure the isotope 
concentration term (S), assuming that this is a reasonable estimate of 
specific activity in the precursor pool for protein synthesis. This 
allows the calculation of Q.
6It is in the use of the model1 s oxidation path that the two 
approaches show a basic difference. In methods based on the plasma 
measurement of flux, this pathway is used to determine only the 
oxidation rate (E) . In excreted end-product methods, the products 
of the oxidative pathway are used to determine both flux (Q) and 
protein oxidation (E). However, despite this difference, both approaches 
use the same oxidative pathway equation to calculate these quantities, 
based on the assumption that the proportion (e) of tracer dose or 
infusion (i) being channeled into oxidation, reflects the proportion 
of flux (Q) being channeled into oxidation (E) . Put another way, the 
proportion of oxidation end-product that is labelled (e/E) reflects the 
proportion of labelling in the metabolic pool, and hence reflects the 
proportion of flux that is labelled (i/Q) . Thus Equation 2
Plasma measurement methods use this relationship to calculate E, as 
flux (Q) has already been measured from plasma specific activity.
For excreted end-product methods, Equation 2 is equivalent to Equation 1 
because the proportion of labelling of the end-product (e/E) is 
assumed to represent the specific activity (S) in the precursor pool, 
and is thus used to calculate flux (Q) .
Both approaches then use Equation 3, previously shown as one of 
the model's assumptions, to calculate whole—body protein synthesis (Z)> 
and protein breakdown (B) where the intake of protein (D is also known.
With both the plasma measurement and excreted end-product 
methodologies, there are two different isotope administration techniques 
the single dose and continuous administration (eg. Infusion) , each of 
which has' advantages and limitations. And for all four of these
e i Equation 2
Q - Z + E ~ I + B Equation 3
7techniques there are 2 alternative analysis models that can be used 
to calculate a value as an estimate of flux - compartmental analysis 
and stochastic analysis. However compartmental analysis can only be 
applied to rising or falling specific activity-time curves, and 
is consequently of little value when constant infusion methods 
are used. In their book "Protein Turnover in Mammalian Tissues and 
in the Whole Body, Waterlow, Garlick and Millward (1978) have 
discussed in detail the techniques that have been used to estimate 
flux and calculate whole-body protein turnover.
Two methods have been used for the protein turnover data presented 
in this thesis. They include:
14(1) the constant infusion of (1- C)leucine with measurements 
of plasma leucine specific activity to estimate flux;
(2) the (15N)glycine method, administered both continuously 
or by single dose, with measurements of the abundance of
in excreted urinary ammonia, to estimate flux.
14However, this thesis is primarily orientated around the use of (1- C)leucine 
- a plasma measurement method. One of the underlying aims of the work 
has been to develop this method, test its limitations and extend its 
use. The (15N)glycine method has been used for both comparative purposes, 
and for carrying out some of the repeated measurement monitoring of 
protein turnover.
The following discussion briefly summarises some of the main 
assumptions and limitations specific to each method for estimating flux, 
and particularly as they apply to the isotopes and techniques used.
f  ,
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81.2. ESTIMATION OF FLUX FROM MEASUREMENTS ON PLASMA
The underlying assumption, with plasma measurements of specific 
activity, in addition to those already listed for the two pool model, 
i s that the plasma represents the precursor pool from which protein 
synthesis occurs. In fact the nature and boundaries of the true 
precursor pool remain obscure for both tissues and whole body. How 
it relates to the intracellular free amino acid pool or the plasma 
pool is not understood, nor whether the precursor pool for protein 
synthesis is immediately related to the free ainino acids derived 
from protein breakdown. Perhaps the true precursor pool cannot be 
defined for the whole body, nor directly sampled, as its functional 
boundaries may differ in different tissues and it may change under 
varying conditions. However evidence suggests that it lies between 
the intracellular free amino acid pool and plasma free amino acid pool, 
and the closer functionally it relates to the plasma pool, the better 
will plasma specific activities reflect precursor pool specific 
activities.
Nevertheless estimates of flux from plasma measurements are likely 
to be too low. This is because the values that are actually calculated 
from plasma specific activity measurements, whether by stochastic or 
compartmental analysis, are usually "disposal rates" of amino acid from 
the plasma pool (ie. its net rate of disappearance from the plasma). 
This does not take account of internal recycling in which amino acids 
released by protein degradation enter and dilute the precursor pool and 
are then immediately available for protein synthesis again, without 
entering the plasma pool. Clearly the specific activity of a tracer 
introduced into the plasma euni.no acid pool will be higher than its 
specific activity in the precursor pool whicli cannot unfortunately be
9directly sampled, and consequently estimates of precursor pool flux, 
derived from plasma disposal rate measurements, will be too low.
The mathematical principles underlying the calculation of plasma 
amino acid disposal rate relate to two different analytic approaches - 
compartmental analysis and stochastic analysis. However both methods 
turn out to be mathematically equivalent if used to calculate disposal 
rates using the two pool model.
Compartmental analysis can only be applied to rising or falling 
specific activity-time curves in plasma (or urine), so that although 
it can be applied to the rise to plasma plateau in a constant infusion, 
there is often difficulty in accurately defining that early part of 
the curve. It is more appropriate to use the falling specific activity­
time curves in plasma following single dose tracer administration.
In compartmental analysis a multi-exponential equation is fitted 
to the falling specific activity curve. It assumes that the change 
in plasma specific activity results from the flow of tracer through 
a scries of compartments in steady state, with first order kinetic 
exchange between them, and with each exponential term representing one 
compartment. By curve peeling or computor analysis usually 3 exponential 
terms have been derived although Hea th & Barton (1973) obtained 4. 
Waterlow, Garlick a Millward (1978) point out that the apparent 
existence of multi-compartments is probably not only unverifiable, but 
in fact may not represent reality, whilst factors such as measurement 
error and biological variation significantly contribute to the curve 
form. The general multi-exponential equation which is fitted to a plasma 
specific activity curve is:
- X  t
+  X  e  2
n
- X  t
= X  e  1 t  1 2 1-1
Equation 4.
io
where is the plasma specific activity as a function of time t, 
and ^ are exponential coefficients, X^ • exponential rate
constants and n the number of compartments. The techniques of 
curve fitting and mathematics of curve peeling, and solution of the 
multi-exponential equation for the exponential parameters are given 
in detail by Atkins (1969) and Shipley & Clark (1972).
The fitted exponential equation can be used to calculate 
estimates of flux in a number of ways. These include laboriously 
calculating a value for the absolute transfer rate from a theoretical 
compartment that may represent the precursor pool, or most simply, 
calculating the plasma amino acid disposal rate D, known to under­
estimate flux by not accounting for internal recycling. The disposal
rate D is the easiest to calculate, using the equation
*d
Equation 5.
where d* is the dose of tracer, and the terms and X^ the derived
parameters from the appropriate multi-exponential equation. In
addition the order of error associated with internal recycling can at
least be approximated from other methods, such as comparison between
14oxidation rates measured by CC>2 and by urinary N outputs, or by 
tissue intracellular pool measurements in animals. Therefore,disposal 
rate D is used as the best and most convenient estimate for flux.
The substantial disadvantages associated with compartmental 
analysis include its being of little value for constant infusions, 
the complicated calculations involved, its dependence on values derived 
from exponential curve fitting and therefore possible errors, and the 
probably unverifiable assumptions it requires about the system.
11
Stochastic analysis, in distinct contrast, can be used with 
plasma specific activity measurements from both single dose or continuous 
infusion methods, it makes no assumptions about compartments, it uses 
direct measurements, and the calculations are simple. It calculates 
the plasma disposal rate, and so as an estimate of flux, is probably 
too low because of internal recycling.
When a tracer amino acid has been given as a single dose (d*) , 
and the falling plasma specific activity values (S^ ) produce the 
characteristic specific activity-time curve, once the whole dose (d*) 
ha3 cleared the plasma pool then
where D is the plasma amino acid disposal rate. This can simply 
be shown to be mathematically equivalent to Equation 4 from 
compartmental analysis.
For the single dose technique the area under the plasma specific 
activity-time curve needs to be evaluated to calculate D. When the 
labelled amino acid is administered by constant infusion at rate (i) , 
the plasma specific activity rises to a constant plateau (S) so that 
rate of tracer entry in to the plasma pool is equal to the net amount 
leaving, and thus at plateau
■j = D.S Equation 7
This is analagous to Equation 1, except that it indicates that plasma 
amino acid disposal rate is used as an estimate of flux.
A comparison of the relative merits of administration of labelled 
amino acid by single dose or by constant infusion, substantially favours 
the constant infusion method. The major advantage of this method is
d Equation 6
0
12
the ease and accuracy of specific activity definition at plateau, and 
hence the better estimate of D. Furthermore-, fewer blood samples are 
needed to define the plateau value than are needed for definition of 
the specific activity curve following a single dose. Constant infusion 
also avoids the error that may arise at the tail end of the single dose 
specific activity curve, caused either by the need to extrapolate 
or by the necessity to distinguish when recycling of label is signifi­
cantly contributing to the tail.
Recycling of label also occurs at a very slow rate with constant 
infusions so that the 'plateau' specific activity is really a gradually 
rising 'pseudo-plateau', but in infusions of short duration this 
is probably negligible. This effect can be seen in figures in 
Sections 4 and 6.
With measurements on plasma for estimates of flux,and thereby 
protein turnover, one further source of error is the conversion of amino 
acid flux into protein turnover, 'the conversion factor being an 
estimate of the weighted mean of the concentration of the particular 
tracer amino acid in all body proteins.
The particular tracer amino acid used for the plasma measurement
14method of estimating protein turnover, has been (1- C)leucine. The 
reason for its choice, and the background studies that led up to its 
use, are outlined in the following resume.
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141.3. BACKGROUND TO THE PRESENT USE OF THE (1- OLEUCINE CONSTANT 
INFUSION METHOD.
Measurements of plasma specific activity to estimate flux have 
usually implied the use of radioactive amino acid tracer s, at least 
until the very recent use of the stable (^ \:) leucine. One of the 
major advantages of radioactive tracers is the sensitivity and ease of 
measuring their specific activities in plasma or tissues, and hence 
the development of the plasma measurement method.
When first used to measure whole body protein turnover, radioactive
amino acids were given as a single dose either intravenously or
35 14orally. ( S)Methionine (Maurer, 1960) , ( C)phenylalanine (Grumer
et al, 1962) and (^H)glycine (Nyhan & Childs, 1964) were used, but
assumptions about parts of the specific activity-time curves and
calculations amounting to compartmental analysis resulted in protein
turnover rates that were not correct.
Waterlow (1967) was the first to use the constant infusion
technique to measure whole body protein turnover in man, using 
14uniformly labelled (U- C) lysine. A problem that then became apparent 
was the inconveniently long (10 - 18 hours) rise to plateau, resulting
from the large size of the plasma free lysine pool (166 ymoles/litre,
. 14Moller et al, 1979). Uniformly labelled (U- C) tyrosine was subsequently
chosen (James et al, 1976) because of its much smaller plasma free
tyrosine pool (60 ymoles/litre) producing a more rapid rise to plateau
(about 4 hours), and because a convenient automated method had been
developed for its measurement.
14 14With the early infusions of (U- C)lysine and (U- C)tyrosine, the 
estimated flux rate was taken to approximate the rate of whole body 
protein synthesis. The oxidation rate was assumed to be small compared
14
with synthesis, and it was felt that the resultant small overestimate
of synthesis would be partially balanced by the underestimate arising
14from internal recycling. However it was found with (U- C)tyrosine
that amino acid oxidation could be measured, because the proportion
of infused radioactivity expired in CO^, represented the proportion
of flux being oxidised (James et al, 1974; Sender et al, 1975).
14Unfortunately, problems emerged with (U- C) tyrosine when the 
expired CO^ specific activity sometimes failed to reach plateau even
after lo hours, despite achievement of a rapid plasma plateau. This
14was probably because some of the labelled carbon from the (U- C)tyrosine 
skeleton (as with any uniformly labelled amino acid) would not have 
been immediately excreted as C02, but recycled into fatty acid 
synthesis or gluconeogenic pathways, before eventually being excreted.
In addition tyrosine is non-essential.
14(1- C)Leucine was consequently introduced (O'Keefe et al, 1974) ,
as it seemed likely to overcome all the above problems. It seemed
to meet all the major theoretical requirements for a tracer amino
acid to succeed in measuring whole body protein turnover from plasma
measurements. It is an essential amino acid so there is no de novo
synthesis. It has no known significant metabolic pathways other than
oxidation and incorporation Into protein synthesis. It has a reasonably
small plasma free leucine pool (121 ymoles/litre), and reaches plasma
plateau in a conveniently short period ( 5 - 8  hours). In its oxidative
pathway, immediately following the first step (transamination),
Irreversible oxidative decarboxylation occurs (Figure 1.2), removing the
14C as ^4C02 which is then expired, so that after applying a known
14correction factor to account for a loss of some 10% of the C02 into
14bone and other pathways, expired C02 is an excellent measure of 
leucine oxidation, and specific activity of expired CC>2 reaches plateau
FIGURE 1.2. Leucine metabolism.
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wi1-' about 1 hour of acquiring plasma plateau.
By comparing oxidation rates derived from the (1- C)leucine 
method with those from urinary N excretion. Golden & Waterlow (1977) 
calculated that rates of flux and protein synthesis based on plasma 
measurements underestimated precursor pool flux and true protein 
synthesis by 20%, and that the leucine specific activity at the 
site of oxidation (and thus supposedly protein synthesis) was only 
80% of that in the plasma. Internal recycling of leucine from protein 
degradation into the precursor poo), was thought to have been responsible 
for this. Thus their figures imply that 20% of amino acids entering 
the precursor pool come from protein breakdown, and 80% from plasma.
This factor is considered further in this thesis.
It can be seen that there are several major advantages in the 
techniques that have been developed for estimating whole body protein 
turnover from plasma specific activity measurements.
(1) Radioactive tracers, used most commonly with this
technique, are easily and accurately measured,
13 15although stable isotopes ( C and N) can now be 
measured in plasma.
(2) Constant infusion gives clearly and accurately definable 
plateau values for plasma specific activity, from which 
amino acid disposal rate is calculated and flux estimated.
This is more accurate and requires fewer blood samples
than a single dose technique.
14(3) (1- C)Leucine is an excellent tracer amino acid, being 
an essential amino acid, with no known significant 
metabolic pathways other than oxidation and protein synthesis, 
and having a rapid rise to plasma specific activity
plateau Immediately followed by a specific activity plateau 
for expired COj.
14
17
(4) Oxidation rate of leucine, as a proportion of flux, 
can be directly measured from 14C02 excretion. This 
can be combined with leucine intake and nitrogen 
balance to estimate internal recycling, which can then 
be accounted for in the estimation of protein synthesis 
rates.
It was against this background that the work for this thesis 
commenced in 1975, soon after the introduction of (l-14c) leucine 
as a tracer for protein metabolism (O'Keefe et al, 1974). As 
indicated earlier, one of the aims has been to take up and develop 
the use of the (1-^4C) leucine constant infusion method, and by infusing 
large numbers of subjects (well over 1,200 hours of infusion) 
establish consistent values for adult humans under various dietary
conditions
18
1.4. ESTIMATION OF FLUX BY EXCRETED END PRODUCT
With both the plasma measurement method, and the excreted end 
product method, the underlying aims are identical, ie. to estimate 
the specific activity (relative abundance) of tracer or isotope in 
the precursor pool, so that the same set of general equations 
(Equations 1 - 3 )  can then be applied, and protein synthesis and 
breakdown rates calculated. The previous section has shown that 
plasma specific activity measurements of amino acids differ significantly 
from precursor pool specific activities, and the assumptions on which 
the plasma method is based, particularly in assuming a non-compartmented 
homogeneous precursor pool which ignores internal recycling, can 
lead to significant (though partially quantifiable) error.
Similarly there are assumptions of doubtful validity underlying the 
use of the excreted end-product method to estimate precursor pool flux.
The use of urinary end products for determining whole body protein
turnover, implies that the tracer is ~^*N. The method assumes that if
15an amino acid labelled with N is given, it will enter the metabolic 
pool and reversibly transfer the 15N label with other amino acids in 
such a way that metabolism represents total amino N metabolism.
It is further assumed that this metabolic pool is the precursor pool for 
both protein synthesis and amino acid oxidation, and that the N-containing 
end-product excreted in the urine is derived from the same precursor 
pool as protein synthesis, and only from that pool. Thus the 
specific activity of the end-product N is assumed to represent the 
specific activity of amino acid N in the precursor pool. Hence measure­
ment of the relative abundance of 15N in the chosen urinary end-product
15(eg. N»3) , should represent N relative abundance in the precursor pool.
19
Although both compartmontal and stochastic analysis can be used 
to estimate flux by calculating disposal rate, the same complex 
difficulties arise with compartmental analysis as discussed with its 
use for plasma specific activity measurements. Olesen et al (1954)
fitted a 3-exponential term equation to the 15 day curve of urinary 
15 15excretion of N after a single dose of ( N)glycine, and by assuming 
some re-entry limitations proposed a 4-pool model. Compartmental 
analysis was then used to determine exponential parameters, rate 
constants and pool sizes and hence an estimate of flux.
In contrast, stochastic analysis is unconcerned with the number 
or size of protein pools or excretory pools, but calculation of realistic 
disposal rates from the metabolic pool greatly depends on the validity 
of the assumptions concerning both the tracer, and the derivation of 
end product from (and only from) the metabolic pool, as outlined above.
If these assumptions are valid, then the proportion of the given dose 
of 15N that is excreted in the chosen end product would be the same 
as the proportion of amino acid disposal which is excreted as the end 
product.
Consequently, if the chosen urinary end product is being excreted
• 1Cat rate (E) , and an N-labolled amino acid is given by constant 
infusion at rate (i) so that the rate of excretion of 1jN in the chosen 
end product rises to a constant rate (e) , then
D
Equation 8
where D is the amino acid disposal rate. Since at plateau the 
relative abundance (S) of 15N in the end product is e/E then Equation 8
becomes:
»  D . S Equation 9
20
which is identical to stochastic analysis equations for measurements on 
plasma specific activities (Equation 7).
When an N amino acid is given as a single dose (d) and its 
ultimate cumulative excretion in the chosen urinary end product is 
(ec) / then on the stochastic principle that the proportion of tracer 
dose excreted in the end product is equal to the proportion of amino 
acid disposal rate being excreted as the end product.
The single dose method requires calculation of the area under the 
relative abundance - time curve to achieve a value of the ultimate 
cumulative abundance of in the chosen end product
by summation of values of isotope abundance (Sfc) from a consecutive 
series of urine collections at times intervals (t*=0, t^. . .T) so that 
Equation 10 becomes
There is real difficulty in defining the time point T) when collection 
should cease because isotope clearance is sufficiently complete, but 
before isotope re-entry from the protein can significantly affect the
e Ec
/d /D Equation 10
CO
(ie. /' ) . In practice this area is approximated E
0
T
D = Equation 11
tcO
14tail of the curve. Much of the comparative work between ( C) leucine 
and (15N) glycine (although not presented in this thesis) was aimed 
at clarifying this methodological problem.
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The problems faced in deciding which 15N labelled amino acid, 
and which urinary end product to choose, reflect some of the difficulties 
presented by the underlying assumptions of this method.
The basic requirement for any 15N labelled tracer is that the 
15N should be re-distributed in such a way that it represents the 
metabolism of all amino-N. Since it is most unlikely that all 
precursor pool amino acids become equally labelled, the essential 
requirement is for the same proportions of different labelled amino 
acids to enter protein synthesis as enter oxidation. In fact this can­
not be fully satisfied as the majority of body protein synthesis is 
separate from the liver where a substantial proportion of oxidation 
and hence urea synthesis occurs.
This is also the objection to the other main assumption of 
15N methods - that the same precursor pool of amino acids serves 
protein synthesis, and whole body amino acid oxidation with its 
resultant end product formation. Obviously this cannot be true, as 
urea is only formed in the liver, urinary ammonia is mainly formed 
from glutamine in muscle so that the precursor pools for both these 
end products are unlikely to be representative of a 'whole body' 
precursor pool.
An advantage of the (1-14C)leucine method is that although 
errors are associated with its underlying assumptions, they con largely 
be accounted for and even quantitated. With the 15N excreted end- 
product method, the errors associated with assuming a common synthesis/ 
end-product precursor pool cannot be tested as there is no such pool.
Because of the difficulties associated with these basic assump­
tions, two questions of great practical importance remain:
(1) which 15N labelled amino acid gives the most valid 
protein turnover measurement?
The problems faced in deciding which 1SN labelled amino acid, 
and which urinary end product to choose, reflect some of the difficulties 
presented by the underlying assumptions of this method.
The basic requirement for any 15N labelled tracer is that the 
■* should be re-distributed in such a way that it represents the 
metabolism of all amino-N. Since it is most unlikely that all 
precursor pool amino acids become equally labelled, the essential 
requirement is for the same proportions of different labelled amino 
acids to enter protein synthesis as enter oxidation. In fact this can­
not be fully satisfied as the majority of body protein synthesis is 
separate from the liver where a substantial proportion of oxidation 
and hence urea synthesis occurs.
This is also the objection to the other main assumption of 
methods - that the same precursor pool of amino acids serves 
protein synthesis, and whole body amino acid oxidation with its 
resultant end product formation. Obviously this cannot be true, as 
urea is only formed in the liver, urinary ammonia is mainly formed 
from glutamine in muscle so that the precursor pools for both these 
end products are unlikely to be representative of a 'whole body' 
precursor pool.
14An advantage of the (1- C) leucine method is that although 
errors are associated with its underlying assumptions, they can largely 
be accounted for and even quantitated. With the 15N excreted end- 
product method, the errors associated with assuming a common synthesis/ 
end-product, precursor pool cannot be tested as there is no such pool.
Because of the difficulties associated with these basic assump­
tions, two questions of great practical importance remain:
(1) which 15N labelled amino acid gives the most valid 
protein turnover measurement?
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(2) which urinary end-product should be used (bearing 
in mind the tracer amino acid used)', to give a 
relative abundance of most representative of the 
precursor pool?
A third practical question with its own set of possible errors has 
also been tackled in the development of this method, and concerns 
the simplicity and convenience of the method:
(3) which method of tracer administration (eg. single dose, 
multiple dose, constant infusion, etc) gives satisfactory 
results with the greatest convenience?
The following resume of previous use of ^N/excreted end-product
method summarises how these questions have been approached in the
past, and how they relate to some of the ongoing programmes, of
relevance to this thesis. One of the best available tests of the
validity of the 15N methods used, is a comparison of their estimates
of absolute rates of whole body protein turnover and th^ir ability to
14measure change, with other independent methods, such as (1- C)leucine.
14Section 5 undertakes such a comparison of (1— C) leucine against 
various methods.
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1.5. BACKGROUND TO THE PRESENT USE OF (15N) GLYCINE
The first attempt to measure whole body protein synthesis in 
man used oral (^ ~*N) glycine, and was based on the simple 2 pool model 
(Sprinson & Rittenberg, 1949). Protein synthesis was calculated from 
the slope of the excretion curve. Subsequent studies tended to
propose increasingly more complicated multi-compartmental models 
attempting to explain and solve the observed multi-exponential 
profiles of urinary 15N excretion and thus achieve more likely estimates 
of protein synthesis (eg. San Pietro & Rittenberg, 1953; Olesen et al, 
1954) .
The early studies using 15N produced rather scattered results and 
non-conclusive protein turnover changes in pathological states, and 
probably this uncertainty, along with the enormously complicated 
mathematics of these models, caused stable isotope protein turnover 
studies to fall from favour. Morè recent studies have tended towards 
simple models with simple analysis methods, with emphasis on making 
the technique a useful practical one that can give consistent sensible 
results. Picou & Taylor-Roberts (1969) developed the constant 
administration technique with (15N)glycine, measuring plateau 
abundance of 15N in urinary urea, and they used this method to measure 
changes in protein turnover in malnourished, recovering and recovered 
children. A disadvantage of this method was the relatively long times 
needed for the 15N abundance in urea to reach plateau - 24 hours in 
children and 48 hours or longer in adults - a result of the large 
urea pool with its half-life of about lO hours. The rates they 
measured were therefore averageo of whole body protein turnover over 
long périodes, this method being unable to show acute changes.
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In theory any urinary N end product can be used to calculate flux, 
provided it is derived from the same 'metabolic pool' from which 
whole body protein synthesis occurs (and only from that pool) , so that 
it reflects abundance from that pool. As previously mentioned,
urea does not satisfy this criterion because it is synthesised in the
liver, separate from synthesis of the majority of body protein, and
15 15so when ( N) glycine is introduced and its N transfers to other
amino acids throughout the body, the proportions of different (15N)amino-
Iacids entering protein synthesis are unlikely to be the same proportions
oxidised and excreted as urea.
Recently the use of urinary ammonia has been suggested as a
suitable end-product of N metabolism, its advantage being a more rapid
rise to plateau of 15N abundance in about 12 hours, during constant
infusion with (15N)glycine (Waterlow et al, 1978; see also Figure 2.5
in Section 2) . Urinary NH^ arises from different precursors to urea,
the most important being the amide—N of glutamine (mainly from muscle) ,
and also from direct metabolism of amino acids by the kidney, but in
any case there appears to be no significant pool to delay its excretion. Some
15 14early comparative work has been done with ( N)glycine and (1- C) leucine,
estimating whole body protein synthesis from both urea and ammonia as
end-product (Waterlow et al, 1978) , and also simultaneously with
(1-14C)leucine (Golden & Waterlow, 1977). In malnourished and recovering
children, the ammonia method persistently gave lower synthesis rates
than either total N or urea methods, but all methods showed the same
proportional effects. In elderly subjects the same relationship was
14also shown, and protein synthesis rates from (1- C)leucine were
intermediate between the HH^ and urea methods' values.
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An ongoing programme directed by Professor J C Waterlow has
been aimed towards further validating the NH^ end-product method
and simplifying the technique of dose administration. This
programme conveniently coincided with the aims and work in this
thesis, so that the testing of different techniques of the (15N)glycine
method, their ability to estimate whole body protein turnover could
14be compared with the (1- C)leucine method - an advantage to both 
methods - as well as these techniques being used to monitor protein 
synthesis changes when the use of a radioactive tracer was precluded. 
This work is presented in Section 5.
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1.6. PROTEIN TURNOVER AND DIET: BACKGROUND STUDIES
Several attempts have been made in the past to discover how levels 
of protein and energy intake, both long and short term, might affect 
protein synthesis and breakdown. However the results have been quite 
confusing.
14Waterlow & Stephen (1967; 1968) using (U- C)lysine in rats, 
showed a 30% decrease in flux following 6 weeks of protein depletion, 
but little change in flux following a variety of short term dietary 
changes. Tschudy et al (1959) measured protein turnover in a single 
subject with (^N)aspartate at 4 different combinations of protein 
and energy intake between 1200 Kcal/40 g protein and 1800 Kcal/80 g 
protein, They found increasing rates of synthesis with the increasing 
protein/energy intakes, but all their synthesis results were very 
low and probably inaccurate because of their use of the compartmental 
method of San Pietro & Rittenberg (1953). Kassenaar et al (1960) 
using the same method found no significant changes in synthesis rate 
in a patient with anorexia nervosa, fed at 5 different levels of 
protein and energy intake.
There was also no change in the rate of protein synthesis when 
children (recovered from malnutrition) were given different levels of 
protein intake at equal energy intake levels. However, an increased 
retention of N (ie. growth) was noticed on the higher protein diets, and 
the authors concluded that this resulted from a decrease in protein 
breakdown (Picou & Taylor-Roberts, 1969; Golden et al, 1977). However 
malnourished children on a maintenance diet prior to recovery were 
shown to have markedly decreased whole body protein synthesis rates, 
then during recovery synthesis rates rose to almost twice the 'normal1 
recovered rates (Golden et al, 1977). Nutritional status therefore appears
to effect whole body protein synthesis rates
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In contrast to all these studies Sender et al (1975) demonstrated
a 50% fall in whole body protein synthesis and a 60% fall in protein
oxidation when 5 obese adults were measured by continuous infusion 
14with (U- C)tyrosine initially on a 2000 Kcal/70 g protein diet and 
then again after 3 weeks on 300 Kcal/O g protein diet.
g Protein DAILY INTAKE
per day
SYNTHESIS OXIDATION
FIGURE 1.3. The effect on whole body protein synthesis and oxidation 
in 5 obese subjects, before and after 3 weeks on 300 Kcal protein-free 
diet. (From Sender et al, 1975).
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1.7. SCHEME OF INVESTIGATIONS FOR THIS STUDY
The work presented in this thesis really had its beginning at
this point in 1975, stimulated by the recent availability of 
14(1- C)leucine for protein turnover measurements, as well as dramatic 
findings of Sender et al (1975) that diet itself could affect 
protein metabolism so greatly.
The scheme of work commenced with consideration of the 
(1-^^C)leucine method itself. Although this method seemed to offer 
the most valid theoretical means of measuring human whole-body 
protein turnover, it was realised that the many techniques involved 
in making these measurements were potential sources of large errors. 
Section 2 describes the technical problems associated with the method, 
and how these and other necessary correction factors were tested and 
resolved.
At the same time it was decided to measure the effect of a 
prolonged protein-free/low energy intake on protein turnover in obese 
patients, similar to the study of Sender et al (1975) . It was felt
that this was a sensible preliminary step, since significant errors
14were known to be associated with their (U- C)tyrosine method.
It was also planned to distinguish whether any change in protein 
turnover resulted from the low energy intake or from the prolonged 
absence of dietary protein, and this intial study is described in 
Section 3.
The findings in that study encouraged investigation of acute and 
diurnal changes in human protein metabolism. As exciting data from both 
normal and obese subjects emerged, the question of inherent circadian 
rhythms, diurnal changes in amino acid pools, and the patterns of the 
acute sensitivity of protein turnover to protein Intake, wore considered
mSECTION 2 METHODS AND TECHNIQUES
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1 42.1. CON STANT INFUSION WITH L-(1- C)IEUCINE : A PLASMA SPECIFIC 
ACTIVITY MEASUREMENT METHOD.
2.1.1. The Method
Consistent with the principles discussed in the 
Introduction, this method of measurement of whole body protein turnover 
requires particular skills and techniques, to obtain the following 
data:
(i) A very constant and accurately known infusion 
rate of (1-*4C)leucine (i DPM/hour).
(ii) Plasma leucine specific activity at plateau 
(S DPM/pmole leucine).
(iii) Expired C02 specific activity at plateau.
(iv) Total COj production rate throughout the 
measurement period.
(v) A constant and accurately known intake of 
leucine (I) .
As shown previously, the plasma leucine disposal rate can then be 
calculated from Equation 1, and this is used as a reasonable estimate 
of leucine flux (Q jimoles/hour) through the precursor pool.
1 = Q S  OF Q = Equation 1.
Leucine oxidation rate (E) is estimated by calculating the rate of 
excretion of 14C02 <e) from the product of C02 specific activity and 
total CC>2 production rate, and then assuming that the proportion of 
infused isotope being oxidised is a reflection of the proportion of 
leucine flux being oxidised, as In Equation 2.
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E Equation 2
Whole body protein synthesis (Z) and breakdown (B) can then 
be calculated from Equation 3. Flux, synthesis, breakdown, and oxidation 
rates, all initially measured and calculated in terms of leucine, 
can then be converted into 'whole body protein', a theoretical 
protein with an amino acid composition in weighted mean proportion to 
the composition of all body proteins. The conversion assumes that 
the leucine content of whole body protein is 8% (Block & Weiss, 1956).
2.1.2. Subjects
Subjects were chosen on the following basis. Obese subjects were
selected from patients attending Professor J.C. Waterlow's Obesity Clinic
(University College Hospital, London), and control subjects from
volunteer staff members (Dept. Human Nutrition, London School of Hygiene
and Tropical Medicine). All subjects were of post child-bearing age,
and had no disease known to be associated with protein metabolism.
The infusion procedures were fully explained to the subjects, who
signed consent forms confirming their prerogative to terminate the
infusion at any time. The Isotope Advisory Panel of the Medical Research
14Council had approved the administration of up to 50 jiCi of (1- C)leucine 
and subjects received amounts up to this maximum, usually by two infusions 
or a prolonged single infusion. Subjects were admitted as inpatients 
to the Hospital for Tropical Diseases, London NWl, either specifically 
for the (1-* 14C)leucine infusion, or for a period (usually 6 weeks) of 
Inpatient weight reduction. These studies were approved by the Ethical 
Committee of University College Hospital, London.
Q = Z + E = B +  I Equation 3
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2.1.3. Constant Infusion System
The isotope infusion solution was prepared by mixing the required
14total infusion dose (eg. 25 jiCi) of L-(l- C)leucine (Radiochemical 
Centre, Amersham, Bucks, U. K.) with approximately 25 ml of sterile 
0.9% saline, and injecting this solution through a millipore filter 
(0.22 urn) into a sterile 25 ml disposable syringe, and was thus ready 
for use.
The constancy of isotope infusion is crucial for this technique, 
and even small changes in infusion rate, lasting only a few minutes, 
were able to alter plasma specific activity, and hence spoil plateau 
measurements. Initially the isotope/saline solution was infused 
directly intravenously into subjects through fine bore Silastic tubing, 
using a constant infusion syringe pump. This system proved unsatisfactory, 
as its delicacy restricted the subjects movements during the 8 - 1 0  hours 
of infusion, and the combination of changes in hydrostatic pressure 
in the tubing (as a result of subject movement relative to the 
syringe pump), and the compliance of the tubing itself, produced an 
unacceptable variability in the rate of isotope delivery at needle tip.
The constant infusion system that was eventually developed involved 
a constant rate intravenous infusion of N-saline controlled by a 
Tekmar T92H Volumetric Infusion Pump (Tekmar Medical Ltd, Milton, Oxon,
U.K.), usually run at a rate of 50 ml/hour. Through a side arm of the
14intravenous line, a syringe pump infused the (1- C)leucine/saline 
solution via a long 25 gauge needle. The great advantage of this system, 
proved to be the reliability and consistency of the Tekmar infusion 
pump. There was never more than ±0.2% variation from a measured mean 
delivery rate (C.V. _ 0.13%), and the built-in alarm systems for 
air bubbles, blockages, completion of infusion solutions, and power 
failure actually rescued some Infusions.
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2.1.3. Constant Infusion System
The isotope infusion solution was prepared by mixing the required
14total infusion dose (eg. 25 nCi) of L-(l- C)leucine (Radiochemical 
Centre, Amersham, Bucks, U.K.) with approximately 25 ml of sterile 
0.9% saline, and injecting this solution through a millipore filter 
(0.22 pm) into a sterile 25 ml disposable syringe, and was thus ready 
for use.
The constancy of isotope infusion is crucial for this technique, 
and even small changes in infusion rate, lasting only a few minutes, 
were able to alter plasma specific activity, and hence spoil plateau 
measurements. Initially the isotope/saline solution was infused 
directly intravenously into subjects through fine bore Silastic tubing, 
using a constant infusion syringe pump. This system proved unsatisfactory, 
as its delicacy restricted the subjects movements during the 8 - 1 0  hours 
of infusion, and the combination of changes in hydrostatic pressure 
In the tubing (as a result of subject movement relative to the 
syringe pump), and the compliance of the tubing Itself, produced an 
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The constant infusion system that was eventually developed involved 
a constant rate intravenous infusion of N-sallne controlled by a 
Tekmar T92H Volumetric Infusion Pump (Tekmar Medical Ltd, Milton, Oxon,
U.K.), usually run at a rate of 50 ml/hour. Through a side arm of the
14intravenous line, a syringe pump infused the (1- C)leucine/saline 
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delivery rate (C.V. « 0.13%), and the built-in alarm systems for 
air bubbles, blockages, completion of infusion solutions, and power 
failure actually rescued some infusions.
34
The rate of constant infusion of (1- C)leucine was measured 
for each infusion by immersing the infusate syringe needle tip directly 
into a series of scintillation vials each containing 10 mis of 
scintillant (Triton X/toluene 1:2 v/v with 0.5% 2,5 diphenyloxazole) 
for an exactly determined time interval, and the rate in DPM/hour 
determined.
2.1.4. Measurement of specific radioactivity of leucine in plasma
Blood samples were usually taken from a forearm vein, via an 
indwelling intravenous cannula thus facilitating repeated sampling, 
even with the subject remaining asleep. Once it was anticipated that 
plasma leucine specific activity had achieved plateau (usually about 
6 hours after commencement of infusion) , 10 ml blood samples were 
taken hourly or even more frequently, transferred to heparinised 
tubes, immediately plunged into ice, and as rapidly as possible spun 
in a refrigerated centrifuge, the plasma being retained and stored 
frozen.
The plasma samples were prepared in the following manner, for 
measurement of leucine specific radioactivity. The plasma proteins 
from a known volume of plasma (3.0 ml), were precipitated with 
1 ml of 10% perchloric acid, then spun and separated off, and the pH 
of the retained supernatant readjusted to approximately pH 4 with 
10% potassium hydroxide. After allowing this to stand cold for an 
hour, it was centrifuged, the supernatant freeze dried, and subsequently 
reconstituted to 0.9 ml with pH 2.2 citrate buffer. The sample was 
then loaded on to an automated amino acid analyser (Locarte Ltd, London) 
and an accurately measured proportion of the column effluent diverted 
by a stream splitter and fraction collector. The fractions containing 
the leucine peak were transferred to glass scintillation vials, a
14
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lO ml aliquot of 'Tritosol' scintillant (0.3% 2,5-diphenyloxazole in 
a mixture of ethanediol/ethanol/Triton X 100/xylene in v/v proportions 
of 1:2.9:6.9:10.8) was added, and the vials counted for radioactivity 
in one of three available liquid scintillation counters (Beckman LS 150, 
Packard 2420, and a Nuclear Chicago Delta 300). In this way the 
plasma leucine specific activity was measured, for each sample. 
Furthermore, by adding 0.4 pinoles of cycloleucine to the initial 
3.0 ml of plasma and measuring its proportional recovery from the 
amino acid analyser, plasma leucine concentration (and hence pool size) 
was estimated for some subjects.
2.1.5. Measurement of specific radioactivity of expired CO^
The rate of leucine oxidation can be estimated, as outlined in
14the Introduction, by measuring the rate of expiration of CC^. This
14was achieved by measuring the proportion of CC^ in expired CO^ (ie. its 
specific activity) , and the rate of total CC>2 production.
The specific radioactivity of expired CO^ reaches a plateau value 
soon after plasma leucine reaches its plateau specific activity (Fig. 2.1). 
Subjects filled a 2 litre polythene bag with expired breath, and this 
was then bubbled into 3.0 mis of 1M hyamine hydroxide/ethanol solution 
(1:2, v/v) with 0.1% phenolphthalein as indicator (Kaihara & Wagner, 1968) 
in a glass scintillation vial, until the solution became colourless, 
indicating saturation of the hyamine with breath C02. For each leucine 
Infusion, a nev; batch of scintillation vials, each containing 3.0 mis 
of freshly mixed solution was prepared, and several vials were titrated 
against 0.15N HC1 to determine the mean molar combining affinity for 
Co2 per vial.
T
36
DPM/pmole of 
Plasma Leucine
„ • , 14„„Expired CO2 as
% of Infused
TIME
14FIGURE 2.1. The rise to plateau of plasma (1- C)leucine specific activity (•), 
and percent of infused (1-14C)leucine appearing as (^). The changes in the
plateaux result from feeding and fasting. (Patient F.B.)
An aliquot (10 ml) of scintillant (0.4% 2,5-diphenyloxazole in 
toluene) was added to each CO^-saturated vial, and the radioactivity 
measured by counting in one of the three available liquid scintillation 
counters. Appropriate quenching correction factors were applied, 
quench curves for each machine being periodically checked using 
external standards. Thus each vial contained a known molar quantity of
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CO^ and its specific activity (DPM/mole CO^) was calculated. Once 
at plateau the respiratory CO2  specific activity was measured at 
half hourly intervals.
2,1.6. Measurement of total CO  ^production (and uptake)
The rate cf CC^ production was initially measured using a mouthpiece 
and valve connected to an 80 litre polythene bag and in this way 
the subject's expired air was collected over timed intervals on several 
occasions during the infusion period. The collection bag was expelled 
into a Morgan Mobile BMR System (containing an Analytical Development 
Co. 854 dual range infra-red CC> 2  analyser, a Servomex OA272 oxygen 
analyser, and a Parkinson Cowan CD4 gas volume meter fitted with 
photo pulse generator) and gas volume, percent CO2  and percent were 
determined. A variant of this technique involved the subject breathing 
directly through a Max Planck respirometer to determine total 
expiratory rate, and simultaneously collecting several small (2 litre 
bags) samples of expired air for COj and analysis.
This whole approach proved most unsatisfactory. The awareness 
and discomfort of mouthpiece and valve were shown to cause marked 
overbreathing and high CC^ output values, distinctly unrepresentative 
of the subject's steady state C02 output (see Fig. 2.2). In additicn 
the polythene bags were found to be significantly permeable to CO2  
(Fig. 2.3).
These problems were overcome by developing a ventilated tent system 
that allowed the patient to sit, lie, relax, talk, eat, watch T.V., or 
even sleep, and yet simultaneously have continuous measurement of CO2  
output and C> 2 uptake rates. This system is shown in operatioi, in the
accompanying photographs
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FIGURE 2.2. CC>2 output, as influenced by the respiratory gas collection 
systems, measured in the same patient (M.B.+ age 43). The ventilated 
tent value (10.17 1/hr) is designated lOO %.
A ventilated tent (10.17 1/hour)
B ventilated hood (10.70 1/hour)
C valve & Douglas bag (13.78 l/hour)
percent
% co2
FIGURE 2.3. Moan (± S.D.) percentage concentration of C02 in 
5 polythene gas collection bags (2 litre), initially filled with 
standard 0.400% COj.
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The great advantages of this system were only fully appreciated 
when investigation of diurnal patterns of protein turnover and energy 
metabolism were commenced (see Results 2). A major limitation in past 
studies where estimations of protein oxidation or energy expenditure 
have been attempted, has often been the inability to obtain accurate 
measurements or collect samples representative of 12 hours or 24 hours 
CC>2 output and uptake. Our leucine infusions were prolonged up 
to 40 hours, and yet C02 output and 02 uptake were able to be monitored 
almost continuously throughout. Furthermore it was the development 
of this facility that made it possible to investigate compartmentation 
of energy metabolism on a diurnal basis, as described in Part B of 
this thesis.
The system (see Fig. 2.4) consisted of an oxygen tent set up 
around the subject's bed, and connected by corrugated piping, to a 
mixing cone, the CD4 gas volume meter, a 2-way valve, and finally to a 
high pressure 4MS-8 centrifugal blower motor (Air Control Installations Ltd, 
Chard, U.K. ) . A sampling pump withdrew air from the mixing cone, 
circulated it through the C02 and C>2 analysers, and returned it to the 
inlet of the CD4 gas volume meter. As well as a digital readout 
facility for rate of gas flow, COj concentration and 02 concentration, 
these outputs were also fed into a multichannel pen recorder, for 
continuous monitoring of these parameters.
The high pressure 4MS-8 electric blower motor was chosen because 
it sucked air at a constant rate of seme 4000 litres/minute. A 2 — way 
valve on the input side of the motor acted as a controlled Y-junction 
so that the required flow rate through the system (usually set at about 
70.0 1/minuto) camo through one arm of the valve, and room air (ie. at 
some 3,930 1/minute) came through the other arm. By operating the
2-way valve in this manner so that the required flow rate through the
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The (1 - 14C)leucine infusion system and ventilated tent system in operation.
A. Daytime
B. Night-time ('Control' colleague Prof. R.W.S.)


BFIGURE 2. . The Ventilated Tent System
AA
B
C
D
E
F
G
H
I
J
K
Patient in ventilated tent 
Mixing/Sampling cone 
Infra-red C02 Analyser 
Sampling line pump 
Paramagnetic 02 Analyser 
CD4 Gas Volume meter 
Photo pulse generator 
Flow-rate control valve 
High Pressure 
Multichannel pen recorder
x Main line flow from 
tent
y Sampling line 
z Room air intake 
X+Z Total out*flow
blower motor4MS-8 Centrifugal
C02/Voluma/02 Digital display
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system was only a very small proportion (approx. 1.75%) of total flow 
through the valve and blower motor, extremely constant flow rates 
were achieved.
It became apparent that constancy of flow was crucial to precision 
of results, as total COoutput is calculated as a product of the 
system's ventilation rate and the small percentage changes in C02 
concentration. Earlier use of rheostat controlled electric motors in 
line with the system sucking 70 litres/min directly through both 
system and motor, resulted in substantial flow variability 
(eg. 70 ± 1.2 litres/minute) due to mains voltage fluctuations and 
minor resistance changes in the system itself. Use of the high 
pressure motor and 2-way valve a3 described above, dramatically 
improved this (eg. 70.0 ± 0.2 litres/minute) with a coefficient of 
variance of only 0.16%.
The CD4 gas volume meter with photo pulse generator allowed 
accurate monitoring and continuous recording of this constant flow 
rate. It had been found that a flow rate of about 70 litres per 
minute adequately ventilated the tent for comfort, yet still permitted 
sufficiently large changes in and C02 concentrations in the room 
air as it passed through the tent, for accurate measurement. The output 
signals from both C02 analyser and analyser were amplified so that 
a full scale pen deflection on the multichannel pen recorder represented 
only a 1.00% change in absolute concentrations of and CC>2 from room 
air. This permitted excellent precision and enabled the continuously 
monitored 02 and COpercentages in the ventilated air to be measured 
within 1 .005% (absolute) of a mean.
After trying various hoods and helmets, it was found that an 
oxygen tent with a volume of approximately 1000 litres produced the 
best results, being large enough for both complete patient comfort and
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damping of respiratory fluctuations in O2 and CC>2 concentrations, yet 
small enough to produce accurately measurable changes in and CC>2 
leve Is when the tent was ventilated at about 70 litres/minute.
Immediately prior to each infusion, and every 6 hours during 
an infusion, the CO2 analyser was calibrated against a 0.50% CO2/
99.50% N2 gas mixture (British Oxygen Company - Special Gases.
Hy-line Grade analysed and certified ± 0.02% absolute).
The accuracy of the entire ventilated tent system was tested on 
a number of occasions, by burning ethanol at an accurately measured 
constant rate in the tent, and comparing the theoretically predicted 
values of 02 consumption and C02 production with those measured and 
recorded. The rate of C2H^OH combustion (measured by a Sartorius 
1212MP electronic balance) was set so that 02 consumption and C02 
production rates were similar to those in adults. The results below 
demonstrate the rather impressive accuracy (eg. only a relative 
difference of 0.31% between measured mean C02 production rate and its 
predicted value) and excellent precision (eg. C.V. of only 0.22% for 
C02 production measurement and 1.45% for 02 consumption measurement) 
achieved by the whole system.(see predicted and measured rates on 
following page).
The development and details of this system are described here in 
detail, because it was really this ability to make prolonged continuous 
measurements of rates of 02 uptake and C02 output over many hours, that 
enabled confident measurements to be made of diurnal changes in protein 
oxidation rates and hence protein synthesis rates, and that subsequently 
led to investigation of hourly and diurnal changes in deposition and 
mobilisation of fuels in energy metabolism.
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P R E D I C T E D  R A T E S
MEAN RATE C_HrOH COMBUSTION TEMP/PRESSURE THEORETICALLY PREDICTED VALUES
C02 OUTPUT RATE 02 UPTAKE RATE
g/hour °C/mmIIg litres C02/hr litres 02/hr
9.592 22°C/773mmHg 9.831 1 4.860
M E A S U R E D  R A T E S
CO„ PRODUCTION RATE 0„ UPTAKE RATE
1/hour 1/hour
at 30 mins 9.818 1 4. 904
at 45 mins 9.777 1 4. 477
at 1 hour 9.806 14.679
Mean ± S.D. 9.8 00 + 0.021 14.687 ± 0.214
C.V. 0.22 % 1.45 %
Measured Rate , „  -------------- x 100 %
Predicted Rate
99.69 % 98.8 4 %
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2.1.7. Dietary intakes and protocols
Far all infusions it was necessary to know accurately the intakes 
of leucine, protein, and energy and to ensure that they were administered 
at a constant rate over a daily feeding period. The rate of leucine 
intake had to be known for calculation of whole body protein breakdown 
rates, using Equation 3. It was important to know protein and energy 
intakes because of their influence on protein turnover - one of the 
effects investigated in this thesis. Different dietary regimes 
were therefore devised to supply planned quantities of protein and 
energy. The details of diets are summarised below, but they were 
usually either aimed at maintenance of weight (the 'Normal' Diets) or 
weight reduction in which case they contained 500 Kca 1 (2.1 MJ) and 
varying quantities of protein, depending cn the experimental protocol 
(eg. Diet P, Diet O, etc).
Most of the subjects can be classified into one of several different
experimental groups, distinguished by dietary regime and/or method of
protein turnover measurement. Their experimental protocols are shown
below, followed by details of the specific diets use.
1.'DIET O' group of obese patients (see Section 3)
The obese patients of this group were initially given a weight
maintenance diet 'Normal' Diet A or B (detailed below) over the first
1 43 days. Protein turnover was then measured by (1- C)leucine infusion
on the 3rd day, the infusion lasting 12 hours and co-inciding with
the feeding 12 hour period in which 'Normal' Diet A or B was administered
in 12 equal hourly portions. Then followed a 3 week period on Diet O,
aimed at supplying 500 Kcal (2.1 MJ) and 0 g protein per day. On the
1 420th day of this diet, a second infusion of (1- C) leucine remeasured 
protein turnover rate, again over the feeding 12-hcur period of Diet O.
20 Days 463 Days 
"NORMAL 
DIET DIET O 500 Kcal/O g Protein
C-Leucine Infusion 
12 Hours
14C-Leuome Infusion 
12 Hours
2. 'DIET P' group of obese patients (see Section 3)
These obese inpatients adhered to an identica 1 protocol to the
Diet O group except that their 3 weeks weight reducing diet was
Diet P, aimed at supplying 500 Kcal (2.1 MJ) and 50 g protein per day.
3 Days 20 Days
normal!
DIET DIET P 500 Kcal/50 g Protein
I T 1
14C—Leucine Infusion 
12 Hours 3*
\
C-Leucine Infusion 
12 Hours
3. 'DIURNAL' group of obese patients (see Section 4)
These obese patients were usually admitted for 2 or 3 days only.
On the first day resting metabolic rate was measured, and their 
daily energy intake on 'Normal' Diet A or B tailored to meet estimated
energy requirement. On day 3, protein turnover was measured by 
1 4(1- c) leucine infusion prolonged over 24 hours, including the 12-hour
feeding period in which 'Normal' Diet was administered in 12 equal
hourly portions, followed by 12 hours of fasting (ie. 'post-absorptive state').
NORMAL DIET A or B 
'■ Day 1 Day 2 Day 3
C-Lcucine Infusion 
24 Hours
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4. 'DIET O - DIURNAIi* grcup of obese patients
The protocol for this group was identical to that for Diet O
1 4grcup, except that both infusions with (1- C) leucine were prolcnged 
over at least 2 4 hours, and for some patients a protein refeeding 
regime with Diet P was commenced after 20 days on Diet O.
NORMAL
DIET DIET O 500 Kcal/O g Protein
---- Dfe ETh
t  t
14 . 14C-Leuaine Tnfuszon C-Leuavne Infusvon
24 Hours 24 Hours or longer 5
5. GLYCINE group of obese patients (see Section 5 )
Most of these obese patients initially had 3 days on 'Normal* Diet A 
or B and then a period of 3 weeks or more on cne of several 500 Kca 1 
(2.1 MJ) per day diets, including Diet O, Diet P, 500 Kcal/25 g protein, 
500 Kcal/25 g gelatin. The distinguishing ccmmcn feature was that 
protein turnover was repeatedly measured at frequent intervals using
the (15N)glycine method. In some patients protein turnover was
14 15measured simultaneously with (1- C) leucine and ( N)glycine.
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6. >CONTROLl group (sec Section 4)
These subjects were nai-cbese departmental colleagues. The 
energy intake for their 'Normal' Diet was estimated by measurement 
of each subject's resting metabolic rate one or two days prior to 
the infusion. Protein turnover was measured by simultaneous 
continuous 24 hour infusion of both (l-1 ^ C) leucine and (*5N)g lycine, 
thereby giving values far both feeding 12-hour phase, and the fasting 
(post-absorptive) 12-hour period, from two different measurement 
methods. In cue subject (R.S) protein turnover measurement was 
commenced with the night (fasting) phase first.
Day 1
flf
NORMAL DIET A or B 
Day 2
T
M R
m I m m :
j p p ^ W E ß K i N S J i ä i : ® .......
sM H M M  FASTING
UUBBBfRRflfRfo o o o o o o o o o
14,C-Leuoine Infusion
N-Glycine Infusion 
24 Hour8
IS
7. ' (1-13C, 15N)LEUCINF,' group (see Section 7)
This was also a group of departmental colleagues, participating 
in a joint study (Rennie et a 1, I960). There were 2 series of
(1-13C, 15N) leucine infusiens, the first with each subject cn a 'Normal' 
Diet, with the infusion measuring protein turnover during the feeding 
phase. For the second series the subjects were in a fasting state, 
having fasted overnight and continued their fast through the day time 
measurement period. Muse le biopsies were taken cn 2 occasions from both 
thighs during each infusion.
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Most patients began their dietary protocol with a period on
'Normal' Diet. This diet was intended to supply sufficient energy
for weight maintenance, as well as an adequate or excess intake of
protein, usually about 70g protein per day. For the earlier infusions, 
14such as the first (1- C) leucine infusion for each of the obese 
patients of Diet P group and Diet O group, the energy intake during 
the 3 days of 'Normal' Diet was arbitrarily set at 2000 Kcal 
(8.4 MJ)/day for women, and 2500 Kcal (10.5 MJj/day for men. Later 
this protocol was changed because of the presumed difference in energy 
requirements for patients with different degrees of obesity, the use 
of non-obese 'control' patients, and particularly because of increasing 
interest in energy expenditure measurements. The practice then 
adopted was to make a preliminary measurement of the resting rate 
of energy expenditure (from 0  ^consumption measurements) for each 
patient, on the first day of their 'Normal' diet, and adjust the 
energy content of the diet to equate with this. The individual values 
of the 'Normal' Diet energy intakes for each patient are given in the 
Results, but usually amounted to a daily energy intake of approximately 
1,600 Kcal (6.7 MJ).
The 'Normal' Diet was either a liquid milk-based diet ('Normal'
Diet A) formulated from 'Slender' (a commercial powdered-milk based 
food replacement product — Carnation Foods Ltd, London, U.K.), milk, 
double cream, and fruit juice, or alternatively a sandwich diet 
('Normal' Diet B) composed of bread or crackers, butter,. Cheddar cheese, 
and tomato. Most patients used 'Normal' Diet A as it was only in 
later stages that 'Normal' Diet B was developed to cope with the 
occasional patient unable to tolerate the large quantities of milk in 
'Normal' Diet A. Although the component quantitites were varied to 
supply estimated energy requirements for each patient, the following
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table gives a typical nutrient composition for the 'Normal' Diets A 
and B.
T A B L E  2 . 1 .  T y p i c a l  d a i l y  n u t r i e n t  i n t a k e  o n  ' N o r m a l '  D i e t s  A  a n d  B.
ENERGY PROTEIN LEUCINE N CHO FAT
Kcals (MJ) 9 mmoles 9 9 9
'NORMAL* DIET A 1,932 (8.08) 74.8 55.18 11.73 250.4 75.9
'NORMAL* DIET B 1,902 (7.96) 74.3 53.45 12.15 137.2 121.6
The weight-reducing diets all contained 500 Kcal (2.1 MJ) per day, 
and were designed to vary only in protein content, which was nevertheless 
accurately known. Diet P, aimed at supplying 500 Kcal (2.1 MJ) and 
50 g protein per day, was formulated entirely from skimmed milk and 
'Slender*. Diet O was composed of a glucose syrup 'Hycal* (Beecham 
Products, Middlesex, U.K.) and supplied 500 Kcal (2.1 MJ) and no protein 
each day. Occasionally other diets were supplied, particularly for 
a group of obese patients having repeated (15N)glycine measurements 
of protein turnover, and although their daily energy Intake remained 
at 500 Kcal (2.1 MJ) their protein intake was changed to 25 g protein, 
and even 25 g gelatin. These diets are detailed further in the 
relevant Results sections. The following table (Table 2.2) shows 
the composition of Diet P and Diet O.
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T A B L E  2 . 2 . T y p i c a l  d a i l y  n u t r i e n t  i n t a k e  w i t h  t h e  two m a i n  w e i g h t  
r e d u c i n g  d i e t s ,  D i e t  P and D i e t  0 .
ENERGY PROTEIN LEUCINE N CHO FAT
Kcal (MJ) g mmol g g g
DIET P 541.8 (2.27) 49.6 37.98 7.77 85.1 1.7
DIET O 504.8 (2.1) O O O 132.0 o
Whilst the energy, protein, carbohydrate, and fat composition
of the diets were calculated from food tables (McCance and Widdowson's
The Composition of Foods, Vol 3 and Vol 4), duplicate samples were
taken from all diets for all subjects, homogenised and analysed
for N by the Kjeldahl method, for fat by Soxhlet extraction method, and
for energy by bomb calorimetry. Dietary leucine was estimated by
ohydrolysis of an aliquote from the homogenate in 6N HC1 at 110 C for 
48-72 hours followed by ion exchange chromatography in an automated 
amino acid analyser using 0.1 pmol nor leucine as standard. These 
analyses confirmed the food table values used.
A significant correction, accounting for digestibility, still had 
to be applied to these intake values whether derived from food tables 
or direct analysis. This was because the intake values (I) for leucine 
or protein, used for calculation of whole body protein breakdown rates, 
needed to be the actual quantities entering the 'metabolic pool'. The 
same correction was also required for calculation of energy metabolism 
values. Appropriate digestibility factors (Watt & Merrill, 1963» 
Southgate *. Durnln, 1970) for the protein, fat, and carbohydrate content 
in each of the constituent foods in every subject's diet were applied.
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Thus the intake values of leucine, protein, nitrogen, carbohydrate, 
and fat presented in the Results sections and used for calculation 
of protein breakdown rates, and fuel and energy balances, represent 
as closely as possible the quantities immediately available for 
metabolism.
2.1.8. A correction factor for incomplete excretion of
14,
14,CO,
One of the disadvantages found in using (U- C)tyrosine as an
amino acid tracer, was that some of the labelled carbon released
14during tyrosine oxidation was not immediately excreted as C02,
but was probably recycled via fatty acid synthesis and gluconeogenesis
14before being eventually excreted. When (1- C)leucine is oxidised,
14 14the C is irreversibly removed (as C02> in the second step of the
14oxidative pathway, and the C02 excreted with expired C02. Neverthe-
14 14less it has been found that the C02 produced by (1- C)leucine 
oxidation is not completely excreted, a small proportion being retained 
probably in the bone bicarbonate pool and other pathways. Estimates 
of this proportion range from 13 - 30% (Clague et al, 1979; James 
et al, 1976; Winchell et al, 1970; Issckutz et al, 1968).
Accurate determination of the proportion of leucine flux contributed
14by leucine oxidation, requires an estimate of total rate of C02
production at the actual site of oxidation. A correction factor to
14account for the small proportion of CC>2 not excreted with expired
14CC>2 needs to be applied to the measured rate of C(>2 output. The
value of this factor can bo obtained from the proportional recovery of 
14 14CC>2 during an infusion of C-labelled bicarbonate. James et al (1976) 
showed an 80% recovery of Infused during short (10 hour)
infusion periods In 3 subjects. Very recently Claguo ct al (1979) have
obtained 86.5% recovery in 5 patients using primed dose 2-hour infusions.
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When our investigations were commenced into the possibility of 
diurnal changes in protein turnover, and infusions were extended over 
24 hours and even up to 40 hours to cover both day and night and
periods of feeding, fasting,and refeeding, it was felt that the correction 
14factor for CO^ recovery should be measured over similarly extended
periods in case diurnal metabolic changes affected its value.
14Ten C-labelled bicarbonate infusions were carried out, most 
lasting seme 36 hours to cover 3 twelve hour periods - ie. feeding, 
fasting, and refeeding. Both obese and ’control' subjects were
represented and indeed five of the subjects also belonged to groups
14of patients who had been infused with (1- C) leucine for measurement
of t.heir protein turnover rates. To exclude any dietary effect on 
14recovery of CO^, subjects were put on one of three dietary regimes,
identical to the regimes used for the protein turnover groups - ie. 'Normal'
Di et (mean « 1675 Kcal/75 g Protein) , Diet P (500 Kcal/50 g Protein) and
14Diet O (500 Kcal/O g Protein). As with the diets for (1- C) leucine 
infusions, these intakes were taken in 12 equal hourly portions over a 
12 hour period, followed by 12 hours of fasting, after which time the 
same diet was recommenced.
14For one of the subjects (R.S) the C-labelled bicarbonate infusion
was commenced at night and so the fasting 12 hour period was the first
14period for measuring the proportion of CO^ recovered.
The salient points of the infusion technique are briefly summarised
14here. A total dose of approximately 10 - 20 pCl of C-labelled sodium 
bicarbonate (Radiochemical Centre, Amersham, Bucks, U.K.) was passed 
by a 1 ml syringe and needle into a 20 ml syringe filled with N-saline 
which already contained approximate)y 5 mmol of sodium bicarbonate. This 
solution was sterilised using a 0.22 pm milllporc filter and infused 
usi.ng a syringe pump and Tekmar T92H Volumetric Infusion Pump, as
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described for the (1- C) leucine infusions. The rate of COj output
was measured by the ventilated tent system described earlier, and
CO^ specific radioactivity was estimated by liquid scintillation
14counting. Thus the rate of CO^ output could be expressed
14as a percentage of rate of C-labelled bicarbonate infusion.
14The percentage recovery of infused C-bicarbonate is shown 
in the results below. In each subject measurements were usually made 
hourly throughout the entire infusion, but the results below show 
the mean values for each 12 hour period for each subject
14
1 4  -T A B L E  2 . 3 . Mean p e r c e n t  r e c o v e r y  o f  i n f u s e d  H C O ^  d u r i n g  f e e d i n g ,  f a s t i n g  
a n d  r e f e e d i n g  1 2 - h o u r  p e r i o d s ,  f o r  s u b j e c t s  o n  d i f f e r e n t  d i e t a r y  r e g i m e n s
SUBJECT 0=0bese DIETARY MEAN % RECOVERY OF INFUSED H^COl
C=Control REGIMEN 
SEX F/M Kcal/Protein 
per 24 hours
Feeding Fasting Refeeding 
12 Hours 12 Hours 12 Hours
A.'NORMAL' DIET GROUP
87.1 % 91.2 % 92.8 %
90.7 % 97.1 %
90.2 % 93.8 %
95.7 % 103.7 %
80.4 % 90.7 % 93.2 % 
84.2 % 88.7 %
88.8 % 93.5 % 91.6 % 
± 5.6 ± 6.5 ± 2.5
R.P. O f 1300/ 71 
M.B. O F 1400/ 72 
R.S. C M 2500/80 
M.L. O F 1550/77 
M.M. O M 1600/79 
G.C. 0 F 1700/70
MEAN ± S.D.
B.DIET P GROUP
87.0 % 88.2 % 86.7 %A.G. O F 500/50
C.DIET O GROUP
90.1 % 99.4 % 94.2 %
81.2 % 92.1 %
91.0 % 85.8 % 92.4 %
87.4 % 92.4 % 93.3 % 
t 5.4 ± 6.8 ± 1.3
M.L. O F  500/0 
M.W. O F  500/0 
E.S. O F  500/0
MEAN ± S.D.
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For each of the 3 feeding/fasting phases, there was no statistically 
significant difference between the mean values of the 3 dietary groups.
Combining the values for all 10 subjects for each 12 hour 
phase (Table 2.4) indicates a constant proportional recovery over the 
whole 36 hour period.
14 -T A B L E  2 . 4 . Mean p e r c e n t  r e c o v e r y  o f  I n f u s e d  H C O g  f o r  a l l  1 0  S u b j e c t s
FEEDING 12 hrs FASTING 12 hrs REFEEDING 12 hrs
MEAN % RECOVERY 
± S.D.
88.2 % 
± 4.9
92.6 % 
± 6.1
91.3 % 
± 2.9
Paired t-testing showed no significant difference between these
mean recovery rates apart from the comparison between feeding and fasting
periods which showed 0.01<p<0.05. It seems unlikely that this is a
genuine difference, particularly since the refeeding period value of
91.3% is not significantly different from either of the other periods.
14The mean value of the percentage recovery of infused H CO^ > calculated
from all subjects in all phases, is 90.7% (standard deviation ± 5.3),
14indicating a mean loss of 9.3% of infused C, into bone or other 
metabolic pathways.
14 13It can be concluded that when (1- C)leucine (or (1- C)leucine)
14 13is infused for measurement of protein turnover, 90% of C02 (or COj) 
produced from decarboxylation of the leucine keto acid (2-keto isocaproate) 
is excreted and can be measured, 10% being retained in the body, probably 
mixing with the bicarbonate pools of bone or other pathways.
Consequently, a correction factor of 100/90 has been applied to 
all the measured rates of 14C02 output in the results in this thesis,
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as it is an estimate of 14CC>2 production rate in the metabolic pool 
that is required for calculation of valid leucine oxidation rates.
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2.2. ( N)GLYCINE - AN EXCRETED END PRODUCT METHOD
14Although development and use of the (1- C) leucine constant 
infusion method has been the mainstream of protein turnover investigation 
in this thesis, some measurements were also made using (^N) glycine,
particularly for comparative purposes. It initially became clear, using 
14(1- C)leucine constant infusions, that the level of dietary protein 
intake could significantly affect whole body protein synthesis, at 
least over a number of weeks. Consequently it was decided to measure 
protein turnover using (^N)glycine, as this not only offered an 
alternative and independent (ie. an excreted end-product method) estimate
of protein turnover which could confirm the changes shown with the 
14(1- C) leucine method, but being a stable isotope it had the advantage 
of being able to be administered on numerous occasions (eg. every two 
days) and could therefore be used to monitor just how rapidly any dietary 
induced changes in protein turnover occurred.
Principles involved in the use of a urinary excreted end-product 
method, the choice of end product, and the choice of isotope administration 
technique (ie. single dose, multiple dose, constant infusion, etc), have 
been mentioned earlier and are discussed in detail by Waterlow, Garlick 
and Millward (1978) in their book Protein Turnover in Mammalian Tissues 
and in the Whole Body. The practical aspects of how (15N) glycine was 
administered and the abundance of 15N in a urinary end product measured 
for these patients, require a brief outline.
In a number of both obese and control subjects, simultaneous measure­
ments of protein turnover were made by both (1-^C) leucine constant 
15 15infusion, and ( n )glycine, where the dose of ( N)glycine was admin­
istered in a number of different ways. These studies, using two 
simultaneously administered Independent methods, not only confirmed the
15
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changes in whole body protein turnover induced by different levels of
dietary protein over a number of weeks, but allowed a comparison of
different administration techniques for (^N) glycine. The following
14techniques were used, each case having a (1- C) leucine infusion 
at the same time:
- continuous I.V. infusion (^N) glycine;
- multiple oral dose (15N)glycine;
- single I.V. dose (*5N)glycine ;
- single oral dose (^^N)glycine.
When (^N)glycine was used to measure protein turnover on
numerous and repeated occasions in the same subject (without a 
14simultaneous (1- C)leucine infusion) , the dose was usually administered 
by oral or intravenous single dose technique.
Continuous intravenous infusion of (^^N)glycine
An accurately weighed quantity of (^N)glycine (usually about 
300.0 mg of (15N)glycine, 95.2 atoms % excess, from Prochem Division of 
British Oxygen Co, London, U.K.) was dissolved in an accurately measured 
volume of an N-saline solution, which already contained the required 
total dose of ( l - ^ 4 c ) leucine dissolved in 2.5 ml of an amino acid mixture.
This infusate was sterilised using a 0.22 vim millipore filter, and
14infused by syringe pump and infusion system, as described for (1- C) leucine 
infusions. The accurately known infusion rate was approximately 
1.0 mg 15N (and 1.5 pCi (1-14C) leucine) per hour for most subjects, and 
for this group of subjects all infusions were of 24 to 30 hours duration, 
covering a 12 hour feeding phase and a 12 hour fasting phase.
A 'pretest' urine sample was taken immediately before the commence­
ment of the infusion, and during the infusion urine was collected at
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FIGURE 2.5. Control subject ( J . C . W . ) :  Protein turnover measured over
1424 hours, with both (1- C)leucine I.V. infusion method 
(^N)glycine I.V. infusion method
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accurately time intervals, usually hourly during waking hours, and
every two hours during the sleeping phase. The abundance of in
urinary ammonia was measured (detailed below), its rise to plateau
noted (see Fig 2.5) and then subsequent values used to calculate
a plateau mean (S) for the abundance. The flux (Q) could then be
estimated, in an exactly analogous calculation to that used for 
14(1- C)leucine, (ie. Equation 1). The total urinary N excretion over 
24 hours was taken to represent 24 hour protein oxidation (E), so that 
values of protein synthesis (Z) and breakdown (B) could be calculated,
the units being in grams of N per day. Figure 2.5 shows the plateaux
15 14achieved by N abundance in urinary NH^ , plasma f C)leucine specific
14activity, and the proportion of infused ( C)leucine (and thus flux)
14excreted as respiratory C02 in subject J.C.W. having protein turnover
15 14measured simultaneously by ( N)glycine and (1- C)leucine methods.
15.Multiple (hourly) oral doses of ( N)glycine
15As a more convenient alternative to constant infusion, ( N)glycine 
was given orally at an accurately known rate of about 2.0 mg per 
hour, for 14 hours. The calculation of flux, synthesis and breakdown, 
from plateau values of abundance in urinary ammonia was the same as
for constant intravenous infusion techniques.
Single dose of (15N)glycine (Intravenous, oral)
The single dose method used has been described in detail by Waterlow 
et al (1978). For Intravenous administration, an accurately weighed 
quantity of about 100 mg (15N)glycine was dissolved in 22.0 ml of N-saline, 
sterilised by Millipore filtration, and 20.0 ml of this solution 
administered by syringe pump over a 1 hour period. When administered 
as a single oral dose, the same quantity of isotope was dissolved in
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water and consumed as a bolus. Urine was collected immediately prior 
to administration of isotope, and used to measure the pretest abundance 
of 15N for that subject. Initially urine was collected over 2 time 
intervals, 0 - 1 2  hours and 12 - 24 hours after the isotope was 
given. As the results from different methods emerged,the urine 
collection endpoint was changed from 12 hours to 9 hours, so collection 
intervals were made 3 hourly over the first 9 hours and a final 
'9-24 hour' sample.
The flux of N (Q in g N/24 hours) was calculated from the equation 
described by Waterlow et al (1978) (Equation 11 in Introduction):
o
E q u a t i o n  1 1
where d 
at time 
ammonia
is the dose of given, S^_ the abundance of in ammonia
t, and S the weighted mean of the 15N abundances in urinary 
in the time urinary samples over the collection period T hours
(ie. )
Chemical estimations
These were routinely but meticulously done by Miss Hilda Sheppard, 
and included analysis of most urine samples for total N, NH^, creatinine 
and abundance, as described by Golden and Waterlow (1977). Total
urinary nitrogen was measured by the micro-Kjeldahl method with distillation 
with a Markham still into 2% (w/v) borate. For NH^ quantitation urine 
was made strongly alkaline and the NH^ collected into boric acid by 
aeration. After titration the NH^ was redistilled into 0.1 N HC1, and
t;'
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'
the distillate assayed for abundance by the method of Sprinson
i
and Rittenberg (1949) , with a single collector MS20 mass spectrometer 
(AEI Scientific Apparatus Ltd, Manchester, U.K. ), Samples usually 
contained between 0.01 and 0.2 atoms % excess of in urinary NH^.
These measurements of protein turnover, as part of a collaborative
study with Professor J.C. Waterlow and Dr P.J. Garlick, were used
15 14to compare the ( N )glycine/NH^ end product results with (1- C) leucine
results, to monitor the time-course of adaptive changes in protein
turnover in response to diet, and to compare the validity of different
dose-administration techniques of (15N)glycine. The results are
presented in Section 5.
/
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2.3. PRESENTATION OF RESULTS
Throughout this thesis protein turnover results are usually 
expressed in grams of protein per 12 hours. In the literature, 
a number of protein-related units are used, including grams of 
protein, grams of protein/Kg body weight, grams of N, millimoles of amino 
acid, but in most cases the rates are expressed over a time interval 
of 24 hours. The results in this thesis show that this is mostly 
unsatisfactory, and results expressed in terms of 'protein-units' 
per day, are often far from the actual quantity of 'whole-body protein' 
likely to be synthesised or broken down over 24 hours. This is because 
most methods measure protein turnover rates over a small portion of the 
24 hour day, and these rates are then assumed to be representative of 
24 hour rates.
This thesis demonstrates that whole body protein synthesis is 
acutely sensitive to dietary intake, and hourly rates of protein 
synthesis depend on hourly rates of protein intake. It becomes 
clear that protein turnover rates measured during a feeding phase 
are very different from post absorptive (fasting) rates, and not at 
all representative of genuine rates over a normal 24 hour day.
Our experimental protocols have been designed so that the 24 hour 
day is divided into a 12-hour feeding phase and a 12-hour fasting 
(post-absorptive) phase and although this is somewhat artificial, it 
allowed food intake to be administered at a constant rate in 12 equal 
hourly portions, the constant intake being necessary for valid protein 
turnover measurements. The results showed remarkably different 
turnover rates in both these phases, indicating that protein turnover 
should cither be expressed as an hourly rate, or as a representative rate 
for each of the rates for the 12-hour feeding or 12-hour fasting phases.
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The 12-hour rates seemed easier to conceptualise, and hence results 
are usually expressed for this period. Twenty-four hour rates can then 
be calculated ns a summation of the two different 12 hour rates.
Although results are expressed as grams of protein per 12 hours, 
measurements are actually made in terms of pmoles of leucine per hour 
for the leucine constant infusions, and grams of N per urine collection 
period (eg. 9 hours) for (^N)glycine measurements. However, it is 
protein metabolism that we are fundamentally interested in, rather 
than leucine metabolism, so results are converted into terms of 
'whole-body protein'. An accurate conversion would actually require 
knowledge of the leucine content, the quantity, and turnover rate 
of every individual body protein, clearly quite unknown at present.
Thus the assumption that the factor of 8% can be used as the leucine 
content of total body protein (Block & Weiss, 1956) introduces an 
unknown error.
Because rates of flux, synthesis, breakdown and oxidation are 
all expressed in terms of 'whole-body protein', a discrepancy appears 
to arise because in these terms protein breakdown (B) does not 
mathematically equal the difference between flux and Intake (ie. Q - I) . 
This is because the leucine content of dietary protein always differed 
from the 8% of 'whole body protein', and was usually between 9.6% - 10.0%. 
The dietary protein was thus a different protein from 'whole-body protein'. 
Nevertheless, results were always calculated in terms of pmoles of 
leucine, and in those terms there was no such discrepancy, and 
Q » Z  + E -  B + I .  Results for Q, Z, B, and E are thus presented in 
terms of 'whole body protein' (containing 8% leucine) whilst intake I 
is expressed as true dietary protein (with measured leucine content, 
usually between 9.6% - 10.0%).
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The results also show that protein turnover iii adults seems 
to be unrelated to body weight, and no advantage is gained by expressing 
them in terms of grams protein/Kg body wt/12 hours. The following 
table (Table 2.5) shows the coefficients of variation for flux 
measurements in both obese and control patients.
T A B L E  2 . 5 . C o e f f i c i e n t s  o f  v a r i a t i o n  f o r  mean f l u x  r a t e s ,  f o r  a g r o u p
o f  1 0  o b e s e  p a t i e n t s  a n d  5 c o n t r o l  p a t i e n t s ,  e x p r e s s e d  as g / d a y  a nd g / K g / d a y .
% COEFFICENT OF VARIATION FOR MEAN FLUX RATES (Q)
For Q in 
g Protein/24 hrs
For Q in
g Protein/Kg/24 hrs
CONTROL GROUP
OBESE GROUP
1 2 . 1 1  %
10.28 %
12.92 %
13.28 %
James et al (1976) reached the same conclusion in their measurements
of protein turnover in 6 normal subjects. They also expressed results
40as a function of lean body mass (measured by K), and as a function 
of metabolic rate (uptake of O^), but found their best coefficient of 
variation with results expressed in grams protein/day (see Table 2.6).
T A B L E  2 . 6 . C o e f f i c i e n t s  o f  v a r i a t i o n  f o r  t h e  mean p r o t e i n  s y n t h e s i s  r a t e  f o r  
a g r o u p  o f  6 n o r m a l  s u b j e c t s ,  e x p r e s s e d  i n  4 d i f f e r e n t  w a ys  ( f r o m  J a m e s  e t  a l  1 9 7 6 ) .
FOR MEAN RATE OF PROTEIN SYNTHESIS EXPRESSED AS
% Coefficient of 
Variation
g/day g/Kg/day g/kg LBM/day Kg protein/1 of 02
12.2 % 1G.7 % 15.20 % 21.2 %
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They therefore concluded that variations in protein synthesis rates 
seemed unrelated to anthropometric or physiological indices commonly 
used in metabolic studies, and as our measurements also confirmed this, 
the results presented in the following sections are whole body 
measurements,simply expressed as grams of protein per 12 hours.
These studies have generated a large amount of individual 
patient data, and the majority of those data have been tabulated in 
a series of Appendices at the back of the thesis. In the Results 
Sections the mean values for different experimental groups have been 
presented, as it was felt that the significance of both absolute 
values and relative changes in protein turnover, could best be 
appreciated in this form.
SECTION 3 PROTEIN INTAKE AND PROTEIN TURNOVER
RESULTS 1
DISCUSSION 1
6G
RESULTS 1
It was the remarkable data of Sender et al (1975) that prompted
the planning of this first series of protein turnover measurements.
14They used L-(U- C)-tyrosine infusions to measure protein turnover in 
5 obese women before and after a 3 week diet of only 300 Kcal/day of 
glucose syrup (1.3 MJ, O protein), and demonstrated a halving of the 
rate of protein synthesis and a 60% fall in the oxidation rate of 
tyrosine. They concluded that this effect was a marked adaptive 
process in response to restriction of both dietary protein and energy.
Although there have been many past studies investigating the effect 
of dietary protein and energy on nitrogen balance, relatively few 
have tried to measure the effect of diet on whole body protein 
synthesis and breakdown. Where this has been attempted, an tracer
has usually been used (eg. Tschudy et al, 1959» Kassenaar et al, 1960» 
Picou & Taylor-Roberts, 1969), and results have usually suggested 
that energy content, but not protein content, influenced the rate of 
protein synthesis. Yet the data and conclusions of Sender et al (1975) 
were in marked contrast to this.
It was consequently decided to examine some of the effects of 
dietary protein and energy on whole body protein metabolism, to 
ascertain whether adaption does occur in response to a prolonged period
of low protein and/or low energy intake, and if so its nature, extent
14and timing. The suggested superiority of (1- C) -leucine as a 
tracer (James et al, 1976), still largely untested at that time 
(apart from a study on 4 patients by O'Keefe et al, 1974), made the
l-*4C-leucine infusion method the method of choice for those studies, 
thereby avoiding the 2 notable disadvantages of incomplete oxidation 
to 14cOz and an unknown contribution to flux from other pathways,
C9
phenomena found to occur with (U- C)tyrosine infusions.
It was planned to initiate this study by repeating the work of
14Sender et al (1975), using (1- C)leucine, in an attempt to confirm 
their findings of a marked decrease in whole body protein synthesis 
and oxidation in response to a prolonged low energy/protein-free diet.
The study would then continue using an altered dietary protocol so 
that results might indicate whether the low protein intake, the low 
energy intake or a combination of both was responsible for the protein 
turnover changes.
Obese patients, admitted to our metabolic beds for a period
of inpatient weight reduction, were all initially maintained and
stabilised for 3 days on 'Normal' Diets A or B, as detailed in Section 2
(Methods and Techniques)»designed to meet energy requirements, and
supply about 70 g Protein (accurately known) per day. They were
then allocated into one or other of two low energy diet groups - Diet O
(supplying approximately 500 Real (2.1 MJ) and no protein each day),
or Diet P (supplying approximately 500 Real (2.1 MJ) and 50 g protein
each day), and were kept on these diets for 3 weeks. The composition
details of 'Normal' Diets A & B, Diet O and Diet P are given in
Methods and Techniques section. Whole body protein turnover was measured
on two occasions in each patient, initially on day 3 of the 'Normal'
Diet, and finally after 3 weeks on either Diet O or Diet P, whilst still
14on that diet. In these measurements (1- C)leucine was infused over 
12 hours (9 am - 8 pm), and the daily dietary intake was also administered 
hourly over this period, in 12 equal portions.
Originally there were 5 patients allocated to Diet 0 group 
(500 Rcal/O protein for 3 weeks) , but with subsequent investigation of 
diurnal changes in protein turnover (3ee next section: Results 2), a 
further 4 patients wore added to this group Except for a slightly
14
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lower daily energy intake in the 3 weeks weight reduction phase 
(ie. 300 Kcal/day) the dietary regime used by Sender et al (1975) 
was identical to that of our 9 patients in the Diet O group.
It was therefore hoped that the results from the Diet O group would 
confirm and quantitate the "adaptive changes", suggested by Sender 
et al (1975) , in both protein synthesis and oxidation. The results 
from the Diet P group should then indicate whether the presence or 
absence of dietary protein can significantly influence rates of protein 
synthesis, oxidation and breakdown, at least at a low energy intake 
of 500 Kcal/day.
The following tables show the mean values for anthropometric 
features of the two groups of obese patients. The values for the 
individual patients are tabulated in Appendix 1.1. (Diet O group) 
and Appendix 1.2. (Diet P group).
T A B L E  3 . 1 .  M ea n v a l u e s  o f  d i e t a r y  a n d  a n t h r o p o m e t r i c  c h a r a c t e r i s t i c s  
f o r  p a t i e n t s  i n  t h e  D i e t  0 g r o u p .  ( S e e  A p p e n d i x  1 . 1 . ) .
Mean D a i l y  D i e t a r y  1 
I n t a k e  a n d  D u r a t i o n  J
1 7 8 2
4 8 4
K c a l / 6 7  g P r o t e i n  
K c a l /  0 g P r o t e i n
f o r  3 
f o r  20
D a y s
D a y s
N o  S E X A G E
( Y r s )
H E I G H T
(c m )
I N I T I A L
W EIG H T
( K g )
%
I D E A L  WT 
(% )
W H G H I - L O S .S _  
T O T A L  p e r  D a y  
( K g )  ( g / d a y )
M E A N  ± S . D .  9 8 F 5 0 . 7 1 6 2 . 7 9 7 . 9 1 5 9 . 8  % 6 . 4 321
1M ± 6 .6 ± 5 . 1 ± 1 0 . 7 ± 1 5 ± 1 . 0 ±4 8
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T A B L E  3 . 2 . Mean v a l u e s  o f  d i e t a r y  and a n t h r o p o m e t r i c  c h a r a c t e r i s t i c s  
f o r  p a t i e n t s  i n  t h e  D i e t  P g r o u p .  ( S e e  A p p e n d i x  1 . 2 . ) .
Mean D a i l y  D i e t a r y  1 1 9 2 5 K c a l / 7 0  g P r o t e i n f o r  3 d a ys
I n t a k e  a n d  D u r a t i o n  J 5 1 0 K c a l / 4 8  g P r o t e i n f o r  20 d a y s
N o  S E X A G E H E I G H T I N I T I A L  % W E I G H T  L O S S
( Y r s ) (cm) W E I G H T I D E A L  WT T O T A L  p e r  D a y
( K g ) ( * ) ( K g )  ( g / d a y )
MEA N ± S . D .  4 3F 4 9 . 8 1 6 5 . 8 1 2 2 . 0 1 8 1 . 9  % 6 . 5  325
1M ± 8 . 1 ± 8 . 7 ± 3 7 . 7 ± 4 5 . 3 ± 2 . 4  ± 1 2 0
Although the Diet P group of obese patients appears, from its 
mean values, to be a little heavier than the Diet 0 group, this is 
largely because of one particularly enormous male patient (S.B. - see 
Appendix 1.2.). In fact the groups are well matched overall, and the 
t-test for sample means shows no significant difference between the 
two groups for age, height, initial weight, percent of ideal weight, 
or weight loss.
The first set of results (Table 3.3.) shows the mean values of flux 
(Q), synthesis (Z) , breakdown (B) , oxidation (E) , and intake (I) for 
the Diet O group, all expressed in grains protein/12 hours. It should 
be reiterated that results are actually measured and calculated in terms 
of pmoles of leuclne/hour, and the conversion to grams of protein assumes 
that a single factor (8.0%) can be used for the proportion of leucine 
in total body protein. This assumption is an approximation and the 
error it introduces is unknown. However, since leucine is used as 
a representative tracer for protein, the basic interest being protein 
metabolism rather than leucine metabolism, the results are presented
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T A B L E  3 . 2 . Mean v a l u e s  o f  d i e t a r y  a n d  a n t h r o p o m e t r i c  c h a r a c t e r i s t i c s  
f o r  p a t i e n t s  i n  t h e  D i e t  P g r o u p .  ( S e e  A p p e n d i x  1 . 2 . ) .
Mean D a i l y  D i e t a r y  1 1 9 2 5 K c a l / 7 0  g P r o t e i n f o r  3 d a y s
I n t a k e  a n d  D u r a t i o n  J 5 1 0 K c a l / 4 8  g P r o t e i n f o r  20 d a y s
N o  S E X A G E
( Y r s )
H E I G H T
(cm )
I N I T I A L
W E I G H T
( K g )
%
I D E A L  WT 
( * )
W E I G H T  L O S S  
T O T A L  p e r  D a y  
( K g )  ( g / d a y )
MEAN ± S . D .  4 3F 4 9 . 8 1 6 5 . 8 1 2 2 . 0 1 8 1 . 9  % 6 . 5  3 25
1M ± 8 . 1 ± 8 . 7 ± 3 7 . 7 ± 4 5 . 3 ± 2 . 4  ± 1 2 0
Although the Diet P group of obese patients appears, from its 
mean values, to be a little heavier than the Diet O group, this is 
largely because of one particularly enormous male patient (S.B. - see 
Appendix 1.2.). In fact the groups are well matched overall, and the 
t-test for sample means shows no significant difference between the 
two groups for age, height, initial weight, percent of ideal weight, 
or weight loss.
The first set of results (Table 3.3.) shows the mean values of flux 
(Q), synthesis (Z) , breakdown (B) , oxidation (E), and intake (I) for 
the Diet 0 group, all expressed in grams protein/12 hours. It should 
be reiterated that results are actually measured and calculated in terms 
of pmoles of leucine/hour, and the conversion to grams of protein assumes 
that a single factor (8.0%) can be used for the proportion of leucine 
in total body protein. This assumption is an approximation and the 
error it introduces is unknown. However, since leucine is used as 
a representative tracer for protein, the basic interest being protein 
metabolism rather than leucine metabolism, the results are presented
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in terras of protein*. Appendix 1.3. presents this set of protein turnover 
results for the individual patients in terms of vimoles leucine/hour, 
whilst Appendix 1.4. gives the individual values as grams of 
protein/12 hours.
T A B L E  3 . 3 . Mean (± S . D . )  P r o t e i n  T u r n o v e r  R a t e s  i n  9 O b e s e  S u b j e c t s ,  
m e a s u r e d  o v e r  t h e  1 2  h o u r  f e e d i n g  p h a s e ,  i n i t i a l l y  on a ' N o r m a l '  D i e t  
a n d  t h e n  a f t e r  3 w e e k s  on ' D i e t  0 *  ( 4 8 4  K c a l / 0  P r o t e i n ) .
DIETARY REGIMEN FLUX Q SYNTHESIS Z BREAKDOWN 
Grams of Protein per 12
B OXIDATION E 
Hours
INTAKE I
Normal Diet 162.7 120.4 81.8* 42.3 67.2*
(1782/67) +16 ±16 ±19.5 ±11.6 ±4.5
Diet O 81.5 74.5 81.5 7.0 O
( 484/0) ±13 ±12.3 ±12.6 ±1.3
p < .OOl p < .OOl N.S.D. p < .OOl
The magnitude of these changes in protein turnover resulting from 
3 weeks on a daily diet of 484 Kcal/O protein, can be further appreciated
*An apparent anomaly is that in grams of protein, the sum of B and I does 
not equal Q. This is because the concentration of leucine in the dietary 
protein (1) was not 8.0% (Lhe value assumed for whole body protein and 
hence used for Q, Z, B, and E). Dietary leucine was measured for each 
of the diets, and was usually between 9.6% and 10.0% of protein by weight. 
However, when the results are expressed in terms of umolos leucine 
(Appendix 1.3.), then Q = Z + E « B + I .
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when expressed as percentage of the 'Normal' Diet turnover values. 
Appendix 1.5. gives the mean of these percentage values for each patient, 
whilst Table 3.4. expresses the mean group rates similarly.
T A B L E  3 . 4 . M ean P r o t e i n  T u r n o v e r  R a t e s  f o r  9 P a t i e n t s  on ' D i e t  O ' ,  
e x p r e s s e d  a s  a p e r c e n t a g e  o f  r a t e s  o n ' N o r m a l ' D i e t .
DIETARY REGIMEN FLUX SYNTHESIS BREAKDOWN OXIDATION
Q Z B E
Normal Diet 100 % 100 % 100 % 100 %
(1782/67)
Diet O 50 % 61.9 % 99.6 % 16.5 %
( 484/0)
t Change +49.9 % +38.1 %
NO
CHANGE + 83.5 %
These results are clearly comparable with the data of Sender et al, 
(1975), slowing a large fall in protein synthesis and an even greater 
fall in the rate of protein oxidation. Particularly noteworthy is the 
completely unchanged rate of protein breakdown.
The immediate question then became one of whether the low energy 
intake or the low protein intake, or a combination of both, was 
responsible for these changes. The following tables (Table 3.5. and 
Table 3.6.) show the mean changes that occured for the Diet P group 
(before and after 3 weeks on 510 Kcal/48 g Protein per day), where 
energy intake was similarly low to the Diet O group, but an adequate 
dally intake of protein was supplied. Individual patient values are 
given in Appendix 1.6.
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T A B L E  3 . 5 .  M ea n ( ±  S . D . )  P r o t e i n  T u r n o v e r  R a t e s  i n  4 O b e s e  S u b j e c t s ,  
m e a s u r e d  o v e r  t h e  1 2 - h o u r  f e e d i n g  p h a s e ,  i n i t i a l l y  on a ' N o r m a l '  D i e t ,
a n d  s u b s e q u e n t l y  a f t e r  3 w e e k s  on ' D i e t  P ' ( 5 1 0  K c a l / 4 8  g P r o t e i n ) .
DIETARY REGIMEN FLUX SYNTHESIS BREAKDOWN OXIDATION INTAKE
Q Z B E I
Grams of Protein per 12 hours
Normal Diet 176.3 134.9 91.8 41.4 70.0
(1925/70) +27 ±28 ±26 ±4 ±5
Diet P 144.5 115.0 84.0 29.5 48.2
(510/48) ±30 ±28 ±30 + 5.6 ±0.1
p<. 02 .02<p<.05 N.S.D. p<.02
In these absolute terms, there appears to be very little change in 
protein synthesis or protein breakdown, whilst the oxidation rate decreases 
only to am extent corresponding to the reduction in protein intake. When 
these values are expressed as a percentage of the 'Normal* Diet protein 
turnover values, as in Table 3.6., the apparently minimal percentage 
chamges in protein synthesis and breakdown prompt the question of 
whether these are significant, genuine alterations of whole body protein 
metabolism, or simply measurement variability.
T A B L E  3 . 6 .  Mean P r o t e i n  T u r n o v e r  R a t e s  f o r  4 Ob ese P a t i e n t s ,  b e f o r e
a n d  a f t e r  3 weeks  on ' D i e t  P' ,  e x p r e s s e d  as a p e r c e n t a g e  o f  r a t e s  
o n  ' N o r m a l '  D i e t .  ( A l s o  s e e  A p p e n d i x  1 . 7 . )
DIETARY REGIMEN FLUX
Q
SYNTHESIS
Z
BREAKDOWN
B
OXIDATION
E
INTAKE
I
Normal Diet 
(1925/70)
100 % 100 % 100 % 100 % 100 %
Diet P 
( 510/48)
82.0 % CD Ul to <#> 91.5 % 71.3 % 68.9 %
% Change + 18.0 % + 14.8 % + 8.5 % + 28.7 % + 31.1 %
When the absolute values for Q, Z, B, and E were tested (t-test 
for difference between matched pairs) to determine statistically 
whether they had significantly decreased after 3 weeks on Diet P, 
flux and oxidation rates had both significantly changed (p < .02) , as 
expected. However there was no statistically significant difference 
between the rates of protein breakdown on Normal Diet and Diet P, and 
although in statistical terms protein synthesis rates did appear 
significantly different, the calculated probability only marginally 
achieved this status (.02<p<.05).
In fact, as many further measurements of protein turnover were 
completed (results shown in subsequent sections) and improved techniques 
rendered much better measurement precision (S.D. almost halved), it 
became clear that there was no real change in whole body protein 
synthesis, nor in breakdown, as a result of 3 weeks on Diet P, and 
this conclusion was verified by t-test.
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In summary, the following tables show the mean values of all 
protein turnover measurements for obese patients on a 'Normal' Diet 
for 3 days, on Diet P for 3 weeks, and on Diet O for 3 weeks, the 
measurements being made during the 12-hour feeding phase.
T A B L E  3 , 7 .  Mean (± S . D . )  A b s o l u t e  R a t e s  o f  P r o t e i n  T u r n o v e r ,  d u r i n g  
F e e d i n g  1 2  h r s ,  on ' N o r m a l '  D i e t ,  D i e t  P ,  a n d  D i e t  0 .
N.S.D. between those values and their respective rates for 
Normal' Diet group.
T A B L E  3 . 8 .  Mean R a t e s  o f  P r o t e i n  T u r n o v e r  d u r i n g  f e e d i n g  12 h o u r s
o n  ' N o r m a l '  D i e t ,  D i e t  P ,  a n d  D i e t  0 ,  e x p r e s s e d  a s  a p e r c e n t a g e  o f  
' N o r m a l '  D i e t  v a l u e s .
DIETARY REGIMEN No of 
PATIENTS
Q Z B E I
Normal Diet 
(1712/70.5)
19 100 % 100 t 100 % 100 % 100 %
Diet P 
( 510/48)
4 86.3 % S3.6 % 101.2 % 66.1 % 68.4 %
Diet O 
( 484/0)
9 48.6 % 60.6 % 98.2 % 15.7 % 0
When these values are tested to determine genuine changes in 
protein turnover (t-test), it is clear that flux and oxidation rates 
in both Diet P and Diet O groups have significantly decreased from 
their 'Normal' Diet values. This is only to be expected for the 
steady state situation, in which a change in dietary protein intake 
is then reflected in appropriate proportional changes in oxidation 
(and hence flux). On Diet O oxidation rate has fallen by 84.3% to 
a value of only 7.0 g Protein per 12 hours - close to obligatory 
protein loss.
However, it is the effect on whole body protein synthesis and 
breakdown that in remarkable for both Diet P and Diet O. For the 
Diet P group rates of protein synthesis and breakdown remained 
unchanged, showing no significant difference from their rates on 
the 'Normal' Diet. In complete contrast, the Diet O group showed a
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very highly significant drop in the rate of protein synthesis 
(p < .001), a decrease of some 40% below the 'Normal' Diet synthesis 
rate. Yet despite this change, protein breakdown remained completely 
unaffected.
Those results suggest that if protein intake remains adequate, 
then a substantial decrease in dietary energy intake to a level as 
low as only 500 Kcal/day (well below 40% of daily energy requirement 
for these obese patients), even when prolonged for 3 weeks, has no 
effect on whole body protein turnover.
However, the rate of protein turnover is profoundly affected 
at this same low level of energy intake, by the presence or absence 
of dietary protein, normal protein synthesis rates prevailing when 
adequate dietary protein is supplied, but a 40% drop in synthesis 
after 3 weeks of a protein free diet. In a later section (Results 3),
/
an intermediate (below requirement) level of protein intake, still 
at the same lov; energy intake, is shown to cause a proportionally 
intermediate drop in protein synthesis.
It therefore seems quite probable that the rate of whole body 
protein turnover is markedly dependant on (and directly proportional 
to) the level of dietary protein intake, particularly between zero and 
'requirement' levels, irrespective of energy intake. For protein 
intakes varying above 'requirement', protein turnover continues at 
its normal rate uninfluonced by energy intakes ranging from 
500 - 2000 Kcal/day. It is quite possible that low energy intakes 
may alter protein 'requirement' levels, and very low intakes of 
energy (ie. below the 500 Kcal/day level of these studies) may still 
possibly affect the rate of protein turnover.
Protein synthesis and oxidation rates seem to be the 2 processes
sensitive to dietary protein intalco Protein breakdown appears
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insensitive and completely unaffected by low energy and low protein 
intakes, at least over prolonged periods.
u
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DISCUSSION 1
These results are significant, because for the first time, they 
appear to demonstrate that protein intake itself has a substantial 
effect on the rate of whole body protein synthesis.
At first this appears to be in marked contrast to previous studies 
which have tended to show that protein synthesis is uninfluenced by 
varying levels of protein intake. Picou & Taylor-Roberts (1969), and 
Golden et al (1977) found no change in the rate of protein synthesis 
when energy intake was kept constant and protein intake ranged from 
0.6 to 5.2 g protein/Kg/day, in studies on children recovered from 
malnutrition. Steffee et al (1976) showed no significant change in 
whole body protein synthesis when 6 normal adults on a constant, 
adequate energy intake changed their daily protein intake from 
1.5 to 0.38 g protein/Kg/day. Both these studies tended to show an increase 
(not significant) in protein breakdown with the lower protein containing 
intakes. However, in both these studies the levels of protein intake 
were never below maintenance.
In our studies, we have also shown that when protein intake is 
varied only above maintenance levels (eg. Diet P group» 70-48 g 
protein/day H 0.61-0.42 g Protein/Kg/day) there is no effect on
whole body protein synthesis rate. However, in contrast to the trend in the above 
2 studies, we found no change in protein breakdown either.
The initial aim of this study was to repeat the lov; energy/protein 
free dietary protocol of Sender ct al (1975b), and using (1- C)leucine, 
ascertain the validity of their (U-14C) tyrosine measurements of whole 
body protein turnover. They infused their obese patients for 10 hours 
with L-(U-*4C) tyrosine, and over that period fed the appropriate diet 
in equal aliquots at regular intervals. Although their results assume 
that the measured rates are representative of 24 hour protein turnover,
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in fact their results are appropriate only for the period of feeding 
(as will be shown in Results 2). The following table (Table 3.9.) 
compares their results with those for the Diet O group of patients, 
expressing the protein turnover rates in terms of total grams of 
protein synthesised (or oxidised) over the appropriate 12-hour feeding 
period.
T A B L E  3 . 9 .  C o m p a r i s o n  o f  P r o t e i n  T u r n o v e r  R a t e s  i n  O b e s e  P a t i e n t s ,  
i n i t i a l l y  on a ' N o r m a l '  D i e t  a n d  t h e n  a f t e r  3 w e e k s  on l o w  e n e r g y  
p r o t e i n - f r e e  d i e t .  D a t a  f r o m  S e n d e r  e t  a l  ( 1 9 7 5 b )  u s i n g  L - ( U - ^ C ) t y r o s i n e ,  
a n d  t h i s  s t u d y  u s i n g  ( l - ^ C ) l e u c i n e .
Sender et al (1975b) This study
14L~(U- C)tyrosine L- (1-*4C)leucine
5 patients 9 patients
(Diet O group)
A. NORMAL DIET
INTAKE Kcal(MJ)/Protein 2000(8.4)/04 1782(7.5)/67
<v SYNTHESIS g Protein/12 hr 200 ± 61 120.4 ± 16«V OXIDATION g Protein/12 hr 44 42.3 ± 12
B. LOW ENERGY/?,ERO PROTEIN DIET
INTAKE Kcal(MJ)/Protein 300 ( 1.3 ) /CJ 484 (2.0) /0
(V SYNTHESIS g Protein/12 hr 97 ± 43 74.5 ± 12(v OXIDATION g Protein/12 hr 17 7.0 ± 1
PERCENT CHANGE
(ZN - zo ^ 100 % {51.5 % {38.1 %
<en - V ___ _ 100 % { 61.4 % {83.5 %
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Although differences in the absolute values are immediately
noticeable, both studies show large and similar proportional decreases
in loth synthesis and oxidation, as a consequence of the prolonged
simultaneous deficit of both energy and protein in the diet.
The notably higher protein synthesis rates obtained by Sender et al
(1975b) as well as the larger percentage drop in synthesis and smaller
percentage decrease in oxidation rate, are probably a result of their 
14use of L-(U- C)tyrosine, rather than the slightly lower energy intake
14 14of their obese women. Both (U- C)tyrosine and (1- C) leucine may
underestimate synthesis rates because their intracellular specific
activities are diluted by internal recycling, and tend to be lower.
than their measured plasma specific activities. However the
14disappearance of some (U- C)tyrosine into other metabolic pathways or 
body stores is another source of error which tends to underestimate 
oxidation and overestimate synthesis rates. In addition, the de novo 
synthesis of tyrosine from phenylalanine, makes it difficult to 
estimate confidently protein breakdown (James et al, 197G).
As well as confirming the changes in protein synthesis and 
oxidation that Sender et al (1975b) demonstrated with prolonged combined 
protein and energy deficit, our study has gone on to demonstrate the 
unique finding, that in these obese patients, it was largely the 
protein deficit itself that was responsible for the 40% drop in 
protein synthesis. The results clearly show that when daily energy 
intake was only 500 Kcal (2.1 MJ) for 3 weeks, so long as protein v/as 
supplied in quantities adequate for nitrogen balance (ie. 48 g protein/day) 
then both protein synthesis and breakdown remained normal. Yet if 
no protein was supplied, the rate of protein synthesis fell to only 
f.Ol of its normal value, though protein breakdown still remained
normal.
03
These data appear to imply that protein intake itself is the 
major determinant of protein synthesis rate, and that restriction of 
energy intake, at least to a level as low as 500 Kcal/day, has little 
effect on whole body protein synthesis. Marliss et al (1978) similarly 
concluded that protein supply is the principal determinant of protein 
sparing. Certainly protein breakdown appears completely unaffected 
by either protein or energy intakes, over a prolonged period.
Contrary to these findings, some previous studies have suggested 
a correlation between dietary energy intake and whole body protein 
synthesis. Sim et al (1979) demonstrated a substantial decrease in 
protein synthesis when 5 normal young men being fed intravenously, 
changed from a regime supplying adequate protein and energy (1.0 g amino 
acids/Kg and 30 Kcal/Kg of glucose) to one supplying only the protein 
but no additional energy (ie. 1.0 g amino acid/Kg, only). Protein 
breakdown did not change.
There are a number of differences that could well account for the 
apparent discrepancy between the results of Sim et al (1979) and our 
results. These include the type of subject (normal versus obese) , the
length of time (only 6 days) on the dietary regime, different measure- 
15 14ment methods ( N-glycine versus (1- C) leucine), and difference in the 
dietary regimes. However, it seems likely that the crucial difference 
is one of energy intake levels as shown below.
It becomes clear, from results presented In subsequent sections, 
that the dynamic processes of protein metabolism are acutely sensitive 
to changes in dietary intake, even from hour to hour. The hourly rate 
of protein turnover is dependant on the hourly rate of protein intake 
(below ' requirement* levels). Daily intakes simply expressed as 
Kcal/day and grams of protein/day are often completely incomparable if 
these intakes have, in fact, been delivered over different time periods 
within the 24 hours. Sim et al (1979) administered their protein and
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energy intakes continuously over 24 tours by intravenous infusion. In 
our study daily diets were administered over 12 hours, and our protein 
turnover measurements relate specifically to that feeding period.
When protein and energy intakes are expressed on an hourly 
basis it becomes clear that there is no contradiction between the 
results of Sim et al (1979) and our study (Table 3.10.). The energy 
intake of subjects in their group on amino acids only, was just 
12 Kcal/hour, substantially lower than the 42 Kcal/hour for our Diet P 
group.
Recent data from Jeejeebhoy (1977) have further helped to clarify 
and indeed neatly link all 3 studies. He has shown that the negative 
nitrogen balance in a group of 'not immediately post-operative patients', 
receiving only intravenous amino acids at a rate of 1 g/Kg/day 
(ie. 3 g Protein, 12 Kcal per hour - the same as for Sim et al ,1979), 
could be changed to nitrogen balance, simply by increasing the total 
caloric intake up to only 14 Kcal/Kg/day with the same protein intake 
(ie. 3 g Protein, 41 Kcal per hour - similar to our Diet P group intake). 
He also showed that by increasing the level of protein intake even less 
energy was necessary to achieve nitrogen balance, so that at 
2 g Protein/Kg/day (ie. 6 g Protein, 24 Kcal per hour - an identical 
protein intake to our 'Normal' Diet group) no non-protein energy was 
required at all for nitrogen balance.
It therefore seems probable that below a certain requirement level 
of protein intake, additional energy enhances the influence of protein 
intake in maintaining normal protein synthesis and nitrogen balance.
Thus at an energy intake of 40 Kcal/hour, a protein intake of 
4 g/hour maintains normal, protein synthesis, 3 g/hour still maintains 
N-bnlance (Joojoeb)oy, 1977), but 2 g/hour results in a decrease in 
protein synthesis by some 20% (Garlick, Clugston A Waterlow, 1980),
T A B L E  3 . 1 0 .  The e f f e c t  on th e  r e l a t i o n s h i p  between p r o t e i n  i n t a k e  and whole body p r o t e i n  s y n t h e s i s  
( o r  N - b a l a n c e ) ,  o f  a d d i t i o n  o f  e x t r a  e n e r g y .
DAILY INTAKE 
Kcal/g Protein
HOURLY
PROTEIN INTAKE 
g/hour
HOURLY
ENERGY INTAKE 
Kcal/hour
EFFECT ON NORMAL 
PROTEIN SYNTHESIS/ 
N-BALANCE REFERENCE
0/0 Starvation 0 0 4 48 % in Synthesis (Section 5)
484/0 Diet 0 0 40 4- 40 % in Synthesis (Section 3)
- - 1
500/25 2 41 4  20 % in Synthesis (Section 5)
280/70 I.V. Amino Acids only 3 12 + 38 % in Synthesis Sim et al, 1979
1000/70 I.V. Amino Acids + 3 41 N-Balance Jeejeebhoy, 1977
2100/70 Energy 3 100 N-Balance Sim et al, 1979
2900/70 3 128 +ve N Balance Jeejeebhoy, 1977
510/48 Diet P 4 42 Normal Synthesis (Section 3)
- - 5
560/144 I.V. Amino Acids only 6 24 +ve N Balance Jeejeebhoy, 1977
1712/70 'Normal' Diet 6 142 Normal Synthesis (Section 3)
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and 0 protein results in a 40% drop in synthesis. However without 
the addition of the extra energy, 3 g protein/hour does not maintain 
N balance (Jeejeebhoy, 197 7) but causes a 38% drop in synthesis 
(Sim et al, 1979). Table 3.10 shows these data and suggests that a 
series of curves could be drawn for different levels of energy intake, 
showing how the correlation between protein intake and protein 
synthesis is affected by the addition of extra energy. The state 
of N-balance reflects protein synthesis because on these prolonged 
diets breakdown appears to be unaffected.
All the protein turnover studies referred to for comparative purposes 
(ie. Picou & Taylor-Roberts, 1969? Golden et al, 1977? Steffee et al,
1976? and Sim et al, 1979) measured protein turnover rates with 
1S'N-glycine. It was decided to use this method on our own obese 
patient groups ('Normal' Diet, Diet P, and Diet O), as oven further 
confirmatory evidence of the remarkable influence of protein intake
on the rate of whole body protein synthesis, already demonstrated by 
14the (1- C)leucine measurements.
The following table (Table 3.11) presents the mean group values 
for flux, synthesis, breakdown, oxidation rate, and protein intake for 
6 obese patients. Initially these obese patients were on the 'Normal'
Diet described previously, then half transferred to Diet P for 3 weeks 
and the other half were on Diet O for 3 weeks. The 15N-glycine was 
administered by oral hourly multiple dose technique at an accurately 
known dosage of about 10.0 mg 1SN-glycine per hour. The plateau 
abundance of 15N in urinary Nil ^ was used to calculate flux, a method 
developed by Waterlow et al, 1978. The results for the individual
patients are given in Appendix 1.8
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T A B L E  3 . 1 1 . M e a n  (± S . D . )  R a t e s  o f  P r o t e i n  T u r n o v e r ,  m e a s u r e d  b y  
1 5m u l t i p l e  d o s e  N - g l y c i n e / a m m o n i a  e n d  p r o d u c t  m e t h o d ,  f o r  6 o b e s e  
p a t i e n t s  i n i t i a l l y  on ' N o r m a l 1 D i e t ,  t h e n  f o r  3 w e e k s  o n  D i e t  P o r  
D i e t  0 .
Q Z B E I
Dietary Regime g Protein per 12 Hours
NORMAL DIET 198.2 158.5 136.2 39.7 62.0
±30 ±37 ±30 ±7
DIET P 193.9 167.9 147.9 26.0 46.0
±21 ±41 ±18 ±20 ±4
DIET O 104.4 92.4 104.4 12 .0 0
±34 ±32 ±34 ±3
Those results, in terms of statistically significant changes, are
14identical to the findings with (1- C) leucine, even though the absolute 
values for flux, synthesis and breakdown are all a little higher with 
the 1SN measurements. On Diet P, both protein synthesis and breakdown 
show no significant change from their'Normal' Diet values. On Diet O, 
whole body protein synthesis decreases significantly (p < .05), and 
whilst protein breakdown appears to fall, its decrease is not statistic­
ally significant. With the results expressed as a percentage of their
14 ' 1 5'Normal' Diet values, it is clear that (1- C) leucine and N glycine 
give excellent agreement on the magnitude of change.
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T A B L E  3 . 1 2 . Mean r a t e s  o f  P r o t e i n  T u r n o v e r ,  m e a s u r e d  b y  ^ N - g l y c i n e / N H ^  
e n d  p r o d u c t  m e t h o d ,  e x p r e s s e d  as a p e r c e n t a g e  o f  ' N o r m a l '  D i e t  v a l u e s .
DIETARY REGIMEN Q t B E I
NORMAL DIET 100 % 100 % 100 % 100 % 100 %
DIET P 97.8 % 105.9 % 108.5 % 65.5 % 74.2 %
DIET O 52.7 % 58.3 % 76.7 % 30.2 % 0
‘ Having demonstrated these changes in whole body protein turnover
14 14with three different techniques (ie. L-(U- C) tyrosine, L-(l- C)leucine, 
and (1?N)glycine) it was felt their validity was well established 
and beyond reasonable doubt. Consideration then of the absolute 
values of whole body protein synthesis, breakdown and oxidation rates, 
and the possible significance of their changing in response to protein 
intake, immediately raised a series of fascinating questions:
- Are these particular changes a phenomenon only associated with 
obesity?
- If these changes are 'adaptive', how long docs it take for the 
the protein synthesis rate to fall to the 'adapted' level?
- What happens to protein turnover in response to diurnal feeding 
and fasting patterns - ie. are there acute diurnal changes in 
protein turnover?
- The results have shown protein oxidation rate to be only half the 
rate of protein intake during the measurement (feeding) 12 hours 
Where does the other half of the intake accumulate?
- Is there an expansion of free amino acid pools during the feeding 
phase to accommodate the accumulating 50% of protein intake,
or is there an actual expansion of body protein mass?
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The actual magnitude of the difference between oxidation and intake, 
is best appreciated in terms of leucine rather than protein. This 
is because oxidation rates are measured in terms of pmoles leucine/hour, 
and their equivalent values in terms of protein are based on the assump­
tion that leucine constitutes 8.0% of whole body protein (Block & Weiss, 
1956). Intake was also measured as ymoles leucine/hour but leucine was 
found to constitute 9.6 - 10.0 % of the dietary protein fed to these 
patients, so in fact "whole-body protein" is not strictly comparable 
with dietary protein.
The following table (Table 3.13) presents the mean protein turnover 
rates for each of the dietary groups, with the results expressed (as 
measured) in terms of millimoles of leucine per hour. The results for 
the individual patients in Diet O group are given in Appendix 1.3.
T A B L E  3 . 1 3 . Mean P r o t e i n  T u r n o v e r  R a t e s ,  e x p r e s s e d  a s  m i l l i m o l e s  l e u c i n e /  
h o u r ,  f o r  t h e  o b e s e  p a t i e n t s  on ' N o r m a l '  D i e t ,  D i e t  P ,  a n d  D i e t  0 ,  
m e a s u r e d  o v e r  f e e d i n g  1 2  h o u r s .
DIETARY REGIMEN 
(No. of Patients)
Q Z B E 
millimoles Leucine per Hour
X
NORMAL DIET inCO 6.2 4.2 2.3 m
(n = 19)
DIET P 7.4 5.9 4.3 1.5 3.1
(n *> 4)
DIET O 4.1 3.8 4.1 0.36 0
(n *= 9)
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In this form, not only is it obvious that protein breakdown has 
remained quite unchanged by Diet P or Diet O, and that protein 
synthesis is really only significantly reduced by Diet O, but the 
discrepancy between rate of leucine oxidation and intake is also clear, 
indicating that on both 'Normal' Diet and Diet P only approximately 
half the incoming dietary leucine is disposed of by immediate oxidation. 
Does the free leucine pool expand during the 12-hour feeding phase 
to accommodate half the dietary leucine, or is there really a non­
steady state with an increase in body protein mass? Is there a 
corresponding decrease in the free leucine pool, or in body protein 
mass, releasing leucine during the post-absorptive (ie. fasting)
12 hours, and thereby ensuring 24 hour balance?
The question of whether a diurnal expansion and contraction of the 
free leucine pool occurs in response to feeding and fasting is considered 
in the next section, where results of its actual measurement are 
presented and discussed.
The other obvious discrepancy is between Z and B, particularly on 
the two protein containing diets ('Normal' Diet p<.001, on Diet P p<.01) . 
At first this appears simply to reflect the discrepancy between E and 
I, since synthesis and breakdown are calculated from the relationship 
Q = Z  + E = B + I .  However, if the leucine free pool remains constant 
(or alternatively if any change in the pool can be measured and corrected 
for), then any remaining discrepancy between Z and B either implies a 
genuinely non-steady state of the protein pool and changing body protein 
mass, or an incorrect estimate of the value of flux Q, since the 
calculation of Z, B, and E, all depend on the measured value of Q. In 
fact both of these alternatives are likely.
James et al (1976) in their measurements of protein turnover with 
L-(U-14C)tyrosine, found a discrepancy between tyrosine intake (27t of
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flux) and tyrosine oxidation rate (20% of flux even after correction 
14for retained C02> and interpreted this as a' genuine expansion of 
the whole body protein pool. Indeed they calculated that the resulting 
difference between tyrosine uptake into protein synthesis (2.4 mmol/hour) 
and tyrosine release by protein breakdown (1.9 nmiol/hour), was equivalent 
to an increase in the protein pool at a rate of 3 g protein/hour.
They concluded that there must be a corresponding decrease in the mass 
of body protein "... at night when gluconeogenesis is occurring and 
amino acid oxidation continues without dietary replacement".
A very similar increase in whole body protein mass over the 
12 hour feeding period is apparent for our obese patients on the 
protein-containing diets. For the 'Normal' Diet group the discrepancy 
between Z and B indicates a mean increase in whole body protein of 
39.9 g/12 hours (ie. 3.3 g/hour), whilst for the Diet P group the 
expansion is 31.0 g protein/12 hours (ie. 2.6 g/hour). Although the 
difference between Z and B for patients on Diet O is small and not 
statistically significant, it suggests that in these obese patients, 
subjected to a 3 week diet of only 500 Kcal/day of glucose syrup, 
contraction of the body's protein pool is occurring by some 7.0 g protein 
in 12 hours (ie. 0.6 g/hour) during the glucose feeding phase.
There are 2 assumptions, not accounted for in the calculations 
above, that would affect the values of the estimated changes in protein 
mass. James et al (1976) assumed no expansion to occur in the free 
tyrosine pool during feeding, but this is probably incorrect, an there 
is a small but significant increase in the free leucine pool, as shown 
in the next section. The second assumption concerns the error Involved 
in using plasma leucine disposal rate as an approximation for precursor
pool flux.
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Golden a Waterlow (1977), in their series of 30-hour 
14(1- C) leucine infusions on 6 continuously fed, elderly patients, 
v;ere able to show that the plasma leucine specific activity method 
underestimated precursor pool flux by some 20%, assuming that protein 
oxidation and synthesis share the same precursor pool. They used 
a method independant of flux and based on leucine intake and
urinary nitrogen excretion to estimate leucine oxidation rate, and
14compared these results with oxidation rates derived from CC> 2 output 
and flux. By comparing these 2 estimates of leucine oxidation, they 
concluded from the discrepancy that, precursor pool specific radio­
activity was only about 80% of the plasma specific activity, a direct 
consequence of internal recycling in which leucine, liberated by protein 
breakdown, enters and dilutes the specific activity of the precursor 
pool and is reutilised for protein synthesis without mixing in the 
plasma compartment.
A similar underestimate of flux was probably operative in the 
measurements of flux in our obese patients on ’Normal' diet and Diet P, 
as both these groups were subjected to a continuous protein feeding 
regime over the measurement period, as with Golden & Waterlow (197/). 
However, their technique to obtain this correction requires an accurately 
known continuous dietary intake of leucine over a sufficiently long 
period so that simultaneous measurement of urinary nitrogen excretion, 
representative of protein oxidation, can be obtained. This usually 
requires a urinary nitrogen collection for at least 24 hours ( and 
hence a dietary leucine intake for the same period) , although measure­
ment of changes in urea pool size may shorten the collection period. 
Nevertheless, by modifying their technique, the underestimate of flux was 
able to be calculated in patients having only 12 hours of feeding, or on 
Diet O with no leucine intake at. all (seen in subsequent sections).
In one obese patient EE (discussed in more detail in the next 
section) , hourly feeding was continued for some 30 hours, nitrogen 
balance was measured, and plasma flux was found to underestimate 
precursor pool flux by 21%.
T A B L E  3 . M . P a t i e n t  E E ;  E s t i m a t i o n  o f  P r e c u r s o r  P o o l  F l u x  (Q^ ) and 
c o m p a r i s o n  w i t h  t h e  p la s m a  d i s p o s a l  r a t e  as an e s t i m a t i o n  o f  f l u x  ( Q p ) .
Leucine Intake N- In take N-Excretion Leucine Oxidised Leucine Oxidised
"l XN en EL " XL X V
In
(as % of Flux - 
14from COp output)
mmol/day g/day g/day mmol/day
55.18 11.73 8.15 38.34 24.2 %
Precursor Pool Flux Plasma 'Flux'
Q <- E X —  ) 
1 L 24.2 QP
°P x 100 %
mmol Ieu/day mmol Leu/day
158. 4 125.0 79 %
Any such underestimate of flux will affect the derived value of 
protein breakdown rate more than protein synthesis rate, and consequently 
any correction for the underestimate of flux will alter the calculated 
value of net protein synthesis or breakdowndlfferently (see Sections 4 and 
7). The following table (Table 3.15) shows the mean estimated increase in 
body protein mass over 12 hours of feeding, for obese patients in the
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'Normal' Diet group and Diet P group, after the measured value of flux has 
been corrected for an assumed 20'S underestimate of precursor pool flux.
T A B L E  3 . 1 5 .  T h e  mean i n c r e a s e  i n  b o d y  p r o t e i n  m a s s ,  o c c u r r i n g  o v e r  
a 1 2  h o u r s  f e e d i n g  p e r i o d ,  f o r  o b e s e  p a t i e n t s  or. e i t h e r  t h e  ' N o r m a l '  D i e t  
o r  D i e t  P .
INCREASE
g/hour
IN BODY PROTEIN MASS 
g/12 hours
NORMAI. DIET GROUP 2.4 28.7
DIET P GROUP 2.0 23.6
The issues that have emerged from this first group of results, 
polarise into 2 distinct areas for further investigation - the acute 
diurnal changes in protein metabolism, and the long term 'adaptive' 
changes.
These results have shown that during the daytime feeding 
12 hours, whole body protein synthesis, breakdown and oxidation occur 
at such rates as to produce a progressive state of protein inbalance.
Half the dietary intake of protein is stored rather than being immediately 
oxidised, there is an expansion of the body's protein mass, a possible 
expansion of the plasma free leucine pool, euid a relationship between 
plasma and precursor pools such that plasma measurements underestimate 
flux by 20%. Protein metabolism must subsequently readjust if 
24--hour protein balence is to be achieved. How values of synthesis, 
breakdown and oxidation change, whether the free leucine pool contracts, 
whether these values and phenomena of protein metalmlism are features
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peculiar to obesity, and whether circadian rhythms rather than food 
intake produce these diurnal changes - these are the immediate and 
outstanding questions that determined the protein turnover measurements 
presented in the next section (Results 2) .
The results have also shown remarkable changes in whole body 
protein synthesis and oxidation resulting from a 3 week period of 
low energy/zero protein diet. Once the validity of these changes 
was established, the questions of how much change occurred as an acute 
response, how much was an adaptive response, and how long it took 
for any such adaption to occur, were felt to merit investigation.
Investigation of these two distinct areas of the dynamics of 
whole body protein metabolism, required the use of different methods
and techniques for protein turnover measurement. Prolonged infusions 
1 4with (1- C)leucine extending over 24 hours or longer, and combined 
with continuous energy expenditure measurements, were used to investi­
gate the acute diurnal aspects of metabolism outlined above. This 
work is presented in the next section (Section 4).
The necessity to make repeated measurements of protein turnover
at short intervals, to investigate the dynamics of any adaptive changes,
14precluded the use of a radioactive tracer such as (1- C) leucine.
The excreted end-product method, using the stable isotope '^N-glycine 
with measurement of the abundance of in urinary ammonia, was
therefore used, in conjunction with a programme to develop and validate 
this technique (J.C. Waterlow & P.J. Garlick). The results of these 
measurements are presented in Section 5.
SECTION 4 a c u t e a n d  d i u r n a l c h a n g e s i n p r o t e i n  t u r n o v e r
RESULTS 2
DISCUSSION
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RESULTS 2
The previous section's results clearly imply that diurnal 
changes in protein metabolism must occur, at least in obese subjects 
on a normal daytime feeding/night-time fasting regimen. During the 
feeding 12 hours these subjects actually increased their body protein 
mass to accommodate half the dietary protein intake and so during this 
phase whole body protein synthesis was consistently operating at a 
greater rate than protein breakdown. Yet if these subjects were in 
nitrogen balance over 24 hours, then during their fasting 12-hours 
an equivalent but opposite discrepancy between synthesis and breakdown
must have occurred. James et al (1976) also concluded from their 
14(U- C)tyrosine studies that body protein mass declines at night.
Up to the present time diurnal changes in whole body protein 
synthesis, breakdown, and oxidation have remained a completely unexplained 
area of protein metabolism. Whole body protein turnover lias usually 
been thought of (and expressed) in terms of a constant daily rate, 
largely because of methodological limitations - some of the methods still 
most widely used (eg. (^N) glycine/urea end product: Picou & 
Taylor-Robcrts, 1969) take 2 - 3  days to complete a measurement, and 
the slow turnover of the urea pool also prevents the achievement of 
measurable nitrogen balance in less than 24 hours in adults experiencing 
normal daily phases of feeding and fasting. Even Sender et al (1975) 
believed that the rates of whole body protein synthesis which they 
measured represented daily rates, and they concluded that the 
halving of protein synthesis and 604 fall in oxidation which resulted 
from the 3 weeks of protein—free diet were longer term "adaptive" 
changes. Yet it seems quite possible that if protein turnover were 
acutely sensitive to protein intake, then a significant part of the
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drop in synthesis and oxidation, seen after 3 weeks on a protein-free 
diet, might occur within hours of cessation of protein intake - ie. even 
during normal night-time fasting.
A group of 6 obese patients were admitted to our metabolic beds, 
specifically for the purpose of investigating their diurnal values 
of whole body protein turnover ('Diurnal' group, as shown in Section 2, 
Methods & Techniques). In addition another 4 obese patients ('Diet O- 
Diurnal' group) undertook the same protocol before embarking on a 
weight reducing course. Appendix 2.1 contains the individual protein 
and energy intakes and anthropometric data for each patient, but the 
following table shows the mean values for this group of 10 obese 
patients.
T A B L E  4 . 1 .  Mean (±  S . D . )  d i e t a r y  a nd a n t h r o p o m e t r i c  c h a r a c t e r i s t i c s  
f o r  t h e  10  o b e s e  p a t i e n t s  ( ' D i u r n a l '  + ' D i e t  0 - D i u r n a V  g r o u p )  m e a s u r e d  
f o r  t h e i r  p r o t e i n  t u r n o v e r  r a t e s  o v e r  2 4  h o u r s .
MEAN INTAKE 1 
(over Feeding 12-hours) J
1607
72.6
± 291 
± 4.3
Kcal
g Protein
No SEX AGE HEIGHT WEIGHT % ofIDEAL WEIGHT
(yrs) (cm) (Kg) (%)
MEAN lO lOF 50.3 160.7 96.6 163.5 %
± S.D. ±7.7 ±5.3 ±14.2 ±29.6
Those lO patients were initially given a high protein/woight 
maintenance diet ('Normal' Diet)for 3 days, their individual energy 
requirements being measured as described previously. On the third 
day their whole body protein turnover was measured for at least
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24 hours, by constant infusion with (1— C)leucine, thereby covering 
the feeding 12-hour period (9 am - 8 pm), and the night-time fasting 
12-hour period (9 pm - 8 am).
The results from this group show unequivocally the changes in 
whole body protein synthesis, breakdown, oxidation, and flux, that 
occur in the course of a 24 hour period, when daytime feeding 12-hours 
changes to night-time fasting. Table 4.2 gives the mean valxies for 
the whole group. (Appendices 2.2 and 2.3 tabulate the data for individual 
patients in g Protein/12 hours and mmol Leucine/hour).
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T A B L E  4 . 2 .  Mean (±  S . D . )  p r o t e i n  t u r n o v e r  r a t e s  f o r  t h e  g r o u p  o f  1 0  o b e s e  
p a t i e n t s  on ' N o r m a l '  D i e t ,  s h o w i n g  r a t e s  d u r i n g  F e e d i n g  P h a s e ,  F a s t i n g  
P h a s e ,  a n d  t o t a l  2 4  h o u r  p r o t e i n  t u r n o v e r .
PHASE Q Z
g Protein
B
per 12
E
Hours
I
FEEDING 166.0 119.4 70.1 46.6 72.6
12 HOURS ±17 ±15 ±17 ± 7 1 4
FASTING 106.3 07.6 106.3 18.7 O
12 HOURS ±18 ±16 ±10 ± 4
TOTAL 272.3 207.0 184.4 65.3 72.6
24 HOURS ±28 ±26 ±26 ± 7 ± 4
When these changes are statistically tested by matched-pair t-test, 
they are all highly signifleant, leaving no doubt that the 27% decrease 
in whole body protein synthesis and the 36% increase in breakdown arc
genuine changes.
l o o
Q z B E
Matched-pair t-test p<.001 p<.001 p<.01 pC.OOl
The magnitude of these changes can be further appreciated when 
expressed as the percentage change that has occurred in passing from 
the feeding to fasting phase. Here the results are related to the 
feeding phase values, but later when absolute values under all conditions 
are considered and the fasting phase is considered as basal, values 
are then expressed as a percentage of the normal fasting phase values.
T A B L E  4 . 3 .  M ean r a t e s  o f  p r o t e i n  t u r n o v e r  f o r  t h e  g r o u p  o f  1 0  o b e s e  
p a t i e n t s  on ' N o r m a l '  D i e t ,  w i t h  t h e  F a s t i n g  P h a s e  e x p r e s s e d  a s  a 
p e r c e n t a g e  o f  F e e d i n g  P h a s e  v a l u e s .
PHASE Q Z B E
FEEDING PHASE loo % loo % loo % loo %
FASTING PHASE 64.0 % 73.4 % 136.1 % 40.1 t
% CHANGE +36.0 % +26.6 % +36.1 % +59.9 %
Three remarkable facts are immediately obvious from these results:- 
(1) There was a 38t drop in protein synthesis over the
3 week period on the protein free Diet O (see Results 1) 
yet these diurnal results surprisingly show that 
• over P./3 of that drop occurs overnight, apparently
(2)
lOl
Protein breakdown has increased by 36% during overnight 
fasting - yet low protein and energy diets prolonged 
over 3 weeks (see Results 1) left protein breakdown 
unaffected.
(3) If 24-hour protein synthesis, breakdown, and oxidation
rates are calculated only from feeding phase measurements, 
they will be very different from the genuine 24 hour 
rates which normally result from both feeding and 
fasting phase protein turnover.
These points are analysed further in Discussion 2 where the 
absolute values of protein turnover in the feeding and fasting phases 
are discussed in detail, and the implications and significance of 
the diurnal changes, are considered. It should also be reiterated 
that the apparent feeding phase discrepancy such that Q B + I 
only occurs because there are different leucine concentrations in 
'whole body protein' and dietary protein, and when values are expressed 
in terms of millimoles of leucine (as in Discussion 2) this discrepancy 
vanishes.
The results show that for obese women, on an adequate food intake 
and having the usual intake pattern of daytime feeding and night-time 
fasting, when the change is made from feeding to fasting phases whole 
body protein synthesis decreases while protein breakdown increases. 
Moreover, the discrepancy between synthesis and breakdown during the 
feeding phase which was previously shown to maintain a greater rate 
of synthesis than breakdown, now becomes completely reversed so that 
breakdown rate is constantly greater than synthesis rate during night­
time fasting.
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Two questions concerning the nature and cause of these changes, 
are particularly outstanding in their demand for investigation:
(1) Are these diurnal changes a consequence of obesity?
(2) Are these diurnal changes simply natural circadian
rhythms?
To answer the first question, a study was set up to measure 
24-hour protein turnover in a group of non-obese adults, both 
male and female, and this group of 5 subjects was called the 'Control 
group' (see Section 2). It was anticipated that results from the 
Control group would not only indicate whether diurnal changes 
in protein metabolism are a universal human phenomenon, but would 
also answer the question raised in the previous section (Section 3) ,
- are there any differences in the absolute values of protein synthesis, 
breakdown and oxidation, between obese and normal people?
The Control group subjects were Departmental colleagues or 
their relatives, and their experimental protocol is outlined in the 
Methods S Techniques section. Table 4.4 shows the Control group's 
mean dietary and anthropometric characteristics, while their 
individual data are tabulated in Appendix 2.4.
T A B L E  4 . 4 .  M e a n  ( ±  S . D . )  d i e t a r y  a nd a n t h r o p o m e t r i c  c h a r a c t e r i s t i c s  f o r  
t h e  5 n o r m a l  s u b j e c t s  i n  t h e  ' C o n t r o l '  g r o u p .
MEAN INTAKE 
(over Feeding 12-hours) } 1797 ± 67.2± 440 Kcal 2.9 g Protein
% ofNo SEX AGF. HEIGHT WEIGHT IDEAL WEIGHT
(Yrs) (cm) (Kg) <%)
Moan 5 2F 56.4 172 67.0 96.2
± S.D. 3M ±9 *4.2 ±12.8 ±16
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As with the obese Diurnal groups, the Control group subjects 
consumed their food intake in 12 equal hourly portions over the 
daytime (9 am - 8 pm) feeding phase. Trotein turnover measurement 
continued throughout the entire 24 hour period covering both daytime 
feeding and night-time fasting 12-hour periods. The following table 
(Table 4.5) presents the mean protein turnover measurements for 
these two phases for the Control group, expressed in grams of 
protein per 12 hours, and the 24 hour rates, calculated as a 
summation of feeding phase and fasting phase rates. (The values 
for individual subjects, expressed in both grams of protein and 
millimoles of leucine are tabulated in Appendices 2.5 and 2.6.)
T A B L E  4 . 5 .  M ean (± S . D . )  p r o t e i n  t u r n o v e r  r a t e s  f o r  t h e  C o n t r o l  g r o u p  
o f  5 s u b j e c t s ,  m e a s u r e d  o v e r  24  h o u r s .  E x p r e s s e d  i n  g P r o t e i n  p e r  
1 2  h o u r s .
PHASE Q Z B 
g Protein per 12
E
Hours
I
FEEDING 155.3 112.2 75.1 43.1 67.2
12 HOURS ±17 + 24.5 +19 ± 7.5 ± 2.9
FASTING 100.5 81.6 100.5 18.9 0
12 HOURS ±15 ±15 ±15 ± 4
TOTAL 255.8 193.8 175.6 62.0 67.2
24 HOURS ±31 ±38 ±32 ±10 ± 2.9
When these protein turnover values are expressed as a percentage 
of feeding phase values (Table 4.6) to show the relative changes that 
occurred as a result of passing from daytime feeding to night-time 
fasting, once again largo diurnal swings in protein synthesis, breakdown
./ i
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and oxidation rates are apparent.
T A B L E  4 . 6 . Mean p r o t e i n  t u r n o v e r  r a t e s  f o r  t h e  C o n t r o l  g r o u p  o f  5 
s u b j e c t s  m e a s u r e d  o v e r  24  h o u r s ,  e x p r e s s e d  a s  p e r c e n t a g e s  o f  F e e d i n g  
P h a s e  v a l u e s .
PHASE Q Z B E
FEEDING lOO % lOO % lOO % lOO %
12 HOURS
FASTING 64.7 % 72.7 % 133.8 % 43.9 %
12 HOURS
% CHANGE +35.3 %1 +27.3 % +33.8 % +56.1 %
Not only is it clear that the magnitude of the diurnal changes
in whole body protein synthesis and breakdown is almost identical in 
obese and non-obcse subjects, but the diurnal change in protein 
oxidation rates is also the same for obese and non-obese people. 
Furthermore, there is no statistically significant difference in 
absolute values of protein turnover in the feeding, fasting, or 
24-hour phases, between obese and non-obese people, although the 
Control group means are all marginally less than obese group means.
This is expressed visually in Figure 4.1, whilst it is Table 4.7 that 
shows the results of statistical comparison by t-test for differences 
between obese and Control groups in all 3 phases (the aim of the subtle 
message of this table being to reinforce the finding that fat and thin 
humanity share equality in terms of protein turnover!).
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FIGURE 4.1 Diurnal changes in Protein Synthesis, Breakdown and Oxidation, in obese and non-obese s u b j e c t s
OBESE
III NON-OBESE
SYNTHESIS
FEEDING FASTING FEEDING FASTING
OXIDATION
FEEDING FASTING
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T A B L E  4 . 7 .  C o m p a r i s o n  o f  mean p r o t e i n  t u r n o v e r  v a l u e s  b e t w e e n  C o n t r o l  
g r o u p  a n d  t h e  g r o u p  o f  1 0  o b e s e  p a t i e n t s ,  i n  F e e d i n g ,  F a s t i n g ,  and  
2 4 - H o u r  P h a s e s  ( t - t e s t  f o r  d i f f e r e n c e  o f  m e a n s ) .
Q Z B E
FEEDING PHASE N.S.D. N.S.D. N.S.D. N.S.D.
FASTING PHASE N.S.D. N.S.D. N.S.D. N.S.D.
24 HOUR TOTAL N.S.D. N.S.D. N.S.D. N.S.D.
These results suggest quite conclusively that protein synthesis, 
breakdown, and oxidation rates are much the same in obese and non- 
obese adults, and that the diurnal changes that occur in protein 
turnover occur equally in obese and non-obese adults (Fig 4.1).
The possibility that these diurnal changes in whole body protein 
turnover are simply day/night natural circadian rhythms, was the 
second question provoking obvious attention. To settle this question, 
3 studies were planned and implemented. In the first study protein 
turnover was measured for 18 hours in a patient being continuously fed 
(for 24 hours). In the second study patients having no protein intake 
over a 24 hour period wore then refed protein, with protein turnover 
being measured continuously over 36 hours. Thirdly, to ensure that 
the infusion technique Itself was not contributing to the diurnal 
changes, 24 hour protein turnover measurements in both an obese and 
a Control subject were commenced in the night-time fasting phase, and
continued over 24 hours.
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It was an obese female patient of 54 years (E.E) who endured
hourly feeding for 24 hours whilst her protein turnover was
14continuously measured by (1- C)leucine infusion. Her 24 hour intake 
was 1,870 Kcal (7.8 MJ) and 72.3 g protein, an intake typical of the 
'Normal' Diet category - but because this quantity was consumed over 
24 hours rather than the usual 12 hours, her rate of protein intake 
was only 3.0 g protein/hour, just half the rate of the other obese 
patients on 'Normal' Diet.
Table 4.8 shows her mean hourly protein turnover rates in each 
of 3 consecutive 6 hour periods. All other obese patients on the 
'Normal' Diet fceding/fasting regimen, without exception showed 
large decreases in Z and E between 6 pm - 12 MN, constant low plateaux 
between 1 am - 6 am, followed by a large increase between 7 am - 12 MD 
returning Z and E back to normal high daytime values. In distinct 
contrast E.E showed no change whatsoever in Q, Z, B, or E over the 
whole 18 hour period, and this finding is supported statistically 
by the t-test which shows no significant difference in protein turnover 
between any of the 3 phases. Figure 4.2 (a) shows her individual hourly 
synthesis rates (Z), which fall on the regression line -
Z (mmol leu) *= 4.6 - 0.04t
The slight negative slope probably results from recycling of label from 
protein stores.
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T A B L E  4 . 8 .  M ea n (±  S . D . )  h o u r l y  r a t e s  o f  p r o t e i n  t u r n o v e r  i n  o b e s e  
p a t i e n t  E . E ,  d u r i n g  t h r e e  6 - h o u r  p h a s e s ,  on a c o n s t a n t  h o u r l y  i n t a k e .
These results support the more extensive measurements of protein 
turnover in geriatric patients made by Golden & Waterlow (1977), 
who also found no change in protein synthesis, breakdown, or oxidation 
whilst continuous nasogastric feeding was administered over a period 
of 30 hours.
These data alone are convincing evidence that there are no 
intrinsic circadian rhythms of protein turnover. Rather the presence 
or absence of food intake appear responsible for the diurnal rhythms in 
protein synthesis, breakdown, and oxidation.
The second study is discussed in detail in Section 6 (Results 4) 
where diurnal changes and adaption are further investigated. However, 
the results show that when obese patients were maintained on a 
low energy/protcin-free diet for 3 weeks, not only did protein synthesis 
and oxidation remain at very low constant plateau values for as long 
as protein intake remained zero, but on réintroduction of dietary protein, 
Immediate changes in protein turnover ensued. Figure 4.2 (b) shows
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F IG U R E 4.2. Whole-body protein synthesis, measured hourly, (a) in patient 
E .E .  on a continuous hourly intake of protein; (b) in patient T.D. on a 
continuous protein free diet.
(a) Intake: 3.0 g/Hour (continuous) (b) Intake: 0 g protein
mmoles Leucine Z mmoles Leucine
per Hour (E.E.) per Hour (T.D. )
8 8
6
V ° '-CA ®
6
A4 TH* nO H “
2 2
6 12 6 12 6 12 6 12
pm MN am MD pm MN am MD
Time (t) Time (t)
PROTEIN SYNTHESIS 
mmoles Leucine 
per Hour
7
6
5
4
3
(R.W.S.)
2
1
FEEDING FASTING FEEDING
12 4 8
MD pm
12 4 8 12 4
MN am MD pm
FIGURE 4.2.c. Diurnal changes in whole-body protein synthesis, related to
protein feeding and fasting.
n o
the individual hourly synthesis rates (Z) for obese patient T.D. 
who remained on a protein intake of zero over 30 hours. These values 
create the regression line -
Z (mmol leu) = 4.5 - o.o3t
and once again its slight negative slope probably results from 
14re-entry of ( C)leucine from px'otein stores into the plasma leucine 
pool.
To ensure that the observed diurnal changes in protein
turnover were not an infusion artefact, 2 patients had their 24-hour 
14(1- C)leucine infusions commenced at the beginning of the night-time 
fasting phase and continued throughout the feeding phase on the 
following day (see Table 4.9). As expected, immediately the feeding 
phase was recommenced after night fasting, the low fasting values of 
protein synthesis and oxidation rapidly increased, and protein breakdown 
fell, indicating the acute sensitivity of protein turnover to protein 
intake. Figure 4.2 (c) shows the normal diurnal changes in whole 
body protein synthesis in an obese patient (S.H) and 'Control' subject
R.W.S), both on the biphasic 'Normal' Diet regimen (12 hours feecling/12
14hours fasting) but with the (1- C)leucine infusion beginning in the 
feeding phase for S.H. and in the fasting phase for R.W.S.
Table 4.9 gives the mean protein turnover values for the 2 subjects 
in whom (1-^^C)leucine infusions were commenced with the night-time 
fasting (ie. 'post-absorptive') phase. It is clear from these results, 
that the diurnal protein turnover changes are a consequence of the feeding „
and fasting phases themselves, and that it makes no difference to the 
values which phase is measured first.
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T A B L E  4 . 9 .  Mean p r o t e i n  t u r n o v e r  r a t e s  f o r  2 s u b j e c t s  ( o n e  o b e s e  
f e m a l e ,  t h e  o t h e r  a C o n t r o l  g r o u p  m a l e ) ,  o n  ‘ N o r m a l 1 D i e t  r e g i m e n .
T h e  ( 1 - ^ C ) l e u c i n e  i n f u s i o n s  w e r e  commenced a t  t h e  b e g i n n i n g  o f  n i g h t ­
t i m e  f a s t i n g  1 2  h o u r s .
PHASE Q Z B 
g Protein per 12
E
Hours
I
FASTING 12 HOURS 109.1 90.5 109.1 18.6 O
(9 pm - 8 am) ± 5 ± 7 ± 5 ± 2
FEEDING 12 HOURS 144.6 104.5 57.7 40.1 72.3
(9 am - 8 pm) ±24.5 ±20 ±25.8 ± 4.5
It has been shown that protein turnover remains constant, both day 
and night, if (a) there is continuous intake of protein, (b) protein 
intake remains continuously at zero, whilst normal diurnal changes 
were shown to coincide with the commencement or cessation of protein 
intake. From these results, it can reasonably be concluded that 
protein turnover has no intrinsic circadian rhythm of its own. However 
there are substantial diurnal changes in protein synthesis, breakdown, 
and oxidation rates, but these appear to occur as an acute response to
dietary protein intake
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DISCUSSION 2
A number of exciting, and hitherto unknown characteristics of 
human whole body protein metabolism have been presented in Results 2, 
and perhaps the three most obvious of these are summarised below.
1. There are large diurnal changes in the rates of protein 
synthesis, breakdown and oxidation, and it appears that 
these are acutely responsive to changes in protein 
intake.
2. There are no differences in protein turnover rates 
between obese and non-obose humans on an adequate 
intake. Neither the absolute values nor the relative 
changes in protein synthesis, breakdown or oxidation 
that occur with feeding or post-absorptive fasting, 
are any different in lean and obese adults.
3. There are no natural circadian rhythms per se in 
whole body protein turnover.
The previous section (Section 3 ) showed that protein turnover 
was significantly affected by prolonged low protein intakes, and that 
the absolute values of protein synthesis, breakdown, and oxidation 
during the feeding phase of a normal diet were such that some diurnal 
change had to occur to maintain balance. Yet It was never suspected 
that such large diurnal changes as those shown (Results 2) might occur, 
particularly in protein breakdown which appeared unmoved by drastic 
long term changes in protein and energy intakes.
The dramatic 40% drop in protein synthesis and RO% drop in oxidation, 
shown to have resulted from 3 weeks of low energy protoin-free diet
(Diet O), were interpreted ns being adaptive changes. However the 
24-hour protein turnover measurements in this section have clearly 
shown that when human adults on a normal dietary intake simply 
change to a post-absorptive state, as is usual for most people every 
night, then within hours whole body protein synthesis falls by some 
27% and remains at that level, protein oxidation drops by about 
60% and the rate of protein breakdown appears to increase by some 
.35%. Over 2/3 of the change that resulted from prolonged protein 
free dieting, has occurred overnight, even in normal people on 
a normal intake simply moving into their customary overnight fasting 
period.
The evidence strongly suggests that protein turnover rates are 
acutely dependent on protein intake, and acute changes in the rate 
of protein intake immediately produce changes in the rate of protein 
turnover. Intrinsic circadian rhythms were shown to play no 
part in diurnal protein turnover changes, and changing levels of 
energy intake are unlikely to be of any great Influence, other 
than perhaps modifying the protein turnover-protein intake relationship. 
This was suggested in the previous section (Results 1) where it 
was shown that a large drop in energy intake, with protein intake 
remaining adequate, left protein turnover unchanged.
The extreme sensitivity of protein turnover to acute changes 
in protein intake can be seen from previous figures (Figs. 2.1,
2.5, and 4.2) and from Section 6 whore patients on Diet'O for 
3 weeks suddenly have protein reintroduced to their low energy diets. 
Figure 4.3 shows that within one hour of ceasing or recommencing 
protein intake, whole«body leucine flux is already rapidly changing.
FIGURE 4.3. The rapid change in flux Q (mmol leu/hr) as an acute response to the cessation (D.H.) 
or commencement (M.W.) of protein intake. Intake values are given (Kcal/g Protein).
DH (1335/69.9) MW (500/50)
FASTING ■ ; FASTING
FLUX Q
mmol Leucine/Hour
2 4 6 8 10 12 2 4 6 8 10 12 2
pm MX am MD pm
TIME
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The significance of the absolute values and their imbalance 
is probably better appreciated when expressed in terms of leucine, 
especially because intake (I) is then in comparable terms with Q, Z, 
B, and E. Table 4.10 gives the mean group values for the lo obese 
patients whose protein turnover was measured over 24 hours to 
investigate diurnal changes, and the results are expressed as 
millimoles of leucine per hour.
T A B L E  4 . 1 0 .  Mean ( ±  S . D . )  v a l u e s  o f  p r o t e i n  t u r n o v e r ,  i n  m i l l i m o l e s
L e u c i n e  p e r  1 2  H o u r s ,  f o r  t h e  1 0  o b e s e  p a t i e n t s  ( ' D i u r n a l '  + ' D i e t - 0 -
1 4D i u r n a l '  g r o u p s )  m e a s u r e d  o v e r  24 h o u r s  w i t h  ( 1 -  C ) l e u c i n e .
PHASE Q Z B E I
millimoles of Leucine per 12 Hours
FEEDING 101.2 72.8 47.6 28.4 53.6
12 HOURS ±10.3 ± 9.0 ± 9.8 ± 4.4 ± 3.5
FASTING 64.8 53.4 64.8 11.4 O
12 HOURS ±11.2 ± 9.5 ±11.2 ± 2.5
TOTAL 166.0 126.2 112.4 39.8 53.6
24 HOURS ±17.0 ±16.1 ±16.4 ± 4.8 ± 3.5
There are substantial leucine imbalances, not only in feeding and 
fasting phases, but also over the entire 24 hour period' when leucine 
balance might have been expected. The data in Table 4.10 show an 
accumulation of 25.2 mmol leucine in the body during feeding phase, 
the same imbalance that was found with Diet. O and Diet P groups on 
normal feeding. There is a negative balance and hence loss from the 
body of 11.4 mmol of leucine during the fasting 12 hours, and so over
116
the complete 24 hour period there appears to be a net ascumuZat-Lon 
of 13.8 mmol of leucine somewhere in the body.
However there are several factors that influence the magnitude 
and significance of the above data. These include:
(1) Any diurnal change in the plasma free leucine pool.
(2) The correction factor in feeding and fasting phases 
for the plasma method's underestimation of flux.
(3) 24 hour N-balance.
and the effect each of these has on the results, merits analysis.
It has been proposed by some authors in the past (Adam & Oswald, 
1977) that sleep is a time of anabolic restoration of tissue, and of 
increased protein synthesis. They claim that plasma and intracellular 
amino acid levels are unrelated, that plasma amino acids vary 
independently of protein intake, and the "intracellular amino acids 
are highest while food intake is least" (Adam & Oswald, 1980) .
Their implication is that plasma amino acid levels, by fluctuating 
independently of both protein intake and intracellular levels, might 
decrease so much that the specific activity of a tracer would greatly 
increase and thus falsely Indicate that protein flux and synthesis 
had decreased.
However, in a number of our obese and normal subjects, plasma 
leucine concentrations were measured throughout feeding and fasting 
phases, and the effect of variations in protein Intake on plasma free 
leucine pool measured. The results in Table 4.11 show that plasma 
leucine concentration is significantly affected by protein intake, 
in both obese and non-obese subjects, the high plasma concentrations 
corresponding to the feeding phase, and low plasma concentrations 
during fasting.
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T A B L E  4 . 1 1 .  D i u r n a l  c h a n g e s  i n  p l a s m a  f r e e  l e u c i n e  p o o l  f o r  2 o b e s e  
p a t i e n t s  ( E . K .  a n d  R . O . )  a n d  o ne  ' C o n t r o l '  s u b j e c t  ( J . K . G . ) »  on t h e  
' N o r m a l '  D i e t  r e g i m e n  w i t h  f e e d i n g  a n d  f a s t i n g  1 2  h o u r  p h a s e s .
NAME
FEEDING 12 Hrs FASTING 12 Hrs 
(1) (II) 
pinoles Leuclne/lltre plasma
% CHANGE 
(1~II/I XlOO%
EK
RO
148.7 ± 22.2 109.4 ± 9.0 
148.1 ± 19.4 100.0 ± 3.8
+26.4 « 
+32.5 %
MEAN (OBESE) 
JKG (CONTROL)
148.4 ± 19.6 105.0 ± 8.4 
101.6 ± 10.3 71.2 ± 5.3
+29.4 % 
+29.9 %
These results show a consistent drop of some 30 - 40 pmoles/litre 
In the plasma free leucine concentration, from the daytime feeding 
phase to the night-time fasting phase. It appears the changes In 
plasma leucine are dependent and sensitive to protein Intake, 
as they vary directly with this. Further evidence follows.
Table 4.12*then shows how constant the plasma free leucine 
pool remains, when the feeding/fastlng pattern Is eliminated, by 
continuous (hourly) feeding of a normal total daily Intake 
throughout the 24 hours. The result Is elimination of the diurnal 
fluctuations of the free leucine pool.
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T A B L E  4 . 1 2 *  T h e  e f f e c t  o n t h e  p la s m a  f r e e  l e u c i n e  p o o l ,  o f  f e e d i n g  t h e  
n o r m a l d a i l y  i n t a k e  ( 1 8 7 0  K c a l / 7 2  g P r o t e i n )  i n  e q u a l  h o u r l y  a l i q u o t s  
o v e r  t h e  24  h o u r  p e r i o d .  ( P a t i e n t  E . E .  P l a s m a s  w e r e  t a k e n  f o r  t h e  
l a s t  1 8  o f  t h e  24  h o u r s . )
6 pm - 12 MN
TIM E PERIOD 
12 MN - 6 am 6 am - 12 MD
MEAN (± S.D.)
Plasma free leucine 144.0 140.7 142.3
(pmoles/litre plasma) ±10.7 ± 9.8 ± 5.1
The data from Tables 4.11 and 4.12/are combined In Figure 4.4 
where It cam be appreciated even more clearly, that the plasma free 
leucine pool varies directly with protein intake.
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OBESE CONTROL E.E.
FIGURE 4.4. Plasma free leucine concentrations over 24 hours, in obese and 
non-obese subjects, and under different food intake situations.
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If the fasting drop in plasma leucine concentration were large 
enough, and was reflected by the behaviour of intracellular free leucine, 
then it could possibly account for our claimed decrease in protein 
synthesis with fasting. The data from Table 4.11 show a drop of 
30-- 40 ymoles per litre leucine in the plasma free leucine pool. There is 
no evidence to suggest that intracellular leucine does not behave 
similarly. Indeed recent data comparing plasma with intracellular 
(muscle) free leucine concentrations (Moller et al, 1980; Vinnars 
et al, 1975) have shown that although intracellular free leucine 
concentration is a little higher than plasma, similar changes occur 
in both compartments as a result of surgery and aging.
Assuming that a decrease of about 40 ymoles per litre leucine occurs 
in both Intracellular and extracellular compartments as a result 
of post-absorptive fasting, and using the following body fluid 
data from Elkinton a Danowski (1955), applicable to a 70 Kg man;
Plasma H20 2.4 L 
Total extracellular HjO 11.5 L 
Intracellular H^ O 31.5 L 
Total Body HjO 43.0 L
then the decrease in total body free leucine, as a result of fasting, 
would amount to 1.8 millimoles of leucine.
However, our data from Table 4.10 and Appendix 2.6, show that 
both non-obese and obese subjects decrease their whole body protein 
synthesis by 20 millimoles of leucine as a result of fasting. Clearly, 
any error introduced because of feeding/fasting—induced changes in 
the free leucine pool, leading to an overestimate of the drop in protein
synthesis during fasting, will be less than 10%. It is equally clear 
that there would have to be an enormous and probably impossible decrease
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(eg. some 500 ijmoles Leucine per litre) in the body's free leucine 
pool, if this alone were to explain the decrease we estimated 
to occur in protein synthesis.
As discussed in the previous section, the (1-**C) leucine 
infusion method significantly underestimates flux, because of 
internal recycling and Golden & Waterlow (1977-) estimated that 
in elderly patients under constant feeding conditiors the under­
estimate was 20%. The calculation of this underestimate is based 
on the assumption that protein synthesis operates from the same 
metabolic pool as oxidation, so that the measured underestimate 
in oxidation then becomes applicable to synthesis.
It is worth estimating this error in these diurnal patients 
since fasting conditions may affect its values, and calculation of 
changes in body protein mass may be more accurate with the corrected 
values of Z and B.
Two approaches are used here. Firstly, an estimate of the error 
in calculating flux over the entire 24 hour period (feeding + fasting) 
can be made by comparing the leucine oxidation rate E calculated from 
flux and expired ^CO^, with the leucine oxidation rate Ey calculated 
from urinary-N excretion. For this latter oxidation rate (E^ ) it 
is assumed that the proportion of N derived from leucine oxidation 
should be the same as the proportion of leucine in dietary protein 
as far as N-balance, but then any excess N (and hence leucine) excreted 
should come from 'whole body protein'. The following table (Table 4.12) 
shows the percentage of leucine in dietary protein, the 24 hour urinary 
N excretion and the equivalent calculated leucine oxidation rate over
24 hours (Ey) and compares this value with the oxidation rate
14derived from flux and expired CO. (E ).2 L
TABLE 4.12. 24-Hour Leucine oxidation rates derived from urinary N excretion (E^) and from flu x  and 
expired 4^C02 measurements (EL ). The comparison of the two oxidation rates suggests the under­
estimate of the flux  due to internal recycling .
GROUP & NAME
% Leucine in 
Dietary Protein
24 hr Urinary Excretion
g Protein mmol Leu 
(N x 6.25) (Ey )
e l
mmol Leu/24 hrs
E.
/Eu X  lOO *
OBESE DIURNAL
F B 9.80 % 89.7 65.8 45.4 69.0 %
SH 9.77 % 73.3 54.4 39.2 72.1 %
DH 9.77 % 84.5 61.0 37.5 61.5 %
MH 9.79 % 85.4 61.8 49.6 80.3 %
ML 9.21 % - - (34.8)
MT 9.81 » 85.2 62.8 42.6 67.8 %
MW 9.51 % 85.3 60.3 36.3 60.2 %
TD 9.43 % 88.9 61.5 37.9 61.6 %
EK 10.09 % 71.9 54.7 40.3 73.7 %
RO 9.71 % 74.3 54.7 34.6 63.3 %
OBESE
MEAN ± S.D. 9.69 % 82.1 59.7 40.4 67.7 %
±0.24 ±6.9 ±4.1 ±4.8 ±6.7
CONTROL
MG 9.76 % 67.3 49.8 41.2 83.2 %
JS 9.76 % 84.6 60.4 44.9 74.3 »
JCW 9.24 % 92.9 62.8 29.2 46.5 %
RWS 9.51 % 101.3 70.1 37.0 52.8 %
JKG 9.46 % 76.0 53.8 36.8 68.4 %
CONTROL
MEAN ± S.D. 9.55 % 84.4 59.4 37.8 65.0 t
±2.2 ±13.4 ±7.9 ±5.9 ±15.1
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These data show that for both obese and non-obese subjects, 
over a 24 hour period which includes both feeding and fasting phases 
24 hour whole body protein synthesis, oxidation, and flux, are all
underestimated by some 33%.
There cure 2 factors that are likely to account for the discrepancy 
between this figure and the value of 20% found in patient E.E. (see 
previous section) and Golden & Waterlow (1977). Firstly, it might 
well be expected that during fasting, the amount of amino acid liberated 
by protein breakdown and then reutilised for synthesis without mixing 
in the plasma pool, should increase, especially since the earlier 
data suggest there is an increase in breakdown during the fasting phase. 
Secondly, both E.E. and Golden & Waterlow's subjects were receiving 
their protein intake over 24 hours, and therefore at a much slower 
hourly rate of protein intake than in these subjects with a 12 hour 
feeding phase. Consequently the flux rates of both E.E. and Golden & 
Waterlow's subjects are much lower than the 12 hour feeding phase values 
in the above obese and control subjects. Different flux rates may well 
be associated with different rates of internal recycling.
The second approach to estimating this error in plasma measurements 
of flux, is to measure excretion of urinary N during both feeding and 
fasting phases, and correct these 12 hour excretion rates for the changes 
in body urea pool size that occur with feeding and fasting. These changes 
are estimated as a product of measured plasma urea-N values and total 
body water. Then again assuming that the proportion of urinary N 
derived from leucine is the same proportion as leucine in dietary 
protein until N-balance is achieved, and thence as in whole-body protein, 
leucine oxidation can be calculated from the corrected urinary N excretion 
values from both 12 hour phases-, and compared with the flux-based 
estimates of oxidation. Total body water Is computed from the following
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formula from Watson et al (1980).
TBW = 20.03 - (0.1183 x Age in yrs) + (0.3626 x Wt in Kg)
T A B L E  4 . 1 3 .  E s t i m a t i o n  o f  l e u c i n e  o x i d a t i o n  f r o m  u r i n a r y - N  e x c r e t i o n ,  
o v e r  b o t h  f e e d i n g  a n d  f a s t i n g  1 2 - h o u r  p h a s e s ,  b y  c o r r e c t i n g  t h e  1 2 - h o u r  
u r i n a r y - N  e x c r e t i o n  f o r  c h a n g e s  i n  b o d y  u r e a  p o o l  s i z e .
( C o n t r o l  s u b j e c t  J K 6 ) .
CHANGE IN 
PLASMA UREA-N 
mg/1
CHANGE IN 
WHOLE-BODY UREA-N 
g N
URINARY-N EXCRETION 
AS MEASURED CORRECTED 
g N/12 hrs g N/12 hrs
FEEDING 
12 HOURS
+ 24.3 + 0.952 7.03 7.98
FASTING 
12 HOURS
+ 24.3 + 0.952 5.13 4.18
TOTAL 
24 HOURS
- - 12.16 12.16
PHASE t LEUCINE IN 
DIETARY PROTEIN
CORRECTED 
URINARY EXCRETION
g Protein mmol Leu 
(N x 6.25) (Eo)
el
nmol Leu
e l/Ey X lOO % 
(*)
FEEDING 9.46 t 49.9 36.0 24.9 69.2 «
in
12 Hrs 66.7 g Protein
FASTING - 26.1 17.8 12.0 67.5 *
12 Hrs
TOTAL 76.0 53.8 36.9 68.6 «
24 Hrs
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From these data there seems to be little change detectable, as 
a result of feeding and fasting, in the relationship between oxidation
rates derived from N excretion and those derived from flux and 
14expired CO^. However there may still be some insensitivity to 
acute turnover changes in the urinary nitrogen method, even with 
urea space corrections applied, because expansion in the urea pool still
lags a few hours behind protein intake. Nevertheless, in both obese
14and non-obese subjects, the (1- C)leucine infusion method appears 
to underestimate true precursor pool flux, and thus protein synthesis, 
and oxidation rates, by some 33%, at least over 24 hours when the 
daily intake of 70 g protein is administered over a 12 hour feeding 
period.
There is another important factor that requires appreciation before
changes in body protein mass are considered. Despite a protein intake
of about 70 g protein per day and an energy intake that was just
above requirement in most subjects (energy balances are shown in
*Part B) , all subjects were in significant negative N-balance, and 
consequently negative leucine balance. The following table (Table 4.14) 
shows the mean nitrogen and leucine balances for the obese and control 
groups. As in the previous tables, it is assumed that up until N-balance, 
leucine is excreted in the same proportion to protein as in protein 
intake (ie. approx. 9.7%), but for the N excreted in excess of intake, 
the proportion of leucine in protein excreted is 8%, as in 'whole body 
protein'. The individual intakes, excretion, and balances for 
both groups are shown in Appendix 2.7. *
* N-balances here represent the balance between N intake and urinary N 
excretion, and are thus approximations for true N-balance. Faecal, integu- 
mental, or other losses have not been measured. However use of standard 
digestibility factors (Watt & Merrill, 1963) partly account for faecal N loss.
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T A B L E  4 . 1 4 .  2 4 - H o u r  mean (±  S . D . )  p r o t e i n  a nd l e u c i n e  b a l a n c e s  f o r  
10  o b e s e  a n d  5 c o n t r o l  s u b j e c t s .  ( E x c r e t e d  ' P r o t e i n '  i s  N x  6 . 2 5 . )
GROUP INTAKE EXCRETION (urine) BALANCE
Protein
g/d
Leucine
mmol/d
Protein
g/d
Leucine
mmol/d
Protein
g/d
Leucine
mmol/d
OBESE 72.6 53.6 82.1 59.7 -9.6 -5.8
±6.8 ±4.2
CONTROL 67.2 48.8 84.4 59.4 -17.2 -10.5
±11.7 ± 7.1
All patients, both obese and control, were in quite marked
negative nitrogen balance (-1.5 gN/d for obese; -2.8 gN/d for Controls)
despite the 'Normal' dietary intake. This interesting phenomenon is ^
also seen in many other patients (not listed here), and the typical
N excretion pattern is one of increasing negative balance over the
first 3-4 days of admission to hospital, even though an adequate
energy/high protein diet is consumed. It seems more likely that this
effect is related to immobilisation (particularly as required for 
14(1- c ) leucine infusions). This likelihood is further reinforced by 
the achievement of complete N—balance in 6 colleagues participating in 
(15N)glycine studies (Garlick et al, 1980), but who were active and 
working as usual during the daytime. In complete contrast, our Control 
group (which also consisted of colleagues) were significantly and
suddenly restricted in their movements for the 24 hours of the 
14(1- C)leucine infusion.
From the discussion above, it is apparent that changes in amino 
acid pool size are very small and will scarcely affect the size of any 
diurnal changes in protein synthesis; the correction factor for
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underestimate of flux by the (1- C)leucine method will however have 
a large effect on results; and the fact that all the subjects were 
in negative nitrogen balance needs to be taken into account. Bearing 
in mind that the following corrections for underestimate of flux 
assume leucine oxidation and protein synthesis share the same 
precursor pool, the following tables show the resultant corrected 
mean values of protein turnover over 24 hours in obese patients 
(Table 4.15) and Control subjects (Table 4.16).
T A B L E  4 . 1 5 .  Mean 2 4 - h o u r  p r o t e i n  t u r n o v e r  m e a s u r e m e n t s  i n  1 0  o b e s e  
p a t i e n t s  on t h e  d i p h a s i c  ' N o r m a l '  D i e t  r e g i m e n ,  c o r r e c t e d  f o r  a 
33% u n d e r e s t i m a t e  o f  f l u x  i n  b o t h  f e e d i n g  a nd f a s t i n g  p h a s e s .  E x p r e s s e d  
i n  m i l l i m o l e s  o f  l e u c i n e  a n d  g of Protein.
PHASE Q Z B
*E I
millimoles of Leucine 
g Protein per 12
per 12 Hours 
Hours
FEEDING 151.2 108.7 97.6 42.5 53.6
12 HOURS 247.9 178.3 160.0 57.5 72.6
FASTING 96.7 79.7 96.7 17.0 O
12 HOURS 158.6 130.7 158.6 •24.7' 0
TOTAL 247.9 188.4 194.3 59.5 53.6
24 HOURS 406.5 308.9 318.6 •82.2' 72.6
E expressed in g Protein, is 'Intake Protein' as far as protein 
balance, and thereafter is 'Whole Body Protein'. Thus 24 hour 
protein oxidation (82.2 g) is a combination of the 2 types of 
protein.
»
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If these corrections are valid, then the data in Table 4.15 
would indicate the following features of 24 hour protein turnover, 
some in marked contrast to the previous 'uncorrected* findings.
(1) Diurnal feeding/fasting changes in protein turnover now 
appear somewhat different:
- Protein synthesis still drops by 27%;
- Protein oxidation still drops by 60%;
- But protein breakdown remains completely unchanged.
(2) In the 12-hour feeding phase, although in terms of leucine 
the discrepancy between Z and B equals that between E and
X, in terms of protein this is not the case since the leucine 
concentration in food protein and whole body protein differ. 
The difference between E and I indicates that only 20% of 
protein intake is stored, 80% being oxidised during the 
12 hour feeding period. The leucine that is retained 
is then reflected in the discrepancy between Z and B, 
and this indicates an increase in whole body protein-bound 
leucine of 11.1 millimoles, equivalent to an increase in 
body protein mass of 18.2 g of protein during the feeding 
12 hours.
(3) During the fasting 12 hours, the discrepancy between Z and B 
indicate a net loss of protein bound lencine of 17 millimoles 
of leucine, equivalent to a decrease is whole body protein 
mass of 27.9 g protein during this phase.
(4) Thus over the whole 24 hour period, in these obese patients 
there is a net loss of 5.9 millimoles of leucine from the 
body. In terms of net loss from the body's protein mass
(Z - B) , this is equivalent to a loss of 9.7 g Protein.
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With this same correction for a 33% underestimate of flux 
applied to the Control group results, the absolute values and proportional 
changes are almost identical to the corrected values from the obese 
group. Table 4.16 shows this, and again demonstrates the diurnal 
feeding/fasting changes, with a 27% drop in whole body synthesis, 
a 56% drop in oxidation rate, and no change in protein breakdown 
rate.
T A B L E  4 . 1 6 .  Mean 2 4 - h o u r  p r o t e i n  t u r n o v e r  r a t e s  f o r  t h e  C o n t r o l  G r o u p ,  
c o r r e c t e d  f o r  a 33% u n d e r e s t i m a t e  o f  f l u x .  E x p r e s s e d  i n  m i l l i m o l e s  
o f  l e u c i n e  p e r  1 2  h o u r s ,  a n d  g Protein per 12 hours.
PHASE *Q Z B E
millimoles of Leucine per 12 Hours
g Protein per 12 Hours
n
FEEDING 141.3 102.1 92.5 39.2 48.8
12 HOURS 231. 7 167.4 151.7 53.8 67.2
FASTING 91.5 74.3 91.5 17.2 O
12 HOURS 150.0 121.8 150.0 '25. 6' 0
TOTAL 232.8 176.4 184.0 56.4 48.8
24 HOURS 381. 7 289.3 301.7 •79.4‘ 67.2
E as g Protein is 'Intake Protein* (leucine “ 9.55%) until 
protein balance is achieved and thereafter is 'Whole Body Protein' 
(leucine ■ 8.0%).
With these corrections applied, the protein turnover data for 
both obese and Control group subjects in Tables 4.15 and 4.16 are 
now in agreement with measured nitrogen balance data. Yet even so, 
the validity of these corrections depends on the assumption that
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oxidation and synthesis share the same precursor pool throughout the 
body, and this assumption may introduce significant error, since 
leucine is thought to be largely oxidised in muscle (Young, 1970;
Goldberg & Chang, 1978; Elia et al, 1980), whilst muscle only 
contributes about half of total whole-body protein synthesis (Waterlow,
Garlick & Millward, 1978).
Nevertheless, irrespective of any corrections, the results 
clearly show a 27% drop in whole body protein syntheis, and a 
60% drop in oxidation, in the change from a feeding to a fasting 
phase. Whether this change also causes a 35% increase in whole 
body breakdown, as initially shown, and whether 50% of protein
intake is stored during the feeding phase, is much more dubious. If 
14the (1- C)leucine infusion method does underestimate not only oxidation, 
but also flux, by some 33% (under the dietary conditions of this
W'V
study) , then it would appear that protein breakdown has no diurnal 
change, and only 20% of dietary protein is stored during the feeding 
phase.
Despite this uncertainty about the magnitude of these breakdown 
changes, it has been established in this Section that considerable 
diurnal changes in protein turnover do occur, and are characterised 
by an acute responsiveness to changes in the level of protein intake.
Protein turnover rates and their diurnal changes appear to be identical 
In obese and non-obese subjects at least on normal dietary intakes, and 
there seems to be no evidence of natural circadian rhythms contributing 
to the diurnal changes. This section has also shown that although 
fluctuations do occur in the body's free amino acid pools, these are 
comparatively very small changes when compared with the changes In 
whole-body protein synthesis.
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However the (1- C)leucine method may significantly under­
estimate rates of protein oxidation and flux by some 33%, in both 
obese and non-obese subjects, and it has been suggested that the 
level of this error may be related to the rate of protein intake.
It was originally thought that such a remarkable decrease as a 
38% fall in protein synthesis, resulting from 3 weeks of protein- 
free low energy diet, must be a slow adaptive change, and it was 
planned to investigate the time-scale of this change with repeated 
(^N)glycine measurements (Section 5). However, this Section has 
shown that over 2/3 of that drop in synthesis occurs routinely in obese 
and non-obese adults, within a few hours of post-absorptive fasting.
The (^ 5N) glycine investigations in the next section are left to cope 
with the remaining small decrease.
SECTION 5 (1-14C)LEUCINE (15N)GLYCINE
RESULTS 3
5.1. (1-14C)LEUCINE COMPARED WITH (15N)GLYCINE
5.1.1. Continuous intravenous (15N) glycine 
- •."-5.1.2. Multiple oral dose (15N)glycine
5.1.3T Single (oral and I.V.) dose
*?*. 1 5( N)®tecine
. MONITORING PROTEIN TURNOVER WITH (15N)GLYCINES .2
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RESULTS 3
This section presents protein turnover measurements that were
14made by methods other than (1— C)leucine. As outlined in previous
sections, once it was found that a prolonged protein-free diet
caused major changes in whole body protein turnover, it was decided
to use (^N) glycine to attempt to monitor the rate of fall in protein
synthesis. The use of the stable isotope allowed frequent,
repeated measurements of protein turnover to be made, this being
14impossible with radioactive tracers such as (1- C) leucine, because
radiation hazard strictly limits their cumulative dosage. However
(^N) glycine measurements were also made in a number of subjects
14simultaneously with (1- C) leucine infusions, and thereby offered 
comparative measurements of whole body protein turnover, valuable to 
the understanding of both methods.
It was most fortuitous that these studies coincided with the 
programme of Professor J.C. Waterlow to develop an ammonia end-product 
method using (^N)glycine. Over the last decade the most commonly 
used method of measuring whole body protein turnover has been that 
adopted by Picou & Taylor-Roberts (1969) in which (^N) glycine 
is administered continuously by intravenous or oral routes, until 
the abundance of 15N in urinary urea reaches a plateau. The 
disadvantage of this method is that in adults it takes 2 or 3 days 
for urea to reach this plateau, and sometimes even longer (eg. Stef fee 
et al, 1976) , particularly i.n subjects with a low rate of urea 
excretion and turnover.
However Waterlow et al (1978) suggested the use of ammonia as 
the urinary end product, since the abundance of N rises to a plateau 
in about 9 - 1 2  hours (see Fig. 2.5), a great advantage over the urea
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end-product method. Some of the testing of this method was done
by comparing its estimates of whole body flux and synthesis with the 
14results from (1- C)leucine infusions, in both obese and the Control 
group of subjects. Further modifications of this method were also 
introduced and tested, including the administration of (^^N)glycine 
by single dose, either intravenously or orally. These developments
were also tested in the obese subjects, and against results obtained
14from simultaneous measurement with (1- C)leucine.
These (^N) glycine measurements were thus part of a collaborative
programme, in which the (^N)glycine method was used to obtain protein
14turnover measurements as an independent comparison with the (1- C) leucine
results, the changes in whole body protein synthesis were monitored
during prolonged low protein dieting, measurements were made in a
number of other conditions such as total fasting, and infected babies,
and through all these studies the underlying aim of the programme was
to test the limits, extend, and validate the NH^ end product method.
In view of the collaborative nature of much of this work, this
section mainly presents relevant (15N)glycine results, with little
in-depth discussion about the development of the NH^ end-product method.
The results are shown in two sections here, the first showing the
15 14agreement reached between ( N)glycine and (1- C)leucine in the 
estimation of protein turnover, and the second section showing attempts 
to monitor the progressive changes in protein turnover with prolonged 
low protein diets. The principles involved in the use of this end-product 
method, and the practical details of the method, have been outlined in
Sections 1 and 2
134
14 155.1. A COMPARISON OF (1- C)I£UCINE AND ( N)GLYCINE/NH^ END-PRODUCT 
METHODS IN ESTIMATING PROTEIN TURNOVER
Golden & Waterlow (1977) made simultaneous measurements of protein
14turnover by continuous administration of both (1- C)leucine and 
(^"*N)glycine with NH^ end product, and found that under their 
continuous feeding conditions, the NH^-end product method appeared 
to give slightly (but consistently) lower rates of protein synthesis.
The preliminary results of more extensive comparisons between the 
14 15(1- C)leucine method and ( N)glycine (both single dose and multiple 
dose) have been given by our group (Garlick, Clugston & Waterlow, 1980), 
and these showed that although absolute values from the two methods 
were not identical, the same proportional changes in protein turnover 
as a result of low protein diets were measured.
5.1.1. Continuous intravenous infusion of (^N)glycine
The first set of results is for the Control group of non-obese
14subjects, 4 of whom had simultaneous 24 hour infusions of (1- C) leucine 
and (15N)glycine. Figure 2.5 (Section 2) has already clearly shown 
the rise of the abundance of in urinary NH^ to a plateau, changing
again once the feeding 12-hour phase is completed and achieves a fasting 
phase plateau. These plateau values are used in the same way as plasma 
leucine specific activity to calculate flux Q. Table 5.1 sets out the 
mean values for the group, but the individual values for each subject 
are tabulated in Appendix 3.1.
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TABLE 5.1. Mean (± S.D.) protein turnover rates in 4 non-obese
'Control' Group subjects, measured by simultaneous intravenous
1 5  1 4  14
infusion of ( N)glycine and (1- C)leucine,( (1- C)leucine resu lts
in it a l ic s ) ,  over 24 hours.
PHASE Q z
g Protein
B
per 12 Hours
E
FEEDING 1 (Gly) 134.9 ±24.7 90.8 ±26 68.3 ±28 44.1 ± 8.5
12 HOURS! (Leu) 156.3 ±20 112.7 ±28 75.8 ±21 43.6 ±8.5
FASTING 1 (Gly) 75.6 ±17 31.5 ±11 75.6 ±17 44.1 ± 8.6
12 HOURS! (Leu) 101. 7 ±17 82.9 ±17 101.7 ±17 18.8 ± 4
TOTAL ) (Gly) 210.5 ±38 122.3 ±35 143.9 ±40 88.2 ±17
24 HOURS! (Leu) 258 ±36 190.7 ±52 177.5 ±36 62.4 ±11
Statistically (by matched pair t-test), the results of (15N)glycine 
14and (1- C) leucine sure in much better agreement in the feeding phase
(N.S.D. between the methods for Q, Z, B, E), than in the fasting phase
(p < .05 for all Q, Z, B, E) or for the total 24 hour period. However
in all phases this (15N) glycine method appears to give consistently
14lower flux results than the ( C) leucine method (as was similarly 
found by Golden a Waterlow, 1977).
A difficulty highlighted here is the use of urinary N excretion 
to represent protein oxidation rates for intervals of less than 
12 hours. In Table 5.1 the 24 hour N-excretion, representing 88.2 g 
Protein, was halved for the 12 hour rates. In fact the 12 hour 
urinary-N excretion profiles, for these 4 non-obese subjects, show that 
they excreted some 55.7% of their 24 hour urinary-N output during their 
feeding 12 hours, and the remaining 44.3% during the fasting 12 hours, 
as shown in Table 5.2.
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TABLE 5 .2 . Urinary nitrogen excretion over Feeding and Fasting 12-hour 
periods, fo r  4 non-obese (2 males, 2 females) subjects of the 
'Control' Group. (Protein = N x 6.25)
NAME FEEDING 12 HOURS FASTING 12 HOURS TOTAL 24 HOURS
g Protein % of 24 Hr g Protein % of 24 Hr g Protein % of 24 Hr
excretion excretion excretion
MG 35.8 53.2 % 31.5 46.8 % 67.3 lOO %
JS 50.9 60.2 % 33.7 39.9 % 84.5 loo %
JCW 56.1 60.4 % 36.8 39.6 % 92.9 lOO %
RHS 49.4 48.7 % 51.9 51.2 % 101.3 lOO %
MEAN 55.6 % 44.3 %
± S.D ±5.7 • ±5.6
However, In Section 4 It has been shown with both leucine >'<v
oxidation and correction of uriniu-y-N for changes in whole body urea 
space, that there Is usually a 60% drop in protein oxidation between 
feeding and fasting phases, so that about 70% of protein oxidation 
occurs during the feeding 12 hours, and the remaining 30% during 
the fasting 12 hours.
If this proportional oxidation pattern were applied to the urinary-
N based oxidation rates in Table 5.1, they would probably be a reasonable
approximation of genuine oxidation - but then the (^N)glycine's
estimation of synthesis during the feeding period would become even
lower (73.2 g Protein per 12 Hours) whilst in the fasting period the
estimate of synthesis would Improve (49.1 g Protein per 12 Hours) but
14still remain substantially below the value estimated by (1- C)leucine.
However with these corrections, the magnitude of the diurnal drop in
protein synthesis (33%) now becomes much closer to that shown by 
14(1- C)leucine.
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It does, however, appear that both methods significantly
underestimate flux (and hence synthesis and breakdown). In the previous
14section (Section 4) it was suggested that the (1- C) leucine method 
underestimates flux by some 33%. If this is the case, then the 
intravenous (^N) glycine method, using urinary ammonia as end product, 
may be underestimating true flux by some 45%.
The consistent relationship between the results from the two methods
(in which (15N) glycine gives consistently lower estimates of flux and 
14synthesis than the (1- C)leucine method) is maintained even through 
prolonged dietary changes. The following figure (Figure 5.1) shows 
this relationship for whole body protein synthesis in one of the obese 
patients (R.O) .
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n  (l-^C)Leucine Method
100
40 “
30
,15,( N)glycine/NH3 end-product Method
DAILY DIET 72.3 g Protein 1870 Real
0 Protein 
500 Real
50 g Protein 
500 Real
14FIGURE 5.1. Whole body protein synthesis in an obese patient (R.O.) measured simultaneously by (1- C)leucine infusion 
and (15M)glycine intravenous infi
particularly in Fasting periods.
and (^N)glycine intravenous infusion. The intravenous (^N)glycine method seems to give persistently lower results.
138
139
5.1.2. Multiple (hourly) oral doses of (^N)Glycine
Protein turnover measurements using this method were only made 
during daytime feeding periods, but the method was used to obtain 
results for patients on Diet P and Diet O for 3 weeks, as well as 
initially on the'Normal' Diet. The results have already been presented 
in Table 3.11 (Section 3), and contrary to the Intravenous (^N)glycine
results, the multiple oral doses method appears to produce higher
14absolute values for flux and synthesis, than the (1- C) leucine
14method. However, if the (1- C) leucine results were to be corrected 
for their possible 33% underestimate of flux and synthesis, they 
would be significantly higher than the (^N)glycine multiple dose 
measurements.
Despite these differences in absolute values, it was shown 
(Table 3.12) that the proportional changes in protein turnover,
resulting from 3 weeks on Diet P and Diet O, were almost identical,
15 14measured by multiple doses of ( N) glycine and by (1- C) leucine 
infusion.
5.1.3, Single dose of (15N)Glycine (oral and intravenous)
It was hoped that with the much greater convenience that the
single dose technique offered, protein turnover measurements would still
14compare reasonably well with (1- C)leucine measurements. As 
mentioned In Sections 1 and 2, the use of the single dose method 
Introduced its own problems, such as determining the appropriate 
collection period when sufficient isotope had cleared the metabolic 
pool but the contribution from recycling of was still minimal, and
the necessity to collect serial urine samples because of variation in 
the rate of urinary NH^ excretion.
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Nevertheless, by taking 3-hourly or 6-hourly serial urine 
collections and choosing 12 hours (in later studies this was changed 
to 9 hours) as an appropriate collection time for adequate clearance of 
the isotope, measurements of whole body protein turnover were made
by this method on a group of obese patients, some of whom had 
14simultaneous (1- C)leucine infusions, on the 'Normal' Diet regimen, 
and then after 3 weeks on Diet O. The measurements were made only
during feeding periods, and are thus only comparable with feeding 
14phase (1- C) leucine values. In the table below (Table 5.3), only
2 of the 6 patients in the 'Normal' Diet group had simultaneous 
14(1- C)leucine infusions, so the leucine measurements are the
standard 'Normal' Diet values from Table 3.7. The 3 patients in the
14'Diet O'group all had simultaneous (1- C) leucine infusions, so the 
values given for both measurement methods are specifically theirs.
Appendix 3.2 contains the individual (15N)glycine measurements for 
each patient, and Table 5.3 shows the mean (± S.D.) for each group.
TABLE 5.3. Comparison o f  oral sing le dose (^NJglycine/NH^ end-product 
measurement of protein turnover with (l-^ C )leucine  ( I ta lic s ) . The results  
show Mean (± S.D.) fo r 6 obese patients on 'Normal' D iet, and 3 obese 
patients a fter 3 weeks on Diet 0. (Feeding 12 Hours on ly .)
FEEDING
PHASE
Q Z Bg Protein per 12 Hours
E
NORMAL -1 (15N)gly (n-6) 169.3±61 131.9162 98.3162 37.413
DIET / (14C)leu (n-19) 167.S±17 122.9±17 83.0±17 44.6±8
DIET O I (15N)gly 70.61 4 60.81 6 70.61 4 9.812
(n-3) J (14C)leu 87.9HS 90.S±14 87.9±1S 7.4±2
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These data show a remarkably good comparison between the two 
measurement methods. In fact synthesis (Z) values would be even more 
closely matched if oxidation rate values (E) based on N-excretion, 
were corrected for changes in urea space, as shown in previous 
section (Section 4). Statistical testing (t-test) shows no significant 
difference between the 2 methods for all the protein turnover parameters.
Thus the single oral dose technique with (^N) glycine, gives
14very similar (mean) estimates of protein turnover, to the (1- C)leucine
method, although it appears to produce a much wider scatter of results
14at least on the 'Normal* Diet. Consequently if the (1- C)leucine 
method really does underestimate true flux by 33%, then it appears 
that this particular version of the (^N)glycine method does also.
The single intravenous dose method with (15n )glycine was also
repeatedly tried and tested in both obese and normal subjects, and
14showed a similar close relationship to (1- C)leucine values for
protein turnover, as the single dose oral (^N) glycine method. A
group of 4 normal, slim young adults ('Starvation' Group, see 5.2)
and 2 older non-obese adults, were measured by the single intravenous
dose method of (^N)glycine, and the values in Table 5.4 clearly
show that the (15n )glycine method, despite quite wide scatter results,
14give mean values that compare well with those of (1- C) leucine.
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TABLE 5.4. The intravenous single dose ( N)glycine/NH  ^ end-product
method, used to measure protein synthesis and oxidation in 5 normal
adults during th e ir feeding 12-hours on a 'Normal' D iet. Mean
(± S.D.) values fo r measurements made with (1-^ C)leucine in another
156 normal adults (2 of whom are included in the ( N)glycine group) are 
supplied fo r comparison ( ita lic s ) .
15
NAME PROTEIN SYNTHESIS Z
g Protein per
PROTEIN OXIDATION 
E
12 Hours
RM 146.7 52.8
MB 112.1 25.2
IP 175.4 56.1
PM 64.3 49.4
JKG 126.3 37.7
VT 165.0 46.2
MEAN 131.6 44.6
± S.D. 140 ±11
14( C) Leucine Group
MEAN 110.3 41.2
± S.D. ±22 ±8
14When these and other measurements done by  both (1- C)leucine 
and the different (^^N)glycine methods are compared, it Is apparent 
that although the different <^5N)glycine methods are all characterised 
by a rather wide scatter of results, the magnitude of change in
protein turnover as a consequence of prolonged protein-free dieting, is
14very similar by all methods including (1- C)leucine. This can be seen 
in Figure 5.2.
14 _FIGURE 5.2. Mean (± S.D.) whole body protein synthesis rates, measured by (1- C)leucine and 4 different methods of 
(15N)glycine, on 'Normal' Diet and after 3 weeks on Diet 0. The percentage changes from Normal diet to Diet 0 are shown 
for each method.
PROTEIN SYNTHESIS
□ NORMAL DIET 
DIET 0
(14C)LEUCINE (15N)GLYCINE
METHOD
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A major advantage of the single dose (15N) glycine method is 
its potential for frequent repeatability in the same subject, largely 
because of the rapid rise to plateau of the cumulative excretion of 
■^'’n in urinary ammonia. This capability was tested in patient E.E.
who was having continuous hourly feeding for 24 hours and a simultaneous 
14(1- C)leucine infusion (see Section 4, Table 4.8). Her first 
(15N)glycine (I.V. single dose) measurement of protein turnover was 
completed over the usual 9 hour collection period, and then after an 
interval of only 9 hours, a second I.V. single dose (^N)glycine 
measurement of protein turnover was made. Figure 5.3 shows the 
change in abundance in urinary NH^ over the 27 hour period, and
Table 5.5 below shows the excellent agreement of the two (^^N)glycine
14tests with each other, and with (1- C) leucine.
A tom Z Excess 
(x 1000)
Time
DOSE 1 DOSE 2
FIGURE 5.3. Abundance of 15N in Urinary NH3> Two measurements of 
protein turnover by single dose I.V. (* ’N)glycine, the second test 
commencing only 9 hours after completion of the first. (Patient E.E.)
TABLE 5.5. Protein turnover in  a continuously fed obese patient (E.E)
15measured by single dose I.V. ( N)glycine on 2 occasions only 9 hours
14apart, and also continuously with (1- C)leucine ( it a l ic s ) .
Q Z
g Protein per
B
12 Hours
E
1st 9 Hours
(15N)glycine 93.5 67.4 57.4 26.0
14(1- C) leucine 103.6 79.4 59.6 24.2
2nd 9 Hours » Interval
3rd 9 Hours
(15N)glycine 95.4 69.4 59.3 26.0
14(1- C) leucine 101.6 76.1 57.6 25.5
The reasonable similarity between the single dose (15N)glycine 
14values and the (1- C)leucine values for protein turnover, and the 
advantages of convenience, safety and ability to be used repeatedly, 
encouraged us to use the single dose (15N)glycine method to monitor 
the rate of change in protein turnover in a number of clinical 
situations. It was initially tried in the obese patients on protein- 
free or low protein diets, and as this proved successful, it has 
subsequently been used in other studies such as a 'starvation' study 
(see 5.2), monitoring the recovery of babies from meningitis (to be 
written-up), and a study investigating the effect of typhold/cholera 
vaccination on protein turnover (Garlick et al, 1980).
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5.2. MONITORING PROTEIN TURNOVER CHANGES WITH SINGLE DOSE (^N)GLYCINE/NH^
END-PRODUCT METHOD.
Having shown that the single dose (^N)glycine method could
measure protein turnover daily if necessary, and that the results
14were reasonably comparable with (1- C)leucine measurements, 
particularly in terms of proportional changes, a number of obese patients 
were measured on frequent occasions by this method during their 
weight reduction courses on Diet P and Diet O. In addition, for some 
obese patients protein intake was changed to different levels, and the 
effect of this on protein turnover measured.
It has been shown in Section 3 that after 3 weeks on 500 Kcal 
(2.1 MJ) and with complete absence of protein, that whole body protein 
synthesis drops by some 40%. It has further been shown in Section 4 
that the absence of protein intake for only a few hours (as in 
normal overnight post-absorptive fasting) results in am acute drop of 
27% in the rate of protein synthesis which remains at this depressed 
level until protein intadce is recommenced at the end of the fasting 
12 hours. It therefore appears that the remaining 13% drop in synthesis 
must occur at some stage over the 3 weeks of protein-free diet, and 
it was hoped that frequent measurements with (15N)glycine would 
elucidate the time-course of this decrease.
FIGURE 5.4. Whole body protein synthesis rates in 4 obese patients on Diet 0 (500 Kcal/0 Protein) 
for 21 days, measured by oral single dose (^Njglycine/NHj end-product method. The initial (Day O) 
measurement was made during feeding phase of 'Normal' Diet.
PROTEIN SYNTHESIS 
g Protein per 12 Hours
220 r
D.H.
M.W.
8 10 12 14 16 18 20 22
DAYS ON 'DIET O'
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Figure 5.4 shows this time course for 4 obese patients, and 
although absolute values are spread quite widely, the relative rate 
of fall in protein synthesis is very similar for each patient. The 
total fall in protein synthesis for the group as a whole is approximately 
48%. However protein synthesis rates have already dropped 40% by 
Day 2, 46% by Day 4, and 48% by Day 6 after which there is no significant 
further fall.
A similarly rapid fall in whole body protein synthesis is seen 
in starvation. When 3 young healthy adults embarked on a one week 
starvation programme, consuming only mineral water, their whole body 
protein turnover was measured on three occasions during the week 
by the single dose intravenous (15N) glycine method. Within 2 days of 
complete fasting, protein synthesis rates had fallen by some 50% 
and remained at that level for the rest of the week. Their oxidation 
rates appeared to fall more slowly but this delay was partly a result 
of slow excretion from the urea pool. Table 5.6 shows the results for 
protein synthesis and oxidation.
TABLE 5.6. Mean (± S.D.) whole body protein synthesis and oxidation rates 
for 3 young adults undergoing 1 week of starvation.
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SYNTHESIS
Z
g Protein per
OXIDATION
E
12 Hours
NORMAL DIET 144.7 44.7
±32 ±17
DAY 2 STARVATION 62.6 35.6
± 6 ±16
DAY 5 STARVATION 78.1 32.6
±11 ± 7
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There is more difficulty with protein breakdown however, because 
the interpretation of its changes appears to depend much more on the 
absolute values obtained for flux - and these vary widely with 
(15N)glycine methods. Figure 5.5 indicates this dilemma, showing 
that if the drop in flux that occurs when changing from ’Normal' Diet 
to the protein-free diet, is a small one (ie. smaller than the drop 
in protein intake), then protein breakdown will initially increase 
(Fig. 5.5A) before gradually decreasing with the subsiding flux. If 
the absolute drop in flux with the change in diets is a large one 
(ie. larger than the drop in protein intake) then calculated protein 
breakdown will simply decrease from Day O (Fig. 5.5B) . The
FIGURE 5.5. Protein Breakdown, measured by (^5N)glycine. The pattern 
of change in protein breakdown rates particularly depends on the 
magnitude of the drop in flux.
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(1-14C)leucine data, however suggests an initial increase in breakdown 
is the likely pattern. In Section 4 (Results 2) it was shown from 
(14C)leucine data that there was a diurnal increase in whole body 
protein breakdown of some 35%, as a result of the absence of any 
protein intake. Yet in Section 3 (Results 1) it was clear that after 
3 weeks on Diet O, whole body protein breakdown was unchanged from
normal. This pattern is confirmed by Figure 5.5A. However, if both 
14 15(1- C)leucine and ( N)glycine methods significantly underestimate 
true flux, then the breakdown pattern in Figure 5.5B may be more 
realistic.
When the large protein turnover changes resulting from prolonged
14protein-free dieting, were first measured with (1- C)leucine (Section 3),
it was planned that the (15N)glycine method, as well as being tested
and developed itself, could be used to confirm these changes, and monitor
14their magnitude and time-course. However, the finding (with (1- C)leucine) 
that some 2/3 of the decrease in whole body protein synthesis actually 
occurred in the first few hours of post-absorptive fasting, left only 
the small remaining decrease to be monitored over the 3 week period by the
(^N)glycine method. Nevertheless, this method has confirmed the 
14(1- C)leucine results, not only showing the initial very rapid drop 
in protein synthesis, but indicating that after the second day without 
protein this decrease very rapidly tails-off, so that the total decline 
in protein synthesis has already been achieved after 1 week of protein- 
free diet.
Extending further the monitoring use of this method, the dependence 
of protein synthesis on the level of protein intake, as first suggested 
in Section 3, was further confirmed when the level of protein intake 
was varied whilst energy intake was kept constant (eg. Figure 5.6).
In this obese subject, daily energy intake was maintained at 500 Kcal
Prot. Protein Gelatin Protein Protein
FIGURE 5.6.
Whole-body protein synthesis, 
measured by oral single dose 
(15N)glycine, at different levels 
of protein intake, but with energy 
intakes maintained at 500 Real 
per day.
(Patient P.S.)
10 20 40 50
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(2.1 MJ) whilst the quantity and quality of daily protein intake 
was varied, and protein turnover measured at frequent intervals 
by oral single dose (1^N)glycine using ammonia as urinary end-product. 
Despite the variability of results from this method, it. is clear 
that whole body protein synthesis has dropped by almost 20% on the 
25 g Protein diet, by approximately 45% on the gelatin diet, and 
then risen again with réintroduction of higher levels of utilisable 
protein.
The results from this section have thus confirmed the characteristics
14of whole body protein turnover initially established by the (1- C) leucine
method, and further elucidated the relationship between protein synthesis
and protein intake, including the time-course of changes.
A remaining uncertainty however, associated with both these
methods of protein turnover measurement; is their accuracy in estimating
14true values of genuine precursor-pool flux. If the (1— C) leucine 
method underestimates flux by some 33% (a possibility discussed in 
Section 4) then this (15N)glycine method would also appear to do so, 
considering the comparability of mean absolute values from both methods.
SECTION 6 ADAPTIVE AND ACUTE RESPONSES IN PROTEIN TURNOVER
RESULTS 4
DISCUSSION 4
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RESULTS 4
This concluding group of protein turnover results brings 
together the concepts of adaption and long term change in protein 
metabolism from Section 3, with those of rapid diurnal change and 
acute sensitivity to protein intake, from Section 4.
The consequences of a protein-free 500 Real (2.1 MJ) per day 
diet for 3 weeks (Diet O) were shown to include a 40% drop in whole- 
body protein synthesis and an 85% drop in protein oxidation, measurements 
being made during the feeding 12 hours (Section 3). Section 4 
showed that 2/3 of that drop in both synthesis and oxidation occurred 
within hours of post-absorptive fasting, as a diurnal change. Section 5 
showed that the total 40 - 50% drop in synthesis was already achieved 
after some 6 days, and thereafter little further change took place, 
although once again these (15N)glycine measurements represented 
feeding phase rates.
Two further outstanding questions required investigation*
(1) After 3 weeks on the protein-free Diet O, is there 
any diurnal change in protein metabolism?
(2) How does whole-body protein turnover respond to 
the sudden réintroduction of protein?
Each of the previous results sections have strongly suggested 
that the rate of whole body protein turnover is fundementally dependent 
on the level of protein intake. In the light of these findings, there 
should be no diurnal change whatsoever in people with a daily dietary 
intake of only 500 Real of glucose syrup.
A group of 4 obese patients (Diet O-Diumal group) were subjected 
to the 3 week dietary regimen of Diet O (500 Real (2.1 MJ) and O g protein 
per day), and after 20 days had their protein turnover measured for
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30 - 36 hours by continuous (1- C)leucine infusion. The measurement 
period thus included the daytime feeding 12 hours, the night-time 
fasting 12 hours, and a further 6 - 1 2  hours measurement period. 
During this last period one patient (T.D.) continued on Diet O, but 
the other 3 patients commenced Diet P which effectively kept the 
rate of energy intake unchanged (500 Real) but suddenly reintroduced 
protein (50 g protein in 12 hours).
Table 6.1 shows the mean diurnal rates of protein turnover 
for this group, initially on their 'Normal* Diet prior to 
the commencement of Diet O, and then after 3 weeks on the protein- 
free Diet O. The dietary and anthropometric data for the individual 
members of this group are given in Appendix 2.1 (the last 4 
patients), and the individual protein turnover values are tabulated 
in Appendices 4.1 and 4.2.
14
15?
T A B L E  6 . 1 .  Mean (±  S . D . )  24 h o u r  p r o t e i n  t u r n o v e r  r a t e s  i n  4 o b e s e
w om en , i n i t i a l l y  on ' N o r m a l '  D i e t ,  a n d  t h e n  a f t e r  3 we e ks  on D i e t  0 .  
1 4M e a s u r e d  b y  ( 1 -  C ) l e u c i n e  i n f u s i o n .
Q Z B
g Protein per 12
E
Hours
z
A. 'NORMAL* DIET
FEEDING 161.7 120.5 77.0 41.2 7C.O
12 HOURS +24 ±22 ±25 ±7 ± 2 . 8
FASTING 112.0 92.0 112.0 20.0 C
12 HOURS ±28 ±24 ±28 ±4
« CHANGE +30.0 % +22.8 % +62.5 % +49.5 % _
(FEEDING •+ FASTING)
B. DIET O
FEEDING 79.2 71.9 79.2 7.4 c
12 HOURS ±11 ±10 ±11 ±2
FASTING 76.7 70.4 76.7 6.4 0
12 HOURS ±10 ±9 ±10 ±0.5
% CHANGE NO S IG N IF IC A N T CHANGE
These results are unequivocal. Protein synthesis drops as 
expected with the change from, feeding to fasting phase on the ’Norra!' 
Diet, but on Diet O there is no diurnal change, whole-body protein 
synthesis rate remaining constant, depressed, and unaffected by th* 
diurnal addition or subtraction of 500 Kcal of glucose syrup per
12 hours
There is also very little diurnal change in protein oxidation 
rate on the protein-free Diet 0 regimen. The 50 - 60% drop in 
oxidation characteristic of the change from feeding to fasting phase 
on the'Normal'Diet, has been replaced by a very low almost fixed 
oxidation rate, similar to obligatory protein oxidation.
Protein breakdown, which increases immediately with the onset 
of post-absorptive fasting on the 'Normal* Diet regimen (here by 
62.5%),not only loses its diurnal changes after 3 weeks on Diet O, 
but remains at a constant value that is neither depressed or 
elevated, but equal to the 'normal' feeding phase breakdown rate 
on the 'Normal* Diet.
For the one patient (T.D.) who then continued on Diet O whole- 
body protein synthesis continued to remain completely unaffected.
This has already been shown in Section 4 (Fig. 4.2(b)), where hourly 
rates of protein synthesis extending over the three 12-hour phases 
of feeding, fasting and feeding were shown to lie on an almost 
horizontal regression line. Figure 6.1 shows how breakdown and 
oxidation rates also remain constant irrespective of the acute addition 
or subtraction of 500 Real of glucose syrup. (Once again the slight
downward drift, which also occurs with continuous protein feeding
14over 24 hours, is likely to result from ( C)leucine recycling.)
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FIGURE 6.1. Protein Synthesis, Breakdown, and Oxidation rates over 3 
consecutive 12-hour periods of feeding (A) , fasting (B) , and feeding (C) , 
for patient T.D. on Diet O for 3 weeks.
PROTEIN SYNTHESIS
g P r o t e i n  
per 12 Hrs
The other 3 patients of the group, after having their protein 
turnover measured over 24 hours on Diet O, were refed with protein 
(Diet P: 500 Real and 50 g protein over 12 hours) whilst keeping the 
energy intake at 500 Real per day. Table 6.2 shows the effect of this
sudden réintroduction of protein
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T A B L E  6 . 2 .  Mean (± S . D . )  p r o t e i n  t u r n o v e r  r a t e  f o r  3 o b e s e  women , 
d u r i n g  t h e  f i r s t  1 2  h o u r s  o f  p r o t e i n  r e f e e d i n g  ( 5 0 0  K c a l / 5 0  g p r o t e i n  
p e r  12  h o u r s ) ,  a f t e r  h a v i n g  b e e n  on 500 K c a l s / 0  g P r o t e i n  p e r  d a y  
f o r  3 w e e k s .
Q Z B E
g Protein per 12 Hours
I
PROTEIN REFEEDING 
12 HOURS
97.9 74.1 37.5 23.8 
±12 ±13 ±11 ±2
48.1
Matched-pair t-test 
(cf. Diet O Feeding)
N.S.D p < .02 p < .Ol
These results are most surprising. Protein synthesis remains 
depressed and appears to have lost its acute sensitivity to protein 
intake. Protein breakdown has dropped by a remarkable 51% from its 
value on Diet O. Protein oxidation has imnediately risen to a 
value typical of the feeding phase of Diet P. These changes can 
be visualised better in perspective in Figure 6.2 (A) and (B), where 
the hourly values of synthesis, breakdown, and oxidation are monitored 
for one patient (E.K.), and the mean group values for each phase are
also shown
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FIGURE 6,2.
(A) Protein Turnover continuously measured (Patient E.K.) showing 
the response to réintroduction of Protein.
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FIGURE 6.2.
DIET 0
DIET P
(B) Values for Protein Synthesis, Breakdown, and Oxidation, over
3 consecutive 12 Hour periods of feeding (500 Kcal/O Protein),
Fasting, and Protein Refeedlng (500 Kcal/SO g Protein)
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DISCUSSION 4
The unexpected response of whole body protein metabolism to 
the réintroduction of protein after 3 weeks of protein-free diet, 
revives the question of whether a long term adaption has occurred 
leaving whole body protein synthesis in a suppressed and insensitive 
state.
On a normal dietary intake, it has been shown that protein 
synthesis is acutely responsive to the level of protein intake, with 
diurnal changes of almost 30% (Section 4) . It has also been shown 
that following its initial rapid fall in response to normal post- 
absorptive fasting, protein synthesis continues to decrease if no 
protein is supplied in the diet (eg. total starvation, or Diet O) , 
and the maximum 40 - 50% decrease in the raté of synthesis is achieved 
after about 6 days (Section 5). Perhaps it is whilst this final smaller 
slower decrease is occurring that the body's protein synthetic 
apparatus 'switches off' its sensitivity and acute responsiveness to 
protein intake. The remarkable failure of whole body protein 
synthesis to respond to the réintroduction of protein after a prolonged 
protein-free period, suggests a temporary adaption, possibly resembling 
hibernation. Its eventual increase with the réintroduction of a protein 
intake has been shown in Figure 5.6.
Protein oxidation may also have lost some responsive capability, 
despite its obvious immediate recovery with the réintroduction of 
dietary protein. Section 4 showed the large 60% diurnal drop In 
oxidation that typically occurs on a normal intake with the commence­
ment of post—absorptive fasting. Three weeks on a diet of 500 Kcal/O g 
protein produced an overall 85% drop in oxidation, so that like protein 
synthesis, 2/3 of the total decrease in oxidation rate has occurred
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immediately as an acute response to fasting, followed by a slower more 
gradual decrease over the next several days.
The absolute rate of protein oxidation after 3 weeks on Diet O,
14whether estimated by (1- C)leucine infusion (13.7 g Protein per day) 
or from urinary-N excretion (2.8 g N per day, equivalent to 17.4 g 
Protein per day) represents a rate close to minimum obligatory protein 
oxidation and N excretion (eg. 2.4 g N/day, Calloway & Margen, 1971; 
Jourden et al, 1974). It is only half the rate of protein oxidation 
associated with prolonged total fasting, as is apparent from the 
data of Marllss et al (1978) who found a urinary-N excretion rate of 
5.2 g N/day (equivalent to some 32.5 g protein) in a group of 7 obese 
subjects totally fasted for 3 - 4  weeks. Thus the presence of 500 Real 
of glucose syrup per day has induced significant protein sparing, 
consistent with the findings of Calloway & Spector (1954) who showed 
that negative nitrogen balance is progressively reduced by addition 
of non-protein energy up to (but not beyond) 700 Kcal/day.
However, it is interesting to note that despite the overall protein 
sparing effect of Diet O, and the large effect that glucose seems to 
have on protein metabolism when protein intake is zero, yet on a 
diurnal basis protein-synthesis, breakdown, and oxidation rates appear 
to be unaffected by 12 hour periods alternately on and off glucose, at 
least when protein metabolism is in a depressed 'adapted' state 
after 3 weeks of protein-free diet.
Probably the most remarkable immediate effect of the réintroduction 
of protein after 3 weeks on Diet O, is the huge drop in whole body 
protein breakdown - a drop of 51% in this group. Nor is this effect 
likely to be an artefact of the (1-^4C)leucine method. It was shown 
in Section 4 that if the (1-14C)leucine method were corrected for its 
possible 33% underestimate of flux, then the 35% diurnal increase in
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protein breakdown, seen on commencement of the post-absorptive fasting 
phase of the 'Normal' Diet, would be eliminated, and protein breakdown 
would then appear to show no change between feeding and fasting periods. 
But even if such a correction were applied to the flux rates obtained 
from both Diet O and Protein Refeeding phases,there would still be a 
very significant drop (30%) in protein breakdown as an immediate 
effect of reintroducing dietary protein.
Several recent studies have been concerned with the protein 
sparing effects of glucose, glucose plus amino acids, and amino acids 
alone, in either fasting or surgical patients. The mechanisms proposed, 
suggesting various changes in protein synthesis and breakdown, are 
mostly speculative, as the protein sparing has usually only been 
measured in terms of nitrogen balance data. A confusion of proposals 
and often erroneous assumptions can be seen even from some of the most 
celebrated studies.
Blackburn et al (1973) suggested that in starvation protein 
synthesis and breakdown both fall, but added amino acids spare protein 
by sustaining protein synthesis. They further suggested that 
addition of glucose to the amino acids is more harmful than amino 
acids alone, since glucose augments net protein breakdown by 
suppression of ketogenesis. In complete contrast, Jeejeebhoy (1977), 
Howard et al (1978) , and Elwyn et al (1978) have all shown that the 
protein sparing achieved by glucose plus amino acids is greater than 
with amino acids alone, but whilst Howard et al suggested that the 
addition of glucose causes a decrease in protein breakdown, Elwyn et al 
proposed that it spares additional protein by increasing synthesis 
through the anabolic effect of insulin. Marliss et al (1978) 
have claimed that during prolonged fasting protein breakdown decreases, 
and that the addition of dietary protein leads to increased protein
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breakdown, so that there must be an even greater increase in protein 
synthesis to account for the observed protein sparing effect.
Despite this speculation on how the relative changes in protein 
synthesis and breakdown might balance to promote protein sparing, 
few attempts have been made to measure protein turnover in these 
circumstances. An exception is the study of Sim et al (1979) 
who showed that the additional protein sparing effect achieved 
by adding glucose to a constant intravenous amino acid regime, 
resulted from an increase in protein synthesis, with breakdown 
remaining unchanged.
Our data may contribute to an understanding of the mechanisms 
of protein sparing, since we have measured protein synthesis and 
breakdown in groups of subjects under the following conditions:-
(a) prolonged fasting (see Section 5);
(b) a hypocaloric glucose only intake (Diet O) »
(c) a hypocaloric carbohydrate plus protein intake (Diet P). 
Table 6.3 sets out mean values of protein synthesis and breakdown, 
characteristic of prolonged exposure to these regimens.
T A B L E  6 . 3 .  W h o l e  b o d y  p r o t e i n  s y n t h e s i s  a n d  b r e a k d o w n  i n  r e s p o n s e  t o  a 
p r o l o n g e d  p e r i o d  o f  e i t h e r  t o t a l  f a s t i n g ,  5 0 0  K c a l  o f  g l u c o s e ,  o r  on 
500 k c a l / 5 0  g P r o t e i n  ( F e e d i n g  P h a s e  v a l u e s  a r e  s h o w n ) .
PROTEIN SYNTHESIS PROTEIN BREAKDOWN
Z
g Protein
B
per 12 Hours
Prolonged Fasting 
(1 week)
70 104
500 Kcal Glucose 
(Diet O: 3 weeks)
71 79
500 Kcal/50 g Protein 
(Diet P: 3 weeks)
115 84
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These data suggest that in the absence of protein intake, glucose 
exerts its protein sparing effect by lowering protein breakdown, 
not by increasing synthesis. This is consistent with one of the 
basic findings in this thesis, that protein synthesis is largely 
dependent on (and acutely responsive to) the level of protein intake, 
and when the absence of protein is prolonged whole body protein 
synthesis falls to a low, constant, 'adapted' rate, unaffected by 
glucose intake, and only slowly responsive to protein intake. Thus 
the significant difference between obligatory minimum urinary-N 
excretion (about 2.4 g N/day) and the level of urinary-N excreted 
in prolonged fasting (about 5.2 g N/day), is entirely due to the 
higher rate of whole-body protein breakdown associated with prolonged 
fasting.
The differences between prolonged fasting values and Diet P values 
suggest that the protein sparing which is achieved by administration of 
both amino acids plus glucose to a fasting patient, results from the 
combined effect of an increase in synthesis and a fall in protein 
breakdown. However, in a patient who is already receiving an intake of 
amino acids only, the increased protein sparing benefit resulting 
from the addition of glucose is probably achieved by an increase in 
protein synthesis alone, as shown by Sim et al (1979), and discussed 
earlier in Section 3.
Finally, in a patient on a prolonged intake of glucose alone, there 
is a distinction between the mechanisms of acute and long term 
achievement of protein sparing, when amino acids are added. The initial 
effect is a dramatic drop in protein breakdown, the 'adapted' protein 
synthesis rate remaining unresponsive for several hours. Eventually 
protein synthesis rises to a level determined largely by the level 
of protein intake itself, but also influenced by the energy intake,
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whilst protein breakdown returns to its usual level, seen during the 
feeding phase of most diets.
The remaining question extending from previous sections, is 
whether internal recycling, and the relationship between plasma and 
precursor-pool leucine, have changed after 3 weeks on Diet O, and 
therefore whether the leucine method still appears to give a 33% 
underestimate of flux.
In the following table (Table 6.4), since there is no protein 
intake, urinary-N excretion is assumed to represent the same 'whole 
body protein', containing 8.0% of leucine, that the leucine method 
represents in its estimate of protein oxidation rate.
T A B L E  6 . 4 .  C o m p a r i s o n  o f  p r o t e i n  o x i d a t i o n  r a t e s ,  m e a s u r e d  b y  u r i n a r y - N  
1 4e x c r e t i o n  a nd ( 1  C ) l e u c i n e  m e t h o d s ,  t o  c a l c u l a t e  t h e  p o s s i b l e  u n d e r -
1 4e s t i m a t e  o f  f l u x  b y  t h e  ( 1 -  C ) l e u c i n e  m e t h o d .
NAME
PROTEIN OXIDATION (g Protein/24 Hours)
Ex  * lOO %Urinarv-N excretion <1-14C)leucine
(V (el)
MW 14.7 12.1 82.3 %
TD 16.4 15.6 95.1 %
EK 19.2 15.4 80.2 %
RO 20.5 11.7 57.1 %
Mean 78.7 %
± S.D. t!5.8 %
These results have a wide scatter, and statistical comparison 
(matched pair t-test) with these patients' own 'Normal* Diet 
'underestimate percentages' indicates no significant difference. Never 
theless, the results appear to suggest that under these conditions the
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(1- C)leucine method underestimates oxidation and flux by some 21%, 
a value almost identical with that obtained for E.E. (Section 3) 
and by Golden & Waterlow (1977) .
On a normal dietary intake with feeding and fasting phases, in
both obese and non-obese adults, the discrepancy between urinary-N
14based protein oxidation rates and those obtained from (1- C)leucine 
indicated a consistent 33% underestimate by the leucine method. At 
lower rates of protein intake, and also in this group after 3 weeks 
on Diet O, the discrepancy seems to have lessened to about 21%. If
these discrepancies genuinely indicate the underestimate of flux 
14as measured by the (1— C)leucine method, then it is possible that 
the relationship between plasma leucine disposal rate and precursor 
pool flux, may change with changing rates of protein intake. However, 
the apparent direction of this change (an increasing underestimate 
of flux with increasing protein intake) is such as to accentuate 
the changes in protein synthesis and oxidation shown to occur with 
changing diurnal and long term protein intakes.
14
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FURTHER COMMENTS, SUMMARY, AND CONCLUSIONS
Two underlying aims have persisted through each section of this
14thesis - the development of the (1- C)leucine method for whole-body 
protein turnover measurement, and the use of this method for the 
investigation of protein synthesis, breakdown, and oxidation, 
measuring both absolute values and change under different acute and 
long term dietary conditions.
Some remarkable, and hitherto unsuspected features of human 
protein metabolism have emerged, and most of these are summarised 
further below. However, one of the most significant of these is the 
acute sensitivity and responsiveness of protein turnover to any change 
in the level of protein intake. It was shown in Section 4 that when 
protein intake was either commenced or terminated, whole body protein 
turnover would respond within one hour. It became apparent that the 
hourly rate of protein turnover is dependent on the hourly rate of 
protein intake.
This finding, along with the measurement of substantial feeding/ 
fasting diurnal changes in protein turnover, makes it clear that protein 
synthesis values, measured during a short period of constant feeding 
(or fasting), are not representative of genuine daily rates of protein 
synthesis (unless protein intake rate remains unaltered over the 24 hours). 
It is therefore usually Inappropriate to express measured protein 
turnover rates as daily rates, unless measured over that period, or 
a prolonged measurement method is used (eg. (^N)glycine/urea end-product 
method). Estimated values for protein synthesis in g Protein/day are 
greatly infuenced by diurnal feeding patterns.
A comparison of whole-body protein synthesis values from some 
previous studies, expressed in terms of g Protein per 12 hours
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(appropriate for the C-tracer studies which have all measured turnover
under constant feeding conditions) shows where estimates by the 
14(1- c)leucine method lie, in comparison with other tracer methods.
14The reasons for the probable overestimate by (U- C) tyrosine have
14been previously discussed (Sections 1 and 3). The (1- C) leucine 
results lie between the estimates from urea end-product and NH^ end- 
product methods of (^tOglycine, as discussed in Section 1.
14
T A B L E  7 . 1 .  W h o l e  b o dy p r o t e i n  s y n t h e s i s  e s t i m a t e s  b y  d i f f e r e n t  m e a s u r e ­
m e n t  m e t h o d s ,  f o r  o b e s e  and n o r m a l s u b j e c t s ,  on a n o r m a l  d i e t .
STUDY TRACER SUBJECTS PROTEIN SYNTHESIS g protein/12 Hour
James et al 1976 (U-14C)tyr Normal (6) 173
Sender et al 1975 (U-14C)tyr Obe se (5) 200
O ’Keefe et al 1974 (1-14C)leu Normal (4) 138
Steffee et al 1976 (15N)qly/urea Normal (6) 103
Young et al 1975 (lbN)qly/urea Normal 102
Sim et al 1979 (15N)gly/urea Normal (5) 82
THIS STUDY
14(1- C) leucine I.V. infusion Obese (19) 
Control (5)
123
112
(15N)glycine/NH.
I.V. infusion Normal (4) 91
Oral multiple dose Obese (6) 159
Single dose oral Obese (6) 132
Single dose I.V. Normal (6) 132
The values in Table 7.1 are representative of whole body protein 
synthesis under the influence of a constant protein intake (although 
there are some long gaps between feeds in the ( ^N)glycine/urea end- 
product studies). However, the work presented in this thesis has
TA B LE 7 . 2 .  Mean (± S . D . )  a b s o l u t e  r a t e s  o f  p r o t e i n  t u r n o v e r  measured by ( 1 -  C ) l e u c i n e  c o n s t a n t  i n f u s i o n  m ethod.14
SUBJECTS Number INTAKE (over 12 Hours) 
Kcal/g Protein
SYNTHESIS
Z
9
BREAKDOWN
B
Protein per 12
OXIDATION
E
Hours
NORMAL FEEDING
OBESE GROUP 19 1712/70.5 122.9+17 83.0±17.5 44.6+8
CONTROL GROUP 
NORMAL FASTING
5 1797/67.2 112.2+25 75.1±19 43.1±7
OBESE GROUP 10 0/0 87.6+15 106.3+17 18.7+4
CONTROL GROUP 5 0/0 81.6+15 100.5±15 18.9+4
'DIET P' FEEDING 
(after 3 weeks)
4 511/48.2 115.0±28 84.0+30 29.5+5.6
•DIET O' FEEDING 
(after 3 weeks)
4 495/0 71.9±10 79.2+11 7.4+2
'DIET O’ FASTING 
(after 3 weeks)
4 0/0 70.4+ 9 76.7+10 6.4+0.5
PROTEIN REFEEDING 
(after 3 weeks Diet 0)
4 529/48.1 74.1±13 37.5±11 23.8+2
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g Protein 
per 12 Hours
FIGURE 7.1. Whole body protein synthesis and breakdown, affected by acute and 
prolonged changes in protein intake.
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accumulated a substantial number of (1- c)leucine measurements of 
whole body protein turnover under a number of different dietary 
conditions and in both obese and normal subjects. The absolute 
values for these, as presented in the Sections 3 - 6 ,  are set out 
in Table 7.2 and Figure 7.1.
When these data are considered in terms of the proportional changes 
that occur as a result of protein intake levels, the profiles of 
percentage change vary slightly depending on which level the changes 
relate to. In the previous sections, change has been expressed as a 
percentage of 'Normal' feeding phase values. These are summarised in 
Table 7.3.
T A B L E  7 . 3 . M ean p r o t e i n  t u r n o v e r  r a t e s ,  e x p r e s s e d  as p e r c e n t a g e s  o f  
' N o r m a l '  f e e d i n g  v a l u e s  ( O b e s e  p a t i e n t s  o n l y ) .
14
GROUP SYNTHESIS BREAKDOWN OXIDATION
Z B E
Normal Feeding loo % lOO % lOO %
Normal Fasting 71.3 % 128.1 % 41.9 %
Diet P (500/50) Feeding 93.6 « 101.2 « 66.1 %
Diet O (500/0) Feeding 58.5 * 95.4 « 16.6 «
Diet O (500/0) Fasting 57.3 % 92.4 % 14.3 %
Protein Refeeding (500/50) 60.3 % 45.2 « 53.4 »
When the same results are expressed as a percentage of the normal 
post-absorptive fasting values, one can perceive in clearer perspective 
the effect of any level of protein intake, as well as the further 
adaptation that occurs as a result of prolonged absence of protein.
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T A B L E  7 . 4 . Mean p r o t e i n  t u r n o v e r  r a t e s ,  e x p r e s s e d  a s  p e r c e n t a g e s  o f  
n o r m a l  f a s t i n g  ( p o s t - a b s o r p t i v e )  v a l u e s .
GROUP SYNTHESIS
Z
BREAKDOWN
B
OXIDATION
E
Normal Fasting lOO % lOO % lOO %
Normal Feeding 140.3 « 78.1 « 238.5 %
Diet P (500/50) Feeding 131.3 « 79.0 « 157.8 %
Diet O (500/0) Feeding 82.1 % 74.5 % 39.6 %
Diet O (500/0) Fasting 80.4 % 72.2 % 34.2 %
Protein Refeeding (500/50) 84.6 % 35.3 % 127.3 %
Thus if post-absorptive fasting is regarded as 'baseline', the 
effect of normal feeding is a dramatic 40% increase in protein 
synthesis, a 139% increase in oxidation, and a 22% drop in breakdown. 
However it is the profiles of synthesis, breakdown and oxidation, and 
how these change with protein intake, that are remarkable. The 
adaption and non-responsiveness of protein synthesis to réintroduction 
of protein, the adaption of protein breakdown with an even further 
amazing decrease when protein is reintroduced, and the enormous changes 
in protein oxidation are all apparent particularly from Table 7.4.
It is possible that the absolute values of protein synthesis, 
breakdown and oxidation, shown in Table 7.2, may all be significantly 
too low. In Sections 3,4, and 6, using a method of comparison similar 
to that suggested by Golden & Waterlow (1977), it was shown that the 
(1-^^C)leucine method appeared to underestimate oxidation rates by about 
20%,and that if it were assumed that oxidation and synthesis shared 
the same precursor pool, then it was possible to quantitate this error 
of underestimation for flux, synthesis and breakdown.
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In fact the precursor pools for whole body protein synthesis and 
leucine oxidation are likely to be quite different, since it appears that 
leucine oxidation primarily occurs in muscle (Elia et al, 1980). 
Furthermore in any tissue the precursor pool from which an amino acid 
is incorporated into protein (eg. perhaps in the cell membrane, 
functionally somewhere between plasma and intracellular pools. Airhart 
et al, 1974) may be structurally and functionally very different 
from the precursor pool from which its oxidation occurs.
Nevertheless, if the correction factors calculated for the
14possible underestimate of flux by (1- C) leucine are applied, then 
the absolute values previously shown in Table 7.2, will be increased. 
These 'corrected' rates of synthesis, breakdown and oxidation are 
shown in Table 7.6 further below.
The correction factors themselves appear to be partly dependent on
the level of protein intake, or perhaps flux. The relationship
between plasma and 'precursor pool' does not seem to alter with acute
diurnal changes in protein intake (Section 4), since it was shown that
on the Normal Diet regimen, the underestimate of flux in 15 obese and
control subjects remained at approximately 33%, irrespective of feeding
and fasting. When the rate of protein intake was only half that of the
'Normal' Diet (eg. for patient E.E., and the geriatric patients of
Golden & Waterlow, 1977) , the underestimate improved by decreasing to
approximately 20%. A similar underestimate was found for the 'adapted'
subjects after 3 weeks on Diet O. Thus a possible 'slow response'
relationship may link the rate of protein intake (and hence flux) with
14the level of underestimation of flux by the (1- C) leucine method.
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T A B L E  7 . 5 .  P e r c e n t a g e  u n d e r e s t i m a t e  o f  ' t r u e '  f l u x  b y  t h e  ( 1 -  C ) l e u c i n e  
m e t h o d ,  a t  d i f f e r e n t  r a t e s  o f  p r o t e i n  i n t a k e .
14
STUDY PATIENTS PROTEIN INTAKE % UNDERESTIMATEg Protein/hour Of FLUX
Golden & Waterlow 
(1977)
6 Geriatric CM 23 % ± 6
SECTION 3 Patient E.E. Obese 3.0 21 %
SECTION 6 4 Obese O 21 % ± 15
SECTION 4 5 Normal 5.6 35 % ± 15
lo Obese 6.1 33 % ± 7
Normal Feeding «. 
Normal Fasting -
5.6 31 «
O 32 «
T A B L E  7 . 6 .  Mean a b s o l u t e  r a t e s  o f  p r o t e i n  t u r n o v e r ,  m e a s u r e d  b y  
14( 1 -  C ) l e u c i n e ,  a n d  ' c o r r e c t e d '  f o r  t h e  m e t h o d ' s  u n d e r e s t i m a t i o n  o f  f l u x .
SUBJECTS PERCENTUNDERESTIMATE
SYNTHESIS BREAKDOWN OXIDATION 
Z B E 
g Protein per 12 Hours
Normal Feeding 33 % 183 165 67
Normal Fasting 33 % 131 159 25
Diet P Feeding 33 % 172 65 44
Diet O Feeding 21 % 91 l o o 9
Diet O Fasting 21 % 89 97 8
Protein Refeeding 21 % 94 63 30
These corrections have not affected the proportional changes that 
occur in synthesis and oxidation in response to dietary protein, but 
the response of protein breakdown appears to be quite altered. It now 
appears that diurnal post-absorptive fasting no longer causes an 
increase in protein breakdown, which remains constant.
177
Furthermore, both Diet P and Diet O now appear to drastically reduce 
protein breakdown , whereas in previous tables they had no effect.
Three weeks on 500 Kcal/SO g protein drops breakdown by 60%, whilst 
there is a 38% decrease after 3 weeks of the protein free diet. The 
sudden further drop in breakdown is still seen however, when protein 
is reintroduced after its prolonged absence from the diet.
The argument can only remain unresolved at present, on whether 
these corrections are valid or necessary. Fortunately they leave the 
relative changes in protein synthesis and oxidation unaffected, but 
uncertainty about both the absolute values of protein turnover, and the 
response of protein breakdown to protein intake, will remain, at least 
until other techniques or independent comparisons reveal more of the 
functional relationships between plasma, intracellular and precursor 
pools.
It remains to summarise the findings and conclusions, for both 
methodology and protein metabolism, that have been presented in the
previous sections.
14The (1- C)leucine constant infusion method has been central to 
most of the measurements presented. The development of the method's 
most critical techniques has been described in Section 2, particularly 
showing how a system was built to enable prolonged protein turnover 
measurements. This capability allowed the investigation of diurnal 
patterns of protein turnover, and prompted the energy metabolism 
measurements shown in Part B.
14Two sources of error with the (1- C)leucine method, and their
appropriate correction factors, have been Investigated. In Section 2
it was shown that whenever oxidation is measured from the decarboxylation
of a (1-C) labelled tracer amino acid, a 10% loss of labelled COj needs
14to be accounted for. It was shown with 10 ( C)bicarbonate infusions,
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that the correction factor (ie. 100/90) remains constant for at least 
36 hours of infusion, and is unaffected by diet or diurnal feeding/ 
fasting changes.
The second source of error (the known underestimate of flux by 
14the (1- C) leucine method, because of internal recycling) and the 
validity of its attempted quantitation, has been discussed in every 
section. It appears that the underestimate may increase with increasing 
protein intake or flux, so that on a normal dietary intake of some 
70 g protein given over 12 hours, the underestimate was 33% in both 
obese and non-obese subjects, whilst at lower rates of protein intake 
or even protein-free diets the underestimate was 21%. However, it has 
been pointed out that it is dubious whether these underestimates 
really apply to the precursor pool for protein synthesis.
In Section 5, the (15N)glycine method, using ammonia as the 
excreted end-product, and with a number of different dose-administration
techniques, proved to give reasonable comparative estimations of protein 
14turnover with the (1- C)leucine method, although individual values 
were often widely scattered. On normal protein intakes, the method
usually gave marginally higher estimates of flux and synthesis than the 
(1-14C)leucine method, but on prolonged protein free diets, its estimates 
were usually lower. If the (1-^4C)leucine method underestimates flux, 
then the (^N) glyclne/ammonia end-product would also appear to do so.
The outstanding advantage of this method, particularly with single 
dose administration, was its ability to make repeated frequent measure­
ments of protein turnover. It was shown that such measurements could 
be made within 9 hours of each other, and in addition long term 
monitoring of protein metabolism could be achieved.
Although it was originally Intended to investigate some general 
aspects of human whole-body protein turnover, the unexpected findings
that first emerged, and the direction of research they prompted,
have orientated the results about a fundemental relationship in protein
metabolism - the close dependence of protein turnover on protein
intake. As this close dependence and its sensitivity have been explored
in each section of this thesis, a number of remarkable findings and
conclusions have emerged, and the most notable of these are
summarised here.
1. Whole body protein synthesis is largely dependent on 
protein intake. When protein intake is above requirement 
protein synthesis remains normal. When intake falls 
below requirement, protein synthesis rate falls, and
may fall some 40 - 50% below normal with prolonged 
protein free diets or starvation.
2. Increasing the rate of energy intake, up to approximately 
40 Kcal/hour, will improve the rate of protein synthesis 
if this is already low because of an inadequate protein 
intake. Further addition of energy (above 40 Kcal/hour) 
has little effect. In this way, marginally inadequate 
protein intakes may become adequate, with the addition
of extra energy up to 40 Kcal/hour.
3. There are two rates of response of whole-body protein 
synthesis to changes in protein Intake:
(a) An acute rapid response ( 3 - 4  hours), accounting 
for almost 2/3 of the total eventual change in synthesis 
rate, and immediately reversible.
(b) A slow long term 'adaptive' response in which 
protein synthesis rate gradually approaches a corresponding 
'adapted' level (over 5 - 6  days) if the changed rate of 
protein Intake is maintained. This is not an Immediately
reversible change
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4. There are large diurnal changes in whole body protein turnover, 
resulting from acute changes in the rate of protein intake. 
Within hours of commencement of normal post-absorptive 
fasting, whole body protein synthesis falls by 27%, 
oxidation by 60%, and breakdown may increase by some
35%. These rates return to the original levels within 
hours of recommencing a normal protein intake.
5. After several days on a low protein diet, who 1 e-body 
protein synthesis falls to its own correspondingly 
decreased level. With an energy intake maintained at 
40 Kcal/hour, an intake of 4 g Protein/hour still 
maintains normal feeding phase protein synthesis,
2 g Protein/hour causes an eventual fall of 20% in 
protein synthesis, and at 40 Kcal/O g Protein per 
hour protein synthesis eventually falls some 40% below 
normal (after 6 days). Total continuous fasting leads 
to a fall in synthesis close to 50%.
6. In its 'adapted' state after a prolonged protein-free 
diet, whole-body protein synthesis is depressed and 
unresponsive to the réintroduction of protein. However 
protein breakdown rapidly responds, temporarily dropping 
to an extraordinarily low level, seme 54% below its 
normal feeding rate, and 65% below its normal fasting rate.
7. There are no intrinsic circadian rhythms in whole body 
protein turnover.
8. Plasma free amino acid pools change acutely with acute 
changes in amino acid intake. With a constant leucine 
intake (normal diet) the plasma free leucine pool was 
found to remain constant (148 umoles/litre in obese;
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102 ymoles/litre in non-obese), but with post-absorptive 
fasting the plasma free leucine dropped by 30% and remained
there.
9. There is little difference in protein turnover rates between 
obese and normal subjects. Although on a normal diet 
the lean subjects were shown to have marginally (though 
not significantly) slower whole-body protein synthesis 
rates (lean: 194 g Protein/24 hours; obese: 210 g Protein/
24 hours), the relative diurnal changes that occurred 
in synthesis, breakdown and oxidation were identical for 
both groups.
10. The mechanisms of protein-sparing, in terms of protein
synthesis and breakdown have been suggested. Compared with 
the prolonged fasting state, the addition of glucose 
decreases protein breakdown but leaves protein synthesis in 
its depressed condition. The addition of amino acids 
alone increases protein synthesis and decreases breakdown 
to its normal feeding level. Addition of glucose to that 
same intake of amino acids increases protein synthesis 
further, leaving breakdown normal.
There are many interesting aspects of protein turnover, and other 
side issues, that have arisen during the course of this work, that beg 
further investigation. Indeed some related studies have already been 
undertaken such as measuring the effect of severe infection (meningitis) 
in children, and vaccination fever in adults,on protein synthesis. 
However, two areas of work appear to be outstanding in their need for 
further research. These include a better definition of the dependence 
of protein synthesis on protein intake, and particularly the effect of
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small quantities of non-protein energy, on this relationship.
The other main area is the uncertainty remaining about the
precursor pool for protein synthesis and its relationship to plasma
and oxidation precursor pools, the size of the underestimate of flux
14that results from sampling (1- C)leucine from plasma, whether 
plasma/precursor pool relationships really change with protein intake, 
and the contribution of individual organs and tissues to whole 
body protein turnover under different conditions.
Work is already progressing on this second group of problems.
In a current collaborative study eight infusions with the double- 
labelled stable isotope (1-13C ,15N)leucine have been carried out 
and muscle biopsies taken at both beginning and end of plasma 
plateau period. Half the infusions were done under feeding conditions, 
and half during prolonged fasting. The aim is not only to compare 
protein turnover results from a simultaneous plasma specific activity 
method and an excreted end-product method using the same amino acid, 
but to compare muscle protein synthesis rates (from incorporation of 
label) with whole body protein synthesis, examine the relationship 
between plasma and intracellular free leucine pools, and determine 
how these relationships change with feeding and fasting. (With such 
dedication to protein turnover research as shown by collaborator 
M.J.R., enjoying his 8th muscle biopsy ... what cannot be achieved?)
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Colleague M.J.R. - enjoying his 8th muscle biopsy.
14The (1- C) leucine method has therefore been used not only in 
exploring the nature of whole-body protein turnover, but also in 
promoting the development of other tracer methods such as the 
(14 5N)glycine/NH3 end-product method, and more recently the 
(l-^C) leucine method.
14 .It is hoped that through the exploitation of the (1- C) leucine 
method, and the protein turnover measurements and findings that have 
been presented in this thesis, a small but meaningful contribution 
has been made towards our understanding of the enormous complexity of 
human protein metabolism.
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PART B
ENERGY METABOLISM
SECTION 8 ENERGY METABOLISM
8.1. INTRODUCTION
8.2. BACKGROUND
8.3. DERIVATION AND TESTING OF 'THE FORMULAE'
8.3.1. Derivation I
8.3.2. Derivation II
8.3.3. Testing
8.4. RESULTS AND THEIR ANALYSIS
8.4.1. The Control Group
8.4.2. Obese Patients
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8.1. INTRODUCTION
A system has been developed, based on whole-body protein turnover 
measurements and indirect calorimetry, by which the actual quantities 
of protein, carbohydrate, and fat being oxidised for energy expenditure, 
mobilised from stores, or deposited into stores, can be estimated on 
a whole-body basis, and even monitored hourly, under most conditions.
Calculation of the 'metabolic mixtures' of fuels being utilised 
have been made in some past studies — particularly notable are the 
early calculations of Zuntz & Schumburg (1901); Lusk (1924); and 
Weir (1949). However, even up to the present time, most of these 
estimations have been limited by methodology and restricted by the 
assumption that indirect calorimetry is only valid under conditions 
of overall oxidation. These limitations have meant that the few 
studies attempting analysis of metabolic mixtures have usually 
been under fasting or heavy exercise conditions (eg. the marathon 
runner; Edwards (1934)), and are probably the main reasons why 
indirect calorimetry is usually aimed at short term measurements of 
total energy expenditure, overall energy balance, and comparisons with 
direct calorimetry.
This section shows how these restrictions have been largely 
overcome. By using a system which enabled the continuous measurement 
of protein oxidation, oxygen uptake and carbon dioxide output over 
24 hours or longer, many of the methodological limitations and their 
associated errors have been bypassed. Furthermore, by analysing 
the stoichiometry of the oxidation of fuel constituents (ie. amino 
acids, fatty acids - factors unavailable to the earlier studies), and 
adopting a stochastic 'whole-body' approach to the intake and output 
of carbon and oxygen, formulae have been developed that allow the
estimation of 
hourly basis.
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rates of utilisation or synthesis of fuels, even on a 
and diurnal changes in body fuel stores. It appears
that this has not been attempted previously
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8.2. BACKGROUND
It was Zuntz & Schumburg (1901) and then Lusk (1928) who 
originally established the method for calculating the metabolic 
mixture of oxidation. This involved the measurement of total O2 
consumption, C02 output and urinary N output and then working through 
a multi-step procedure (Brody, 1945). This meant initially calculating 
and subtracting the contribution of protein oxidation from 
consumption and C02 production, then calculating from this non-protein 
and CC>2 the proportional oxidation of fat and carbohydrate.
Finally by using tables (Lusk, 1924) or diagrams (Michaelis, 1924) 
of estimated caloric equivalents for non-protein 02 consumption, 
the caloric contribution of each of the fuels was estimated.
For most studies this was the desired end-product of the 
measurements and there seems to have been little interest in calculating 
actual quantities of fuels oxidised, although this simply involved 
the use of caloric values for fuels in mixed diets, the 'standard 
values' of Rubner (1901) (4.1 Kcal/g for both carbohydrate and
protein, and 9.3 Kcal/g for fat) being most commonly used. Benedict 
(1907) was the first to use this method to determine the quantity 
of glycogen oxidised in seven men during seven days of fasting.
Weir (1949) showed that it was unnecessary to use caloric 
equivalents of for fat and carbohydrate or their percentage heat, 
as given in the standard tables, and both he and later Consolazio et al 
(1963) derived formulae for fuel quantities in the metabolic mixture, 
based on the contribution of protein, carbohydrate and fat to 02 
consumption and COoutput, having measured protein oxidation from 
urinary-N excretion. It is this method, either in its original form, 
or as modified by Weir or Consolazio et al, that is still used for
calculation of the utilisation of fuels (eg. Kerr et alt 1978; 
Bursztein et al, 1980; Ravussin et al, 1980).
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If these formulae, based on the original work of Zuntz, Lusk, 
and Benedict, and modified by Weir and Consolazio, are valid, why 
have there been so few studies attempting to measure fuel utilisation 
or investigate changes in body stores? Contributing reasons have 
probably included the recognised inaccuracies resulting from the 
usual techniques of short-term indirect calorimetry (eg. Douglas bag) , 
and known discrepancies between these and simultaneous direct calorimetric 
measurements (Webb et al, 1980A).
However, even if technical difficulties could be eliminated, it 
appears that the single most convincing objection to the use of indirect 
calorimetry, irrespective of its purpose, has been the underlying belief 
that R.Q. values only have validity between 0.71 and 1.00, and even 
then only when oxidative metabolism far exceeds all other. It is 
argued that because R.Q. values were originally calculated only from 
the oxidative stoichiometry of protein, carbohydrate, and fat, they 
are therefore only relevant to oxidative metabolism, and obviously 
any significant occurrence of other metabolic pathways such as fat 
synthesis, with its totally different °2^C°2 re^at o^nsh^P (e9- t*1® 
production of palmitate from glucose has an R.Q. of 2.751 McGilvery,
1979), will destroy any measurable relationship between C>2 uptake,
C02 output, and whole body fuel utilisation.
This warning, concerning the limited validity of indirect calori­
metry, was given by Brody (1945) who felt that,
"There Is no doubt that the indirect method (of calorimetry) 
is not rigorously sufficient, as when oxygen is used in the 
body for purposes other than oxidation, such as massive 
conversion of carbohydrate containing some 53% 0_ to fat
containing 11 - 12%
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It is interesting to note that both Lusk (1928A) and Benedict (1937) 
thought that R.Q. values above 1.0 were completely valid, and under­
took overfeeding experiments to demonstrate this, achieving R.Q. values 
up to 1.5, and then using the usual method of calculation to estimate 
the quantity of carbohydrate converted to fat.
Nevertheless, it is now usually accepted that the validity of 
indirect calorimetry is limited. McGilvery (1979) reviews the biochemical 
processes such as fat synthesis from carbohydrates, the Cori cycle, and 
interconversion of amino acids, each of which has a gas exchange and 
respiratory quotient of its own, and concludes that,
"... the use of calorimetry for the assessment of oxidative 
metabolism is of value only under two circumstances: when the 
rate of oxidative metabolism far exceeds the rate of synthetic 
processes, and when the rate of amino acid metabolism is 
relatively low, compared to the rate of fat and carbohydrate 
metabolism."
In the following section, using the basic stoichiometric 
relationships of gas exchange and fuels, and using a stochastic approach 
in which gas exchange relationships for the many individual biochemical 
pathways can be ignored, equations are derived from 'first principles' 
for calculating the quantities of carbohydrate and fat metabolised.
The validity of these equations is reinforced by re-deriving them 
from a basic C, N, O, H, and S 'balance' approach, and arriving at 
identical formulae.
When tested theoretically against possible or hypothetical 
metabolic situations where protein, carbohydrate and fat are utilised 
or deposited in many different combinations (eg. massive synthesis of
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fat from carbohydrate and simultaneous oxidation of protein), 
including situations where R.Q. values are above 1, these equations 
appear to give valid quantitative answers for fuel mobilisation or 
deposition.
It appears therefore, as suggested and tested by both Benedict, 
and Lusk (1928), that the relationship between and CO^ at whole- 
body level does not suddenly become meaningless when synthetic 
processes predominate. Indeed, since carbon and oxygen cannot 
disappear, but must be ultimately stored or used and excreted, from 
a stochastic or 'balance' viewpoint net synthesis is simply mathematically 
equivalent to negative net utilisation of any fuel.
These formulae, including a term for protein oxidation as 
measured from protein turnover measurements, are used to measure 
24 hour fuel deposition and utilisation patterns in both obese and 
non-obese normal subjects, on different patterns of dietary regimes.
By taking hourly measurements of all three quantities (g Protein /hour, 
moles Oj uptake/hour, and moles of CO^ output/hour) and using a 
programmable calculator, the quantities of each of the fuels being 
utilised or synthesised each hour have been calculated. These combined 
with fuel intake values, can then give hourly profiles of net fuel 
deposition and mobilisation patterns. The results, showing these 
diurnal profiles of whole body fuel economy, are remarkable.
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8.3. DERIVATION AND TESTING OF THE FORMULAE 
8.3.1. Derivation I
The first method of deriving the formulae is based on the 
assumption that total uptake and CO^ output are solely the result 
of metabolism of protein, fat, and carbohydrate. Consolazio (1963A) 
used this approach, but assumed there was no food intake and oxidation 
was predominant. However if the quantities of oxygen and carbohydrate 
contributed by food are known, and it is assumed that any significant 
storage is in protein, carbohydrate and fat stores, then the following 
relationships should hold irrespective of whether net oxidation or 
synthesis is occurring:
Total 02 intake = 02 + 02 + 02 (in moles o )p c  f 2
Total C O j output = C02 + C02 +  C02 (in moles c o _ )‘ p C F 2
The subscripts P, C, F, refer to protein, carbohydrate and fat.
It is the exact composition and quantity of each of the fuels 
being oxidised (or synthesised) that will determine stoichiometrically 
the quantity of O2 or CC>2 associated with each of the fuels. Thus for 
any particular fuel, whether from food or body stores, a constant can 
be determined stoichiometrically, relating the fuel to 02 uptake and 
C02 output. Hence it is designated that:
P » g Protein metabolised
C * g Carbohydrate metabolised
F - g Fat metabolised
then a series of fuel-specific constants can be determined so that the 
previous equations can be rewritten:
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Total 02 (moles) = a P + bC + <?F Equation 8.1
Total C02 (moles) = xP + t/C + zF Equation 8.2
where the constants a, b, a, x, y, z, are in terms of moles.g and
all depend on the stoichiometric composition of the protein, fat, and 
carbohydrate being metabolised.
When these formulae were initially derived, the rather laborious 
process of working out the values of these constants was undertaken, 
for each of the diets used, as well as for fasting. This was felt 
necessary because it was quite unknown whether meaningful differences 
in C> 2 uptake and C02 output were likely to result from the metabolism 
of the markedly different proteins and triglycerides consumed in the 
diet, or mobilised from body stores. Nor was it known whether these 
were likely to differ significantly from the traditionally used values, 
derived empirically by Zuntz (1897) or Magnus-Levy (1907) or others.
The method of calculation of a, b, O, x, y, and a for the milk- 
based ’Normal' Diet is shown below.
The amino acid pattern for milk ’protein' (from Paul & Southgate, 
1978) was used to calculate the empirical 'protein' associated with 
1 g of N in milk (this pattern is set out in Appendix 5.1). The 
stoichiometry of its complete oxidation to urea was then used to calculate 
the quantities (in millimoles) of C>2 and C02 involved, ie.
C270.8H530.0N70.8°135.1S2.2 +  2 8 5 . 9 5  0 2
*
35.4 CO(NH2>2 ♦ 2.2 SC>2 + 194.2 h 2o + 2 3 5 . 4  C 0 2
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This gives an R.Q. of 0.823, and shows that 1 g N in milk (= 6.38 g 
Protein)is associated withO. 2860 moles O^ and 0.2354 moles CO^. Thus 
the calculated values of a and x are:
a = 0.0448 moles C^/g milk protein
x - 0.0369 moles CC^/g milk protein
A similar approach was used for milk fat. The relative proportions 
of the main fatty acids (and glycerol) in milk (Paul & Southgate, 1978) 
were used to calculate a 'representative triglyceride' (see Appendix 5,2), 
and this was used to calculate stoichiometrically the and CO^ 
associated with its complete oxidation. Thus for the milk 'triglyceride' 
C_, ,H_, c_0„ , with an R.Q. of 0.707, the calculated values of
X 3 • j o • b d  2 1 2 b
b and y are:
b = 0.0845 moles 0^/9 milk fat
y = 0.0598 moles C02/g milk fat.
Milk carbohydrate, expressed in terms of glucose (rather than 
lactose) yielded the following stoichiometric values of o and z: 
o - 0.0333 moles Oj/g milk glucose
z - 0.0333 moles C02/g milk glucose.
By resubstituting these values into Equations 8.1 and 8.2, the 
appropriate formulae for calculating quantities of glucose and 
triglyceride oxidised can be derived, by solving the simultaneous equation 
below.
T o t a l  0 2 ( m o l e s )  «  0 . 0 4 4 8  P + 0 . 0 3 3 3  C + 0 . 0 8 4 5 5  F
T o t a l  C 0 2 ( m o l e s )  -  0 . 0 3 6 9  P + 0 . 0 3 3 3  C ♦ 0 . 0 5 9 7 7  F
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Hence on a milk based diet:
GLUCOSE O XID ISED  q = 102.483 (CC^moles - 0.7070 O^oles - 0.0052 Protein g)
FAT OXIDISED g = 40.365 (C^moles - CC^moles - 0.0079 Protein g)
This same procedure can therefore be used for deriving fuel 
utilisation equations, for any diet or for fasting. By working through 
the amino acid composition, triglyceride/fatty acid composition, and 
carbohydrate components of the fuels being utilised, a series of 
constants. A, B, C, D, E, (see Table 8.1) can be calculated specific 
to any diet, for substitution into the general formulae below 
(Equations 8.3 and 8.4). Thus the quantities of carbohydrate and 
fat being utilised at any moment, can be computed, depending on Oj 
uptake, C02 output, and an independent measurement of protein 
oxidation.
The following general formulae, associated with the diet-specific 
constants A, B, C, D, and E, were used with 0^ uptake and CC>2 output 
expressed in moles, and Protein,in grams, so that the calculated 
quantities of glucose and fat were also in grams. In the 'work-sheet', 
devised by Consolazio et al (1963), which amounts to a procedure similar 
to the formulae below, the term for protein oxidation is obtained by
the traditional N excretion measurement. In our own patients, it was 
14measured using the (1- C)leucine method.
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G L U C O S E  U T I L I S E D = A ( C 02 -  B  0 2 -  C P R O T E I N )
F A T  U T I L I S E D C\J
ocTII -  C 0 2 -  E  P R O T E I N )
Equation 8.3
Equation 8.4
The associated values of A , B , C , D , and E , specific for each diet, 
or for fasting, are set out in Table 8.1. Also calculated into these 
terms are the values derived from the 'standard' calorimetric data 
of Zuntz (1897), and the slight modification of the protein factor 
(O by Lusk (1928) , for O2 and CO^ exchange associated with metabolism 
of fuels in the human body.
The calculated answer from Equation 8.3 will be in terms 
g of glucose utilised (rather than glycogen, starch, or other di- or 
polysaccharide) . This is because for each of the dietary situations 
the carbohydrate being metabolised was converted to its equivalent 
in 'available monosaccharide’. The conversion factors for poly­
saccharides and their application to the polysaccharide syrup Hycal 
(Diet O) are shown in Appendix 5.3.
There are, of course, some underlying assumptions for both the use 
of the general equations, and the analyses of the actual amino acids 
and fatty acids being metabolised, and these will introduce some error.
The assumptions associated with the formulae are largely those of
indirect calorimetry, but Include the accuracy of and CC>2 measurement,
and how representative such measurements are of 24-hour values. These
were discussed earlier in Section 2. The equations also assume that
biochemical pathways not associated with fuel metabolism (ie.other than oxidation,
synthesis, interconversion), contribute and produce negligible quantities
of 02 and CC>2.
TABLE 8.1. Numerical values of the factors A ,  B ,  C , D , and E ,  for Equations 8.3  and 8 .4 , f o r  the 
metabolism of fuels of d ifferent composition. (P) the 'Mean Amino A c id ’ per mole of N, and (F) 
the 'Mean Trig lyceride' are shown fo r  each d ie t .
DIET A B C D E
'NORMAL' DIET A (milk-based)
P: C 3.82H7.49Nl01.91SO.O3 
F: C13.3H26.55°2.25
102.483 0.707 0.0052 40.365 0.0079
'NORMAL' DIET B (cheese & crackers)
P: C3.81H7.35N1°2.17S0.05 
Fl C13.41H26.62°2.25
102.902 0.708 0.0052 40.512 0.0078
FASTING
Pi C3.33H6.7SNI°1.79S0.04 
F‘ C13.61H26.46°2.23
104.355 0.712 0.0040 41.066 0.0063
■DIET O' (HYCAL)
P= C3.33H6.78N1°1.79S0.04 
Fi C13.61H26.46°2.23
104.355 0.712 0.0040 41.066 0.0063
Zuntz (1897) 91.69 0.711 0.0045 38.31 0.008
Lusk (1928) 91.69 0.711 0.0041 38.31 0.008
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The validity of the calculated sets of factors for each diet 
depends on the assumption that the diet being consumed at a particular 
time accounts for total fuel metabolism. This therefore does not 
allow for the contribution from continuous protein,and fatty acid 
turnover whilst fuel intake (from the diet) is occurring. Nevertheless 
this is an error that could be measured by turnover studies. The 
particular sets of factors for both Diet O and Fasting have assumed 
that the metabolised amino acid composition is that of 'mammalian 
whole body' (Block & Weiss, 1956) - obviously not entirely correct 
since proline (in collagen) probably does not turnover in proportion 
to its large amount. The calculated fatty acid composition of 
triglycerides metabolised during fasting and on Diet O is also 
an approximation based on the composition of adipose tissue in humans 
on a random American diet (Field, 1965). Furthermore, it has been 
assumed that fatty acids are all in triglyceride form, so the proportion 
of glycerol will in fact be too high in its contribution to and C02 
exchange.
An important question immediately arises concerning the use of 
these different factors, relating gas exchange to the composition 
of different fuels. Do they really make any significant quantitative 
difference to the calculation of fuels being metabolised? Could we 
not simply continue to use the 'standard* factors of Zuntz (1897),
Lusk (1928) or Magnus-Levy (1907), for are these not applicable to any 
dietary situation?
In fact (and as shown in Table 8.2 below) it doeo appear that 
different amino acid patterns, and different fatty acid patterns 
(and to a lesser extent carbohydrate patterns since different proportions 
of polysaccharides lead to different eventual quantities of available 
glucose) do significantly affect gas exchange and thus the calculated
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quantities of fat and glucose metabolised. In Table 8.2 the O 
uptake, CO2  output, and protein oxidation, measured continuously in 
an obese patient over 12 hours, are used in Equations 8.3 and 8.4 
and the calculated quantities of utilised fat and glucose compared, 
when the constants M, B, C, D, and E) for each diet are substituted 
into the equations.
T A B L E  8 . 2 . C a l c u l a t e d  q u a n t i t i e s  o f  f a t  and g l u c o s e  m e t a b o l i s e d ,  u s i n g  t h e  
d i f f e r e n t  s e t s  o f  f a c t o r s  ( f r o m  T a b l e  8 . 1 ) .  P a t i e n t  E . E ,  on h o u r l y  i n t a k e  
o f  m i l k - b a s e d  ' N o r m a l '  D i e t  A  o v e r  a 1 2 - h o u r  p e r i o d  consumed 5 . 8 3 6  m ole s 0 2 ,  
p r o d u c e d  4 . 5 8 9  m o l e s  C 02 a n d  o x i d i s e d  2 4 . 8 4  g o f  P r o t e i n .  T h e  s e c o n d  
g r o u p  o f  d a t a  s h o w  t h e  l a r g e r  d i s c r e p a n c i e s  t h a t  r e s u l t  i f  f o r  t h e  same 0 2 
and C02 v a l u e s ,  7 0 . 0  g P r o t e i n  had been o x i d i s e d .  T h e  v a l u e s  a r e  co m pared 
w i t h  t h o s e  d e r i v e d  f r o m  Z u n t z  ( 1 8 9 7 ) .
DIET FACTORS GLUCOSE UTILISED
g/12 Hours % Difference 
from Zuntz
FAT UTILISED
g/12 Hours % Difference 
from Zuntz
(A) PROTEIN OXIDATION 24.84 g
42.41 6 « 
42.67 6 % 
44.78 12 « 
40.16
Normal Diet A 
Normal Diet B 
Fasting 
Zuntz (1897)
34.21 14 * 
33.75 12 * 
34.90 16 % 
30.06
!--------------------
! (B) PROTEIN OXIDATIOt< 70.0 g
28.01 6 « 
28.40 8 % 
33.10 26 « 
26.32
1
Normal Diet A 
Normal Diet B 
Fasting 
Zuntz (1897)
10.14 11 * 
9.58 16 * 
16.05 41 % 
11.42
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From these data it can clearly be seen that substantial differences 
do occur as a result of using different sets of factors for the same 
gas exchange data, and it can be concluded that significant error may 
occur if the amino acid, fatty acid, and carbohydrate composition of 
fuels being metabolised are not accounted for. Even if the factors 
themselves are marginally incorrect because of assumptions previously 
discussed, it would appear that they should not be ignored, in the 
calculation of fuel metabolism. Indeed it would seem to be a worth­
while future undertaking to derive as accurately as possible sets of 
such factors.
Having thus established the general formulae (Equations 8.3 and 8.4) 
and their required constants (Table 8.1), It was exhilerating to find 
that completely identical formulae could be independently derived by 
a 'balance' method, particularly as this approach also specifically 
included fuel synthesis as well as oxidation.
8.3.2. Derivation II
The model used in this approach is a stochastic one, with similar 
assumptions to the stochastic analysis described for whole-body protein 
turnover (Section 1.2 and 1.4). It is used to derive formulae 
expressing both oxygen-balance and carbon-balance. Figure 8.1 attempts 
to express the model diagrammatically (even though it may look like 
a multipurpose sanitation unit, or a Massey-Fergusson grain crusher).
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FIGURE 8.1. A model for the derivation of formulae relating oxygen (0) 
and carbon (C) to fuel synthesis, interconversion, and oxidation.
The ringed isthmi C~~'J indicate the site of fuel transfer calculated 
by the formulae.
For this model, it is irrelevant what metabolic reactions occur 
within the 'black box'. It is assumed that this metabolic pool of 
C and O does not expand or contract, and that pathways into and out of 
the metabolic pool are the only important features to be considered. 
Diet and fuel stores and C>2 are the only significant contributions of 
O and C into the black box, and the only significant pathways out are 
body stores (and hence net synthesis of fuels), CO^, urea, SO^, and
STORES STORES STORES
0 ,2 METABOLIC ’BLACK BOX
CO.'2 Urea SO,2
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H20. Small errors will be introduced by ignoring other minor 
pathways of oxygen and carbon in and out of the 'black box'. Thus 
all that matters are any net transfers of O and C in or out of the 
'black box'.
From this model for O and C balance, formulae can be developed showing 
net transfer of fuel into the metabolic'black box' from diet or stores 
(= net utilisation), and net transfer of fuel out of the 'black box' 
into stores (= NET SYNTHESIS). In mathematical terms for this model, 
net synthesis of a fuel is simply negative net utilisation (ie. net 
transfer of fuel into the pool is designated +ve, and net transfer of 
fuel back into stores is -ve).
The term fuel 'utilisation' is deliberately used because the
formulae detect net transfer in and out of the pool, but do not
distinguish how a fuel is subsequently proportioned into complete
oxidation and conversion to another fuel. (Neither can the 
14(1- C)leucine method, nor urinary-N excretion detect whether an 
amino acid skeleton is completely oxidised or converted into fatty 
acids.) Thus the formulae are derived so as to detect net transfer at 
the sites of the ringed isthmi on the model diagram.
Formulae are derived below, using the molar relationships from 
amino acid and fatty acid patterns shown for the milk-based diets 
(see Appendices 5.1 and 5.2),
ie. For Milk-Based Diet
Mean Amino Acid* (N) ............. C3.825H7.486N1°1.908S0.031
Glucose (C) ............. C6H12°6
Mean Triglyceride' ( F ) ............. C13.3H26.55°2.25
202
T A B L E  8 . 3 .
( i )  0 - B A L A N C E
Moles O: IN Moles O: OUT
(Source) (Product)
N moles x 1.908 (Protein) N/2 x 1 (Urea)
C moles x 6 (Glucose) 0.031 N moles x 3 (so2)
F moles x 2.25 (Fat) >j (5.486)N moles x 1 (h2o)
°2 moles x 2 (°2> C moles x 6 (H20 glucose)
F moles x 13.28 (H20 fat)
C02 moles x 2 (COj moles)
BALANCE 2 (O^  moles) 2(C02 moles) + 1.428N + 11.03F
( i i )  C - B A L A N C E
Moles C: IN Moles Cs OUT
(Source) (Product)
N moles x 3.825 (Protein) 
C moles x 6 (Glucose) 
F moles x 13.3 (Fat)
N/2 x 1 (Urea) 
C02 moles (C02)
BALANCE 3. 325N + 6C + 13.3F C02 moles
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From these balance data, 2 simultaneous equations emerge:
2 (02 moles) = 2 (C02 moles) + 1.428N + 11.03F
(C02 moles) = 3.325N + 6C + 1 3 .3F
Solution of these equations, including the conversion of N (x 14 x 6.38) 
to g of milk Protein (P) , and use of the molecular weights of Glucose 
(180.18) and 'Mean Triglyceride* (222.51) for conversion of C and F to 
grams, incredibly leads to the following 2 formulae:
g Glucose (C) - 102.483 (CX>2 - 0 .7 0 7  02 -  0.0052P)
g Fat (F) = 4 0 .3 6 5 (0 2 - C02 -  0.0079P)
These are identical to Equations 8.3 and 8.4 with the milk-based diet 
factors substituted. In a similar manner, the model also gives the 
expected equivalent equations under the other dietary situations.
This achievement gives some confidence in the validity of the 
Equations 8.3 and 8.4 and their sets of factors for different fuels 
being metabolised. However the exciting significance of the model is 
that it was deliberately designed to allow for net transfer of fuel in 
either direction, so that net synthesis of a fuel is simply equivalent 
to negative net utilisation, and the equations derived, using this 
stochastic 'balance' principle, are identical with the previously 
derived equations.
Therefore the appearance of any negative values for glucose or 
fat utilisation, calculated from Equations 8.3 and 8.4, can confidently 
be equated with net synthesis of the fuel (ie. the balance between
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simultaneous total utilisation of the fuel from diet and/or stores, 
and total synthesis, with the balance showing a net synthesis, and 
thus deposition of fuel into stores).
8.3.3. Testing
As a further test of the meaning and validity of the formulae 
they were theoretically tested under many different hypothetical 
metabolic conditions. This was done by proposing different patterns 
of fuel oxidation, interconversion and synthesis, working out by 
stoichiometry the net gas exchange and net fuel transfers, and then 
by substituting the and CO^ values into the formulae (which were 
programmed) calculating what net transfers of glucose and fat had 
occurred.
In all cases the calculated values of glucose and fat net 
utilisation or synthesis agreed entirely with the stoichiometric 
quantities. These included attempts to devise situations which might 
have the same R.Q., and complex patterns of combined oxidation, 
synthesis and interconversion of fuels. The formulae appeared to 
be able to cope with all fuel transfer situations, and It appeared 
impossible to have the same R.Q. produced by 2 different situations.
Two such tests, showing both stoichiometric results and the 
corresponding results calculated by the formulae are shown below.
1. Can 2 metabolic situations exist with the acme R.Q.?
•9.
(a) lOO g Glucose -*• Fat R.Q. > 1 In quantities so that
50 g Glucose -*■ Complete oxidation R.Q. ■ 1 combined R.Q. - 1
39.4 g Fat oxidation R.Q. < 1 .
(b) Glucose oxidation alone R.Q. " 1
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For the stoichiometric calculations:
- the intake was assumed to come from the milk-based diet;
- the intake of Fat was adjusted so that the combined 
metabolism produced an R.Q. = 1.
FUEL METABOLISM STOICHIOMETRY
Oj UPTAKE C02 OUTPUT
(moles) (moles)
lOO g Glucose -*• Fat - 0.975
50 g Glucose -*■ Complete oxidation 1.665 1.665
39.4 g Fat -*■ Complete oxidation 3.330 2.355
TOTAL 4.995 4.995
moles 02 moles C02
When these values for 0„ and CO„ are substituted into the
2 2
programme for the formulae (with milk-based 'Normal' Diet constants), 
the following results are obtained.
GLUCOSE UTILISED FAT UTILISED
150.0 g O g
The formulae have, thus, verified actual net fuel metabolism.
An R.Q. - 1 is only achieved in this situation when the fat synthesised 
from glucose is exactly equal to fat oxidation ie. no net utilisation 
or synthesis of fat. The result is thus equivalent to net utilisation 
of 150 g glucose. This is shown in Figure 8.2, in which C and F stand 
for glucose and fat.
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FIGURE 8.2.
GLUCOSE FAT
150 g C F 3 9 .4  g 3 9 .4  g F
100 g C
50 g  C
2. A complex hypothetical pattern of synthesis and deposition and
oxidation.
For the stoichiometric calculations, the intake was again assumed 
to be milk-based 'Normal' Diet A. The full stoichiometric equations are 
given in Appendix 5 .4.The following table (Table 8.4) sets out a 
hypothetical metabolic tantrum, with fuels simultanenously being 
oxidised, synthesised, inter-converted and deposited in planned 
quantities. The stoichiometry has been calculated and the net 
transfers set out as 'Fuel Balance'. The ultimate net and CO2  
quantities are then substituted into the fuel utilisation formulae, 
along with the quantity of protein utilised.
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FIGURE 8.2.
2. A complex hypothetical pattern of synthesis and deposition and
oxidation.
For the stoichiometric calculations, the intake was again assumed 
to be milk-based 'Normal' Diet A. The full stoichiometric equations are 
given in Appendix 5.4.The following table (Table 8.4) sets out a 
hypothetical metabolic tantrum, with fuels simultanenously being 
oxidised, synthesised, inter-converted and deposited in planned 
quantities. The stoichiometry has been calculated and the net 
transfers set out as 'Fuel Balance'. The ultimate net O2 and CO^ 
quantities are then substituted into the fuel utilisation formulae, 
along with the quantity of protein utilised.
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TABLE 8.4. Stoichiometry Balance Sheet of the 'metabolic tantrum'.
FUEL METABOLISM o„ & CO„ STOICHIOMETRY
0„ Uptake CO„ Output
(moles) (moles) (moles)
IO Glucose —  oxidised 60 60
10 Glucose —  Glycogen stores - -
50 Glucose — 15.95 Fat 87.9
10 AA --- Oxidised 40.4 33.3
5 AA --- 2.8 Glucose 3.6 -
100 AA --- -17.7 Fat 71.4 97.4
5 Fat --- Oxidised 94.1 66.5
IOO Fat — » Fat Stores
FUEL BALANCE (moles) TOTAL 269.4 345.1
57.2 Glucose utilised moles 02 moles CO^
115.0 'Amino Acid' utilised
-28.65 Fat utilised
(ie. synthesised)
When the total O^ and C02 values for this complex metabolic 
tangle are substituted into the formulae, and the quantity of 
oxidised protein (115 moles 'AA' = 11,388.8 g 'AA') is also included, 
then the formulae indicate the following net transfers of glucose 
and fat.
T A B L E  8 . 5 .  G l u c o s e  and F a t  u t i l i s a t i o n ,  c o m p a r i n g  t h e  r e s u l t s  c a l c u l a t e d  
b y  s t o i c h i o m e t r y ,  w i t h  t h o s e  c a l c u l a t e d  b y  t h e  f u e l  u t i l i s a t i o n  f o r m u l a e  
( E q u a t i o n s  8 . 3  a n d  8 . 4 )  w i t h  m i l k - b a s e d  f u e l  f a c t o r s .
From STOICHIOMETRY BY THE FORMULAE
g of Fuel g of Fuel
GLUCOSE 10,305.2 g 10,300.4 g (utilised)
(57.2 moles) (57.2 moles)
FAT - 6, 374.9 g -6,369.2 g (synthesis)
(-28.65 g) (-28.6 moles)
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The excellent comparability of these results clearly indicates 
the potential of this formula to cope with the most complicated 
metabolic situations. It appears to be able to handle fasting and 
feeding conditions, and is able to work out net whole-body fuel 
transfers even when the metabolic scene is complicated by simultaneous 
processes of oxidation, synthesis, interconversion and deposition of 
different fuels. What it cannot distinguish however, are different 
metabolic processes occurring in different parts of the body, eg. if 
there were net glucose deposition in liver and net utilisation in 
muscle. Its measurements, like those of whole body protein turnover, 
reflect the net result of fuel metabolism from tissues all over the 
body.
Before presenting the results, it is worth summarising the 
contribution that this section has attempted to make so far. The 
principles behind the development of the formulae, and even the general 
formulae themselves (Equations 8.3 and 8.4), are certainly not new, 
being a reflection of classical indirect respirometry. What is 
significant however, is:
(a) the theoretical demonstration that Indirect respirometry 
is valid, even when synthesis and interconversion of fuels are 
predominant, or even with R.Q. values over 1. This is not 
widely accepted at present (eg. McGilvery, 1979);
(b) that the formulae for utilisation of glucose and fat can 
be derived not only from the 'sum of uptakes and CO^ 
outputs' method as used by Weir (1949), but also from a 
stochastic balance model which specifically allows for synthesis 
and interconversion of fuels, net synthesis being equivalent
to negative net utilisation;
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(c) that the amino acid, fatty acid, and carbohydrate 
compositions of fuels being metabolised do significantly,
(and measurably) affect gas exchange. It is not sufficient 
to use average gas exchange values for 'protein', 'fat', and 
'carbohydrate', as is usually done, using values of Zuntz 
(1897) or Magnus-Levy (1907), particularly if acute measure­
ments of fuel utilisation are to be made;
(d) that glucose and fat utilisation or synthesis can be 
meaningfully measured acutely (eg. hourly), provided 
acute measurements of protein oxidation can be made.
Because of slow urea pool turnover (and hence delay) , the 
N-excretion method (even if corrected for plasma urea-pool 
changes) is unable to measure protein oxidation more acutely
them 12-hourly. Use of an alternative method (eg. by 
14(1- C) leucine) can give hourly rates of protein oxidation, 
and these, coupled with continuous measurements of O2 uptake 
and CC>2 output, enable the hourly estimation of whole-body 
net fuel utilisation and synthesis.
These fuel utilisation formulae therefore offer an exciting 
opportunity to explore whole-body energy metabolism under many widely 
varied conditions, not only in normal or obese subjects, but also 
in surgical and infected patients, and in other conditions of pathology 
or recovery. Three facilities are required for the success of these 
formulae and these include:
1. A method for acute measurement of protein oxidation 
(eg. (1-14C) leucine rather than N-excretion).
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2. A method for accurate continuous measurement of 0_
2
uptake and CO^ output (eg. a ventilated system rather 
than Douglas bags).
3. 'Fuel factors', as shown in Table 8.1, reflecting 
amino acid, fatty acid, and carbohydrate composition 
of the fuels being metabolised.
Whereas the first two facilities are presently available, sets 
of 'fuel factors', for substitution into the formulae, are not.
Yet they would appear to be well worth future development, because of 
the potential the formulae offer for the understanding and even manage 
ment of energy metabolism, in normal, pathological and recovery states
• - T  ns»-
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8.4. RESULTS AND THEIR ANALYSIS
Simultaneous continuous measurements of O  ^uptake, CC^ output,
14and protein oxidation by (1— C) leucine infusion, were made in many 
of the subjects of the protein turnover groups shown in Section 2.
This allowed the estimation of protein, carbohydrate and fat utilisa­
tion continuously over 24 - 36 hours, in the groups of subjects 
previously distinguished in Section 2. The results that follow 
show an enthralling and somewhat unexpected pattern of energy 
metabolism for both Control Group subjects (5 non-obese Departmental 
colleagues) , and obese subjects (9 obese patients of the Diurnal 
and Diet O-Diurnal groups).
Most of the results are presented in terms of fuel utilisation 
over a 12-hour feeding or fasting period, as these were the periods 
of constant energy intake. However, It should be pointed out that 
these are not derived values from only a few hours measurement, but 
usually total 12-hour measurements. Using hourly measurements of 
Oj, CC> 2 and protein oxidation in the fuel-utilisation formulae, 
hourly rates of glucose and fat utilisation or synthesis were 
calculated, so that the 12-hour and 24-hour values presented in this 
section are actual total rates. For the protein oxidation term, it 
was necessary to estimate the few hourly values between feeding 
phase and fasting phase plateaux. This is closer to reality than 
assuming a constant plateau value of protein oxidation over the entire 
12 hours of feeding or fasting.
When the fuel utilisation results from both Control and obese 
groups were calculated, it became quite clear that the pattern of 
fuel utilisation was particularly related to the proportion of energy 
intake derived from carbohydrate.
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Although both obese and Control subjects were on Normal Diets 
A or B, there were 3 distinct intake patterns of carbohydrate within 
these diets. Since the protein content always remained at much the 
same level (at about 67 g Protein in 12 hours), carbohydrate and fat 
tended to have an inverse proportional relationship in these 3 intake 
patterns. The actual intakes of protein, carbohydrate, and fat are 
shown with the results further below, but Table 8.6 shows the 3 dietary 
patterns, with intakes expressed as a proportion of total 24-hour 
energy expenditure.
T A B L E  8 , 6 . T h r e e  p a t t e r n s  o f  d i e t a r y  i n t a k e ,  w i t h  p r o t e i n ,  c a r b o h y d r a t e ,  
f a t ,  and e n e r g y  e x p r e s s e d  a s  p r o p o r t i o n s  o f  2 4 - h o u r  e n e r g y  e x p e n d i t u r e .  
T h e  r e s u l t s  a r e  means o f  p e r c e n t a g e s  c a l c u l a t e d  f o r  e a c h  s u b j e c t  
( C o n t r o l  a n d  o b e s e ) .
INTAKE PATTERN PERCENTAGE OF 24-HOUR ENERGY EXPENDITURE
PROTEIN CARBOHYDRATE FAT ENERGY INTAKE
I Very low CHO (15%) 18 % 15 % 54 % 87 %
II Low CHO (30%) 16 % 30 % 76 % 121 %
III Normal CHO (50%) 17 % 50 % 43 % 111 %
The results below show that it was this intake pattern of carbo­
hydrate that appeared to have greatest influence on fuel utilisation 
or deposition, for both control and obese groups. Although division 
of the subjects by this carbohydrate intake pattern only leaves 
small numbers in each group, the resultant fuel utilisation patterns 
are consistent and occur in both control and obese patients.
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It should also be reiterated that intake of these fuels was 
always over a 12-hour feeding period. Because the subjects were 
approximately in 24-hour energy balance (87% - 121%) the feeding 
12-hours was always a period of excess intake and fuel deposition, 
and the fasting 12-hours necessarily a period of fuel mobilisation. 
However the patterns of deposition and mobilisation, and the way these 
are apparently influenced by carbohydrate intake, are intriguing.
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For each of the 3 intake patterns, the following tables show 
how fuel utilisation is influenced, and how the body responds in 
terms of deposition or mobilisation of fuels from fuel stores in 
each 12-hour period, as well as over 24 hours.
Group I: The Very Lou Carbohydrate group
T A B L E  8 . 7 .  V e r y  Lo w  C a r b o h y d r a t e  ( 1 5 % )  g r o u p  ( I ) ,  s h o w i n g  f u e l  i n t a k e ,  
n e t  u t i l i s a t i o n  ( o r  s y n t h e s i s  = - v e  v a l u e s  a nd i n  i t a l i c s ) ,  and f u e l  
b a l a n c e  i n  t e r m s  o f  d e p o s i t i o n  (s h o w n  as - v e  and i n  i t a l i c s )  i n t o  
s t o r e s  o r  m o b i l i s a t i o n  f r o m  s t o r e s .  ( 2  S u b j e c t s . )
8.4.1. The Control Group
PROTEIN 
g Fuel
CARBOHYDRATE 
per 12 (or 24)
FAT
Hours
ENERGY
Kcal
A. INTAKE 
j Feeding 12 hours 65.6 62.3 92.8 1326.7
B. UTILISATION 
! Feeding 12 hours 43.7 159.9 - Z.4
!
767.6
Fasting 12 hours 25.8 127.1 6.6 648.1_________
C. BALANCE
Feeding 12 hours -21.9 97.6 -95.2 -559.1
Deposited mobilised Deposited Deposited
Fasting 12 hours 25.8 127.1 6.6 648.1
mobilised mobilised mobilised mobilised
Total 24 hours 3.8 224.7 -88.7 88.8
mobilised mobilised Deposited mobilised
i
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These results are most unexpected. Even though so little 
carbohydrate is supplied in the diet (62. 3 g) , the body appears to 
insist on using carbohydrate as its main fuel (287 g in 24 hours) , 
and consequently has to withdraw large quantities from glycogen stores 
in both feeding and fasting periods. Furthermore, despite the large 
fat intake, only a minute quantity (6.6 g) is mobilised during the Fasting 
Phase, so that almost the entire fat intake remains stored. Some of 
the glycogen mobilised during the Feeding Phase, is even used for fat 
synthesis, this fat then adding to the fat intake deposited into fat 
stores.
So for this Very Low Carbohydrate intake group, 80% of Feeding 
Phase energy expenditure and 75% of Fasting Phase energy expenditure 
has come from carbohydrate, and protein oxidation has supplied most 
of the rest. The following table (Table 8.7) shows the proportions 
of energy expenditure in each phase, coming from each fuel.
T A B L E  8 . 8 . V e r y  Lo w  C a r b o h y d r a t e  g r o u p  ( I ) .  P e r c e n t a g e s  o f  e n e r g y  
e x p e n d i t u r e  i n  e ach  p h a s e ,  d e r i v e d  f r o m  each f u e l .
PHASE PROTEIN CARBOHYDRATE FAT
; Feeding 12 Hours 23.1 % 79.8 % -2.9 %
Fasting 12 Hours 16.1 % 75.3 % 8.7 %
Total 24 Hours 20.0 % 77.7 % 2.4 %
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When the proportion of carbohydrate in the diet is increased to 
a level equivalent to almost 30% of total energy expenditure (= 23% of 
total energy intake), there is a similar pattern of fuel utilisation to 
the Very Low Carbohydrate group, but to a lesser extent. This is shown 
in the following table.
T A B L E  8 . 9 . Low C a r b o h y d r a t e  ( 2 8 % )  g r o u p  ( I I ) ,  s h o w i n g  f u e l  i n t a k e ,  n e t  
u t i l i s a t i o n  o r  s y n t h e s i s  ( - v e ,  i t a l i c s ) ,  a n d  f u e l  b a l a n c e  i n d i c a t i n g  f u e l  
m o b i l i s a t i o n  f r o m  s t o r e s  o r  d e p o s i t i o n  ( - v e ,  i t a l i c s )  i n t o  s t o r e s .  ( 2  S u b j e c t s )
Group II: The Law Carbohydrate Group
PROTEIN 
g Fuel
CARBOHYDRATE 
per 12 (or 24)
FAT
Hours
ENERGY
Kcal
A. ItTTAKE
Feeding 12 Hours 69.0 130.7 157.9 2176.5
B. UTILISATION|
! Feeding 12 Hours 34.1 138.1 35.7 981.9
Fasting 12 Hours| 19.8 109.1 36.3 817.9
C. BALANCE
j Feeding 12 Hours -34.9
Deposited
7.4
mobilised
-122.2
Deposited
-1194.6
Deposited
Fasting 12 Hours 19.8
mobilised
109.1
mobilised
36.3
mobilised
817.9
mobilised
Total 24 Hours -15.1
Deposited
116.5
mobilised
- 85.9 
Deposited
-376.7
Deposited
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Here is the spectacle of the body mobilising 116.5 g of glucose 
(worth 445 Kcal) from glycogen stores, when the diet is already 
supplying an excess of almost 400 Kcal. It appears not to want 
so much fat, at least not for immediate energy needs. So once 
again, the body appears to insist on using much more carbohydrate 
(twice as much) than the diet is offering for the 24 hour period, 
although to a lesser extent than was found for the Very Low 
Carbohydrate group (where 4.6 x the quantity supplied was used).
In absolute terms, protein oxidation has remained much the same as 
in Group I, but while the quantity of carbohydrate utilised is less 
(247 g in 24 hours), fat oxidation plays a more substantial role 
(72 g fat in 24 hours).
So for this Low Carbohydrate group, carbohydrate oxidation is 
responsible for about half the energy expenditure in both Feeding and 
Fasting Phases.
T A B L E  8 . 1 0 . Low C a r b o h y d r a t e  ( 3 0 % ) g r o u p  ( I I ) .  P e r c e n t a g e s  o f  e n e r g y  
e x p e n d i t u r e  d e r i v e d  f r o m  e a c h  f u e l ,  i n  e a c h  p h a s e .
PHASE PROTEIN CARBOHYDRATE FAT
Feeding 12 Hours 14.1 % 53.8 % 32.1 «
Fasting 12 Hours 9.8 « 51.0 % 39.2 %
Total 24 Hours 12.2 % 52.5 % 35.4 «
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One of the Control Group subjects (J.K.G.) was on a much more 
normal diet, with carbohydrate contributing 42% of total energy intake 
(this amount of carbohydrate was equivalent to 47.4% of his 24 hour 
energy expenditure). Consequently his fuel metabolism seemed to 
behave much more sensibly, depositing the excess of all 3 fuels during 
the Feeding Phase, and mobilising them again during fasting. This 
pattern is shown in Table 8.11.
TABLE 8 1 1 . Normal Carbohydrate (47%) group (III) , showing fuel intake, 
net util isation or synthesis, and fuel balance indicating fuel mobilisation 
from stores, or deposition into stores. (J.K.G.)
Group ITT: The Normal Carbohydrate Group
PROTEIN CARBOHYDRATE FAT ENERGY
g Fuel per 12 (or 24) Hours Kcal
A. INTAKE
Feeding 12 Hours 66.7 219.1 98.1 1976.9
1 ----------------
B. UTILISATION
Feeding 12 Hours 
Fasting 12 Hours
37.2
23.1
128.1
73.1
37.4
47.9
971.4
796.9
C. BALANCE
Feeding 12 Hours -29.5
Deposited
-91.0
Deposited
-60.8
Deposited
-1005.5
Deposited
Fasting 12 Hours 23.1
mobilised
73.1
mobilised
47.9
mobilised
796.9
mobilised
Total 24 Hours -6.4
Deposited
-17.9
Deposited
-12.9
Deposited
-208.6
Deposited
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This is a much more rational profile of fuel metabolism than for 
the previous 2 groups. Much less glucose is oxidised (201 g in 24 hours) 
than in the other 2 groups, so that the excess 17.9 g are still left 
deposited in glycogen stores after 24 hours. Fat contributes 85.3 g 
to energy expenditure in 24 hours - a very different situation from its 
contribution in Group I (where only 6.6 g fat were oxidised over 
24 hours, and even then 2.4 g of fat were synthesised).
The proportional contribution of each of the fuels to energy 
expenditure also looks much more 'normal' as a result of this higher 
intake of carbohydrate in the diet. Carbohydrate and fat elegantly 
alternate as the main contributors to energy expenditure for Feeding and 
Fasting Phases. Over the 24 hour period, their proportional contribution 
to energy expenditure is equivalent to their proportional contribution 
to energy intake (42.4% for carbohydrate, 43.9% for fat).
TABLE 8.12. Normal Carbohydrate (47%) group (III) . Percentages of 
energy expenditure derived from each fu e l ,  in each phase.
PHASE PROTEIN CARBOHYDRATE FAT
Feeding 12 Hours 15.6 % 50.4 % 34.0 %
Fasting 12 Hours 11.8 % 35.1 % 53.1 %
Total 24 Hours 13.9 % 43.5 % 42.6 %
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The Control group has thus shown a remarkable and quite ironic 
response of whole—body fuel metabolism to the proportion of carbohydrate 
in adequate protein and energy containing diets. It is apparent that 
the less carbohydrate supplied, the more the body insists on using 
it as a fuel source, even if this means mobilising large quantities 
of glycogen, and irrespective of whether 24 hour energy intake is 
well in excess of 24 hour energy expenditure. Perhaps there is a 
distinct range, with upper and lower limits, defining the proportional 
contribution of glucose to total energy expenditure. The results 
from this group suggest glucose must contribute between 30% to 80% of 
energy expenditure.
These data provoke many questions in terms of both validity and 
significance.
- Are they an artefact due to the small group numbers? It 
stretches credulity somewhat to see the body utilising more 
and more glucose, the less the dietary intake supplies.
If genuine, what has really triggered off such a mobilisation 
of glucose when the intake of glucose is very low?
- What happens when liver and muscle glycogen stores run out?
The stores certainly cannot keep on donating 100 - 200 g of 
glucose every 24 hours.
- What happens in obese patients, having much larger fat stores?
These questions and others were at least approached, by making the 
same measurements in the obese patients, not only when subjected to the 
same carbohydrate intake categories as the Control group, but also after 
3 weeks on Diet O, when it might well be expected that all glycogen 
stores would be completely exhausted.
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8.4.2. Obese Patients
The results for the 9 obese patients, are shown in Tables 8.13 - 8.16 
grouped together on the following 4 pages. Essentially they show 
the same tendency as seen in the Control group patients, although 
they also appear to have a greater ability to mobilise and use fat.
In Group I (Table 8.13) where the very low carbohydrate intake 
was only 17% of energy intake, equivalent to 14.4% of energy 
expenditure, during the feeding 12-hours when energy intake was more 
than 500 Real in excess of expenditure, the body still withdrew glucose 
from glycogen stores, whilst depositing protein, fat, and energy.
However, a clear difference between the obese patients and 
Control subjects in their response to such a low carbohydrate intake, 
is the ability of the obese to utilise fat. Comparison of Table 8.7 
with Table 8.13 shows that whereas both groups have almost identical 
intakes of carbohydrate and fat, the obese group utilise nearly 50% and 
store nearly 50% of their fat intake during the feeding 12 hours, 
then during the fasting 12 hours withdraw the deposited fat - thus 
arriving at fat-balance after 24 hours. In complete contrast, the 
Control group subjects deposit their entire fat intake during the 
feeding 12-hours (even though this means having to withdraw large 
quantities of glycogen), but then appear unable to withdraw the deposited 
fat during the fasting 12 hours. Table 8.16 shows the percentage 
contribution to energy expenditure of each of the fuels, and this again 
reinforces the difference between obese and Control subjects (Table 8.8), 
in the ability of the obese to utilise fat, both from diet and fat stores, 
under these circumstances.
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TABLE 8.13. Very Low Carbohydrate (14.4%) group ( I ) , showing fuel 
intake, net u t i l isa t ion  or synthesis (synthesis -ve, i t a l ic s ) ,  and 
fuel balance indicating mobilisation from stores (+ve), or deposition 
into stores (-ve). (5 Obese Patients.)
PROTEIN CARBOHYDRATE FAT ENERGY
g Fuel per 12 (or 24) Hours Kcal
A. INTAKE
Feeding 12 Hours
!
74.5 62.8 97.5 1405.0
B. UTILISATION
! Feeding 12 Hours 46.1 75.3 48.2 901.5
Fasting 12 Hours 24.2 61.1 50.7 779.9
C. BALANCE
Feeding 12 Hours -28.4
Deposited
12.5
mobilised
-49.3
Deposited
-503.S 
Deposited
Fasting 12 Hours 24.2
mobilised
61.6
mobilised
50.7
mobilised
779.9
mobilised
Total 24 Hours -4.2
Deposited
73.6
mobilised
1.4
mobilised
276.4
mobilised
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TABLE 8.14. Low Carbohydrate (30.5%) group (II) , showing fuel intake, 
net uti l isat ion  or synthesis (-ve), and fuel balance indicating 
mobilisation from stores (+ve) or deposition in to  stores (-ve).
(2 Obese Patients.)
PROTEIN CARBOHYDRATE FAT ENERGY
g Fuel per 12 (or 24) Hours Kcal
A. INTAKE
1
I
Feeding 12 Hours 69.6 131.5 140.6 2028.5
!------------------
B. UTILISATION • 1
Feeding 12 Hours 36.5 102.9 36.5 864.5
Fasting 12 Hours 24.3 95.4 36.9 789.1
C. BALANCE
Feeding 12 Hours -33.2
Deposited
-28.6
Deposited
-104.1
Deposited
-1164.0
Deposited
Fasting 12 Hours 24.3
mobilised
95.4
mobilised
36.9
mobilised
789.1
mobilised
Total 24 Hours -8.9
Deposited
66.8
mobilised
-  67.2 
Deposited
- 374.9 
Deposited
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TABLE 8.15. Normal Carbohydrate (52.1° )^ group (III), showing fuel 
intake, net ut il isation  or synthesis (-ve),  and fuel balance 
indicating mobilisation from stores (+ve) or deposition into stores 
(-ve). (2 Obese Patients.)
1 PROTEIN CARBOHYDRATE FAT ENERGY
1 g Fuel per 12 (or 24) Hours Kcal
A. INTAKE
Feeding 12 Hours 70.4 216.2 71.8 1747.4
B. UTILISATION
Feeding 12 Hours 38.3 95.5 34.2 822.4
Fasting 12 Hours 23.7 57.8 50.9 767.2
C. BALANCE
Feeding 12 Hours -32. 1 
Deposited
-120.8
Deposited
-37.6
Deposited
-925.0 
Deposited
Fasting 12 Hours 23.7
mobilised
57.8
mobilised
50.9
mobilised
767.2
mobilised
Total 24 Hours - 8.4
Deposited
-  63.1 
Deposited
13.3
mobilised
-157.9
Deposited
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TABLE 8.16. Percentages of energy expenditure derived from each fue l, and 
shown for each group of Groups I, II, and III.
Group I:Very Low Carbohydrate (14.4%) group.
PROTEIN CARBOHYDRATE FAT
Feeding 12 Hours 20.8 % 31.9 % 47.3 %
Fasting 12 Hours 12.6 % 30.0 % 57.4 %
Total 24 Hours 17.0 % 31.0 % 52.0 %
Group II: Low Carbohydrate (30.5% ) group.
PROTEIN CARBOHYDRATE FAT
Feeding 12 Hours 17.2 % 45.5 % 37.4 %
Fasting 12 Hours 12.5 % 46.3 % 41.3 *
Total 24 Hours 14.9 % 45.9 % 39.3 %
Group III; Normal Carbohydrate (52.1%) group.
PROTEIN CARBOHYDRATE FAT
Feeding 12 Hours 18.9 % 44.4 % 36.7 «
Fasting 12 Hours 12.6 * 28.8 % 58.7 %
Total 24 Hours 15.8 % 36.9 » 47.3 %
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With the Low Carbohydrate group (II) , once again protein, 
carbohydrate and fat intakes are almost identical for obese (Table 8.14) 
and Control (Table 8.9) groups. Again both groups show the same 
tendency to insist on utilising much more glucose than is supplied by 
food intake, although for both groups the effect is not as severe 
as for the Very Low Carbohydrate groups, and once again the obese are 
less affected than Control group subjects. Thus for both Control 
and obese groups, despite an energy intake 375 Real in excess of 
24 hour energy expenditure, and despite net deposition of large 
quantities of fat into fat stores over the 24 hours, glucose is 
still withdrawn in large quantities (116.5 g in Controls» 66.8 g in 
obese) from glycogen stores.
Table 8.16 (Group II) further demonstrates this effect, showing 
how carbohydrate metabolism is expected to contribute a disproportionately 
large 46% of energy expenditure, when it only receives 30% (of 
energy expenditure) as carbohydrate in the diet. For the Control 
group (Table 8.10) carbohydrate had to contribute a disproportionate 
53% of energy expenditure, for the same 30% carbohydrate intake.
As with the Control subject, the obese patients in the Normal 
Carbohydrate group (III) showed a more expected profile of fuel 
metabolism, all fuels showing net deposition in the feeding 12 hours 
and net withdrawal from stores in the fasting 12 hours. It is interesting 
to note that both Control and obese patients have utilised almost 
exactly the same quantity of fat over 24 hours, but because the fat 
intake in the obese group (71.8 g fat) is substantially smaller than 
the fat intake of the Control group subject (98.1 g fat), the obese 
patients end up using more fat than they take in, and so in a situation 
parallel to low carbohydrate intakes, fat has to be withdrawn from 
stores and utilised, despite an energy Intake in excess of 24 hour energy
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expenditure/ and simultaneous net deposition of glucose and protein.
This pattern is further reinforced by the energy metabolism 
profile of obese patient E.E. (continuous hourly intake over 24 hours). 
Her very high carbohydrate intake (245 g) contributed the equivalent 
of 76% of her energy expenditure (and 50% of her energy intake) , seen 
in Table 8.17. Yet her energy metabolism deliberately chooses to use 
as little glucose as possible for energy expenditure (only 26%).
Rather, it decides that fat should contribute 57% to energy expenditure 
- more than the diet supplies. Hence, fat mobilisation from stores 
is necessary, even though 160 g glucose are in excess and have to be 
deposited, and with energy intake 630 Kcal in excess of expenditure.
TABLE 8.17. Patient E.E. ,  having a very high proportion of carbohydrate 
in the d iet (= 76% energy expenditure), showing intake, u t i l isa t ion ,  
and deposition or mobilisation of fuels.
PROTEIN CARBOHYDRATE FAT ENERGY
g Fuel per 24 Hours Kcal
INTAKE (24 Hours) 72.3 245.4 72.2 1870.4
UTILISATION (24 Hours) 49.7 85.8 80. 3 1240.1
% of Total Utilisation 16.3 % 26.4 % 57.3 % lOO %
BALANCE (24 Hours) -22.6 
Deposited
-169.6
Deposited
8.1
mobilised
-630.3
Deposited
Thus a pattern seems to emerge, both from Control and obese 
subjects, In which energy metabolism appears to insist on utilising 
most, the fuel (glucose or fat) which is least available from intake. 
This pattern is visibly apparent In Figure 8.3, where the contrast
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expenditure, and simultaneous net deposition of glucose and protein.
This pattern is further reinforced by the energy metabolism 
profile of obese patient E.E. (continuous hourly intake over 24 hours). 
Her very high carbohydrate intake (245 g) contributed the equivalent 
of 76% of her energy expenditure (and 50% of her energy intake) , seen 
in Table 8.17. Yet her energy metabolism deliberately chooses to use 
as little glucose as possible for energy expenditure (only 26%) .
Rather, it decides that fat should contribute 57% to energy expenditure 
- more than the diet supplies. Hence, fat mobilisation from stores 
is necessary, even though 160 g glucose are in excess and have to be 
deposited, and with energy intake 630 Kcal in excess of expenditure.
TABLE 8.17. Patient E.E. ,  having a very high proportion o f carbohydrate 
in the diet (= 76% energy expenditure), showing intake, u t i l i s a t io n ,  
and deposition or mobilisation of fu e ls .
PROTEIN CARBOHYDRATE FAT ENERGY
<3 Fuel per 24 Hours Kcal
INTAKE (24 Hours) 72.3 245.4 72.2 1870.4
UTILISATION (24 Hours) 49.7 85.8 80. 3 1240.1
% of Total Utilisation 16.3 % 26.4 % 57.3 % lOO %
BALANCE (24 Hours) -22.6
Deposited
-159.6
Deposited
8.1
mobilised
-630.3
Deposited
Thus a pattern seems to emerge, both from Control and obese 
subjects, in which energy metabolism appears to insist on utilising 
moat'the fuel (glucose or fat) which is least available from intake. 
This pattern is visibly apparent in Figure 8.3, where the contrast
of
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between 24 hour glucose intake and utilisation is shown for all groups. 
Although the Very Low Carbohydrate group (I) of obese patients appears 
to show a 24 hour glucose utilisation inconsistent with the rest of 
the pattern in Figure 8.3, this may result from its substantial 
energy deficit over 24 hours. During the Feeding 12-hours this group 
still shows the characteristic glucose mobilisation pattern, despite 
excess fat and energy intake.
Bearing in mind this paradoxical pattern and the question it 
raises as to what energy metabolism does when glycogen supplies are 
exhausted, fuel metabolism was measured in the obese patients on Diet O, 
after 3 weeks on only 500 Kcal of glucose syrup per day, a situation 
in which one might expect glycogen stores to be exhausted. Table 8.18 
shows how energy metabolism copes with this affront.
T A B L E  8 . 1 8 „ F u e l  i n t a k e ,  i t s  n e t  u t i l i s a t i o n ,  a n d  f u e l  b a l a n c e  i n  t e r m s  
o f  m o b i l i s a t i o n  f r o m  s t o r e s  o r  d e p o s i t i o n  ( - v e )  i n t o  s t o r e s ,  i n  4 o b e s e  
p a t i e n t s  a f t e r  3 w e e ks  o n D i e t  0 ( 5 0 0  K c a l / d a y  g l u c o s e  s y r u p ) .
PROTEIN 
g Fuel
CARBOHYDRATE 
per 12 (or 24)
FAT
Hours
ENERGY
Kcal
A. INTAKE
Feeding 12 Hours O 129.4 0 494.7
B. UTILISATION
Feeding 12 Hours 7.1 68.1 46.3 698.1
Fasting 12 Hours 6.5 49.2 45.3 615.1
C. BALANCE
Feeding 12 Hours 7.1
mobilised
-61.4
Deposited
46.3
mobilised
203.4
mobilised
Fasting 12 Hours 6.5
mobilised
49.2
mobilised
45.3
mobilised
615.1
mobilised
Total 24 Hours 13.6
mobilised
-12.1
Deposited
91.6mobilised
819.0
mobilised
These data show the amazing versatility of the body to ensure that 
glucose is always available to contribute substantially to energy 
expenditure. Feeding phase energy expenditure is almost 60 Kcal/hour, 
whilst the energy intake is only 41 Kcal/hour - yet still the body 
deposits half this intake each hour, so that a glucose reserve can 
accumulate. This is achieved against an energy deficit of 200 Kcal 
during the Feeding phase (amounting to a deficit of over 800 Kcal in 
the 24 hours) .
So although the entire energy intake is only 129.4 g of glucose, 
the body only uses 68 g during the Feeding phase, depositing the 
remaining 61.4 g into glycogen stores, and then subsequently withdrawing 
most of this during the Fasting phase. It is as though the body has 
learnt to anticipate how much glucose it needs to store during the 
intake period, to maintain an adequate supply for fasting energy 
expenditure.
Table 8.19 shows how the proportional contribution of glucose 
to energy expenditure remains adequate in Feeding and Fasting phases, 
with fat mobilisation and oxidation supplying some 2/3 of the energy.
T A B L E  8 . 1 9 . T h e  p r o p o r t i o n a l  c o n t r i b u t i o n  o f  f u e l s  t o  e n e r g y  e x p e n d i t u r e ,  
i n  o b e s e  p a t i e n t s  h a v i n g  a d a i l y  i n t a k e  o f  o n l y  500 K c a l  o f  g l u c o s e  s y r u p .
PHASE PROTEIN CARBOHYDRATE FAT
Feeding 12 Hours 4.1 % 37.3 « 58.6 %
Fasting 12 Hours 4.3 % 30.5 « 65.2 «
Total 24 Hours 4.2 % 34.1 « 61.7 %
The results from all these whole-body fuel metabolism measurements 
demonstrate a remarkable series of responses by the body to different 
levels of carbohydrate intake. Both non-obese and obese subjects 
appear to respond in the same way, although the obese do so less 
dramatically. Although subject numbers in each group are small, the 
patterns of fuel metabolism found in both obese and non-obese groups, 
suggest the following 3 conclusions:
1. The proportion of whole-body energy expenditure contributed 
from glucose seems to be inversely influenced by the 
proportion of carbohydrate in an incoming diet, when 
adequate energy and protein are supplied. Thus the 
closer energy intake from carbohydrate approaches energy 
expenditure, the less carbohydrate is actually used for 
energy expenditure. Conversely, the lower the intake of 
carbohydrate (or ? fat), the higher its proportional 
contribution to energy expenditure.
2. Obese subjects appear to be able to oxidise and mobilise 
fat more readily than non-obese subjects, at least when 
there is an abundance of fat but little carbohydrate in 
the diet.
3. It appears that the body attempts to ensure that at least
a proportion of energy expenditure is derived from glucose, 
even when very little 19 supplied in the diet. In response 
to a prolonged daily intake of only 129 g of glucose 
syrup, the body not only ’adapted' its protein metabolism 
(see Section 6), but ’learnt' to store half this meagre 
Intake during the feeding period, so that glucose could 
supply at least 30% of total energy expenditure in both 
feeding and fasting periods. In all the situations
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measured above, glucose never supplied less than 25% of 
total energy expenditure (and this occurred when glucose 
intake was highest - equivalent to 76% of expenditure) .
These phenomena are difficult to explain, and provoke many questions 
about their significance and the dynamic role of glucose and fat in 
fuel metabolism, (as well as a slight nervousness about their validity 
because of small group numbers and the method itself) . Here indeed 
is much scope for further investigation.
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8.5. SUMMARY AND CONCLUDING COMMENTS
It was the development of techniques for the (1- C)leucine 
method, particularly those required for prolonged and diurnal 
measurements of whole-body protein turnover, that led to an appreciation 
of their potential for continuously measuring whole-body energy 
metabolism and changes in body fuel stores as well. The particular 
techniques that offered these new opportunities were those that 
allowed the continuous measurement of protein oxidation rates, even 
on an hourly basis, as well as continuous accurate measurement of 
uptake and CO^ output over 24 hours.
It has been shown in this section that the principles of 
metabolic mixture measurement were originally developed by Zuntz, Lusk, 
Benedict and others, well over 50 years ago, and the basic formulae 
developed here in this section are really only an expression of their 
principles. However it was also shown that relatively little research 
appears to have been done on fuel utilisation patterns, one of the 
reasons being that the techniques currently used (N-excretion for 
protein oxidation; Douglas bag for and CO^) have remained largely 
unchanged, and these are quite inadequate for accurate or sensitive 
measurement of acute changes in protein oxidation or gas exchange. The 
other main limiting factor seems to have been the concept that indirect 
calorimetry is invalid unless oxidation is predominantly occurring, 
restricting its use mainly to conditions of fasting or prolonged 
exercise. This concept is still widely held.
The contributions that this section attempts to make are both 
theoretical and practical. Fuel utilisation formulae were derived 
by the '0^  uptake/CC^ output' method of Weir (1949) , but then rederived 
from a stochastic balance model which specifically allowed for fuel
14
synthesis and interconversion. In this way it was shown that 
indirect calorimetry is theoretically valid even when synthesis, 
deposition, interconversion, or oxidation of fuels are occurring 
(both Lusk and Benedict tested and accepted this).
It was then shown that if O^, CO^ and protein oxidation can 
be accurately measured, then the formulae for fuel utilisation 
require account to be taken of the actual amino acid, fatty acid, 
and carbohydrate composition of fuels being immediately metabolised. 
Appropriate sets of factors, for substitution into the fuel utilisation 
formulae, were calculated for each of several diets, including fasting, 
and it was clearly shown that gas exchange, and hence fuel utilisation 
patterns, were significantly and measurably affected by different 
amino acid and fatty acid compositions. It was suggested that 
general gas exchange factors for 'protein', 'fat', and 'carbohydrate'
(eg. those of Zuntz, 1897) are inadequate if fuel utilisation patterns 
are to be investigated, and that future worthwhile work in this area 
might include the development of such specific factors for specific 
foods.
The formulae,and their appropriate factors, were then used to 
investigate the fuel utilisation patterns and responses in groups of 
obese and non-obese subjects. Their hourly protein oxidation rates,
02 uptake and C02 output quantities were used in the formulae, and 
12-hour patterns of feeding phase and fasting phase fuel metabolism 
were built up and then compared, for diets distinguished by their 
different proportions of carbohydrate.
The unexpected profiles that emerged seemed to indicate that 
the body attempts to ensure that glucose contributes to energy expenditure, 
that the less glucose there is in the diet, the more the body uses for 
energy expenditure and vice versa, and that this effect is less marked
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in obese subjects because of their ability to withdraw fat from stores 
and oxidise it more readily than the non-obese.
This section has thus attempted to demonstrate that these fuel 
utilisation formulae are an exciting tool, with much wider validity 
than has been realised. The use of more accurate and sensitive 
techniques for measurement of protein oxidation, uptake and CO^ 
output, and the analysis and development of appropriate factors for 
fuels being metabolised, accounting for their cimino acid, fatty acid 
and carbohydrate contents, give these formulae tremendous investigative 
potential. Ahead, largely uncharted, lies human whole-body energy 
metabolism under many conditions, including health, disease, trauma, 
recovery and growth.
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APPENDIX 1.1 DIET O' GROUP OF PATIENTS. INDIVIDUAL DIETARY and AOTHROPOMETRIC DATA
NAME SEX DAILY DIETARY INTAKE AGE HEIGHT INITIAL WEIGHT % of WEIGHT LOSS
Real/Protein Days (Yrs) (cm) (Kg) IDEAL WEIGHT (%) Kg
DR F 1868/72 479/ 0
3
21 46 164 101.5 163.7 % 6.0
MK F 1809/67 479/ 0
3
20 60 161 107.0 178.3 % 5.5
»1 M 1603/62 479/ 0
3
20 55 171 109.0 155.7 % 8.0
MP F 1603/62 479/ 0
3
21 48 159 107.0 184.5 % 7.5
ME F 1602/62 477/ 0
3
20 54 160 82.0 139 % 5.5
MW F 2250/72 495/ 0
3
19 59 169 106.8 161.8 % 5.5
TD F 1807/67 478/ 0
3
20 41 160 94.8 160.6 % 6.5
EK F 1625/68 495/ 0
3
19 46 165 88.4 140.3 % 7.3
RO F 1870/72 495/ 0
3
19 47 155 84.7 153.9 % 5.7
MEAN 1782/67 3 50.7 162.7 97.9 159.8 % 6.4
± S.D. 484/ 0 20 + 6.6 ± 5.1 + 10.7 ± 15 ± 0.98
'WEIGHT LOSS/DAY’ 
g/day
286
275
400
357
275
290
325
384
297
321 
± 48
APPENDIX 1.2 DIET P' GROUP OF PATIENTS. INDIVIDUAL DIETARY and ANTHROPOMETRIC DATA
NAME
MB
SB
MR
MM
MEAN
iS.D.
SEX DAILY DIETARY INTAKE AGE HEIGHT INITIAL WEIGHT % of
IDEAL WEIGHTKcal/Protein Days (Yrs) (cm)
1868/72
528/48
3
20 42 175
(Kg)
86.5
(%)
123.0 %
WEIGHT LOSS 'WEIGHT LOSS/DAY' 
Kg g/day
4.5 225
2361/72
531/48
1868/72
528/48
1603/62
456/48
1925/70
510/48
3
20
3
20
3
20
54 170
59 155
44 163
3 49.8 165.8
20 ± 8.1 ± 8.7
175.0
118.0
108.5
122.0
± 37.7
231.8 %
195.0 %
177.9 %
181.9 % 
+ 45.3
10.0
6.0
5.5
6.5 
+ 2.4
500
300
275
325 
+ 120
APPENDIX 1.3. Individual protein turnover rates, in ymoles leucine 
per hour, for 9 obese patients, measured over the 12-hour feeding 
phase, initially on a 'Normal Diet', and then after 3 weeks on
'Diet O'. 
A. NORMAL
PATIENT
DIET
Q Z
ymoles
B
Leucine per
E
Hour
I
DR 7564.2 5792.7 3121.7 1771.5 4442.5
MK 8446.3 5137.9 4547.9 3308.4 3898.4
MM 7918.6 6695.2 4095.4 1223.4 3823.2
MP 8944.4 6552.6 5121.2 2391.7 3823.2
ME 8676.4 6418.4 4868.6 2257.6 3807.8
MW 8877.2 7137.7 4508.4 1739.5 4368.8
TD 8366.6 5953.0 4358.0 2413.6 4008.6
EK 9158.9 6813.4 4780.5 2345.5 4378.4
RO 6460.8 4587.8 2000.4 1873.0 4460.4
MEAN 8268.2 6121.0 4155.8 2147.1 4112.4
1+ CO b ± 345 ± 834 ± 992 ± 588 ± 292
B. DIET O FOR 3 WEEKS
Q Z B E I
PATIENT ymoles Leucine per Hour
DR 5217.6 4827.8 5217.6 389.7 O
MK 3684.0 3397.8 3684.0 286.2 O
MM 4917.8 4597.7 4917.8 320.1 o
MP 3633.0 3204.6 3633.0 428.4 o
ME 3744.4 3430.6 3744.4 313.8 0
MW 4165.9 3866.4 4165.9 299.5 o
TD 4492.4 4045.2 4492.4 447.2 0
EK 4190.9 3747.4 4190.9 443.5 o
RO 3245.8 2943.3 3245.8 302.5 o
MEAN 4143.5 3784.5 4143.5 359.0 o
± S.D. ±64 3 ± 626 ± 643 ± 67
APPENDIX 1.4. Individual protein turnover rates, in g Protein per 
12 Hours, for the 9 obese patients initially on 'Normal Diet' and 
then after 3 weeks on 'Diet O', the measurements made over the feeding
12 hours. (The t-test for matched pair samples is used to test for 
significant difference in Q, Z, B and E on the two diets.)
A. NORMAL DIET
Q Z B E I
PATIENT g Protein per 12 Hours
DR 148.8 114.0 61.4 34.9 72.1
MK 166.2 101.1 89.5 65.1 66.9
MM 155.8 131.8 80.6 24.1 62.0
MP 176.0 128.9 100.8 47.1 62.0
ME 170.7 126.3 95.8 44.4 61.8
MW 174.7 140.5 88.7 34.2 72.3
TD 164.6 117.1 85.8 47.5 66.9
EK 180.2 134.1 94.1 46.2 68.4
RO 127.1 90. 3 39.4 36.9 72.3
MEAN 162.7 120.4 00r—i00 42.3 67.2
± S.D. ± 16.6 ± 16 ± 19.5 ± 11.6 ± 4.5
B. DIET O FOR 3 WEEKS
Q Z B E X
PATIENT g Protein per 12 Hours
DR 102.7 95.0 102.7 7.7 o
MK 72.5 66.9 72.5 5.6 o
MM 96.8 90. 5 96.8 6.3 o
MP 71.5 63.1 71. 5 8.4 0
ME 73.7 67. 5 73.7 6.2 o
MW 82.0 76.1 82.0 5.9 o
TD 88.4 79.6 88.4 8.8 o
EK 82.5 73.8 82.5 8.7 o
RO 63.9 57.9 63.9 6.0 o
MEAN 81.5 74.5 81.5 7.0 0
± S.D. ±12.4 ± 12.3 ± 12.6 ± 1.3
t-test p < 0.001 p < 0.001 N.S.D. p < 0.001
APPENDIX 1.5. Individual protein turnover rates for 9 obese patients, 
with the rate after 3 weeks on Diet O expressed as a percentage of the 
rate on the Normal Diet for each patient. Measurements made over 
feeding 12 hours for both diets.
A . NORMAL D IE T
Q z B E I
ALL PAT I HUTS l o o  % l o o  % 10O % l o o  % l o o  %
B. DIET O FOR 3 WEEKS
Q Z B E I
PATIENT
DR 69.0 % 83.3 % 167.3 % 22.1 % O
MX. 43.6 % 66.2 % 81.0 % 8.6 « o
MM 62.1 % 68.7 % 120.1 % 26.1 % o
MP 40.6 * 49.0 % 70.9 % 17.8 % o
ME 43.2 % 53.4 % 76.9 % 14.0 % o
MW 46.9 % 54.2 % 92.4 % 17.3 % o
TD 53.7 % 68.0 % 103.0 % 18.5 % o
EK 45.8 % 55.0 % 87.7 % 18.8 % o
RO 50.3 % 64.1 « 162.2 « 16.3 % 0
MEAN 50.6 % 62.4 « 106.8 % 17.7 % 0
± S.D. ± 9.5 ± 10.6 ± 35.9 ± 4.9
\APPENDIX 1.6. Individual protein turnover rates, in g Protein per 
12 Hours, for the 4 obese patients initially on 'Normal Diet' and then 
after 3 weeks on 'Diet P' , the measurements made over the feeding 
12 hours. (The t-test for matched pair samples is used to test 
for significant difference in Q, Z, B, and E, on the different diets.)
A. 'NORMAL DIET' FOR 3 DAYS
Q Z B E I
PATIENT g Protein per 12 Hours
MB 186.4 150.6 99.0 35.8 72.1
SB 207.2 163.2 119.2 44.0 72.0
MR 144.1 99.6 56.7 44.5 72.1
MM 167.3 126.0 92.1 41.3 62.0
MEAN 176.3 134.9 91.8 41.4 70.0
* S.D. ± 27 ± 28 ±26 ± 4 ± 5
B. 'DIET P' FOR 3 WEEKS
Q Z B E i
PATIENT g Protein per 12 Hours
MB 141.0 114.8 80.6 26.2 48.1
SB 187.5 152.2 126.9 35.3 48.3
MR 119.0 86.1 58.6 32.9 48.1
MM 130.5 107.0 69.9 23.4 48.3
MEAN 144.5 115.0 84.0 29.5 48.2
± S.D. ± 30 ± 28 ± 30 ±5.6 ±0.1
t-test p < .02 .02<p< .05 N.S.D.
CMOVa
APPENDIX 1.7. Individual protein turnover rates for 4 obese patients, 
the rate after 3 weeks on'Diet P'being expressed as a percentage of 
the rate on 'Normal Diet' for each patient. Measurements made over 
the feeding 12 hours, for both diets.
A. 'NORMAL DIET' FOR 3 DAYS
Q Z B E I
ALL PATIENTS lOO % lOO % lOO % lOO % ICO %
B. 'DIET P’ FOR 3 WEEKS
PATIENTS
MB 75.6 % 76.2 % 81.4 % 73.2 % 66.8 %
SB 90.5 « 93.3 % 106.5 % 80.2 % 67.1 %
MR 82.6 % 86.5 « 103.4 % 73.9 % 66.8 %
MM 78.0 % 84.9 % 75.9 % 56.7 % 77.9 %
MEAN 81.7 % 85.2 % 91.8 % 71.0 % 69.7 %
±S.D. ±6.6 ±15 ± 15 ± 10 ±5.5
APPENDIX 1.8 Individual protein turnover rates, in g Protein per 
12 hours, for 6 obese patients initially on 'Normal' Diet and then
for 3 weeks on either Diet P or Diet O. Measurement by multiple dose 
^■^N-Glycine/NH^ end product method.
NORMAL DIET Q Z B E I
g Protein per 12 Hours
M. Me 197. 9 155.6 135.9 42.3 62.0
MP 161.8 115.4 99.8 46.4 62.0
CW 220.7 187.1 158.7 33.6 62.0
MMa 160.9 113.9 98. 9 47.0 62.0
RH 227.8 199.3 165.8 28.5 62.0
RQ 220.1 179.9 158.1 40.1 62.0
MEAN 198.2 158.5 136.2 39.7 62.0
±S.D. ±30 ±37 ±30 ±7
DIET P FOR 3 WEEKS
Q Z B E I
g Protein per 12 Hours
MMa 172.5 123.9 131.1 48.6 41.4
RH 215.1 205.3 166.8 9.8 48.3
RQ 194.2 174.5 145.9 19.7 48.3
MEAN 193.9 167.9 147.9 26.0 46.0
±S.D. ±21 ±41 ±18 ±20 ±4
DIET O FOR 3 WEEKS
Q Z B E I
MMc 138. 9 124.3 138.9 14.7 O
MP 70. 9 59.5 70.9 11.4 O
CW 103.4 93.5 103.4 9 .9 o
MEAN 104.4 92.4 104.4 12.0 o
±S.D. ±34 ±32 ±34 ±2.5 o
Statistical comparison of Diet P and Diet O against 'Normal' Diet t-test
z B
Diet P N.S.D N.S.D
Diet O p< .05 N.S.D.
APPENDIX 2.1 •diurnal' and 'DIET 0 - DIURNAL' GROUPS of OBESE PATIENTS. DIETARY and ANTHROPOMETRIC DAr
NAME SEX DAILY DIETARY 
Kcal/Protein
INTAKE AGE
(yrs)
HEIGHT
(cm)
WEIGHT
(kg)
% of
IDEAL WEIGHT 
(%)
FB F 1516/80.9 63 161 99.0 167.8%
SH F 1358/71.4 45 160 77.6 131.5%
DH F 1335/69.9 56 165 81.0 128.6%
MH F 1358/71.4 57 161 99.0 167.8%
ML F 1494/73.8 43 161 117.0 198.3%
KT F 1457/78.6 46 150 118.0 224.8%
MW F 2250/72.3 59 169 106.8 161.8%
TD F 1807/66.9 41 160 94.8 160.6%
EK F 1625/68.4 46 165 88.4 140.3%
RO F 1870/72.3 47 155 84.7 153.9%
MEAN 1607/72.59 50.3 160.7 96.6 163.5%
tS .D . ±291 4.3 ±7.7 ±5.3 ±14.2
APPENDIX 2.2. Individual protein turnover rates, in grams of
protein per 12 hours, for 10 obese patients on 'Normal' Diet, 
measured over both Feeding 12 hours, and Fasting 12 hours('Diurnal' 
and 'Diet-O Diurnal'groups).
A. FEEDING 12 HOURS
NAME Q Z B E I
g Protein per 12 hours
FB 176.0 120.7 77.0 55.3 80.9
SH 158.7 109.0 71.4 49.7 71.4
DH 170.8 12"\2 85.4 43.6 69.9
MH 172.9 116.4 85.6 56.5 71.4
ML 151.0 107.3 66.0 43.8 73.8
mt 184.1 131.5 87.7 52.7 78.6
MW 174.7 140.5 88.7 34.2 72.3
TD 164.6 117.1 85.8 47.5 66.9
EK 180.2 134.1 94.1 46.2 68.4
RO 127.1 90.3 39.4 36.9 72.3
MEAN 166.0 119.4 78.1 46.6 72.6
±S.D. ±16.9 ±14.9 ±16.1 ±7 ±4.3
B. FASTING 12 HOURS
NAME Q Z B E I
g Protein per 12 hours
FB 101.0 81.9 101.0 19.1 O
SH 84.7 70.5 84.7 14.4 o
DH 108.0 90.0 108.0 18.0 o
MH 105.1 80.3 105.1 24.8 0
ML 103.7 90.3 103.7 13.4 o
MT 112.7 95.5 112.7 17.2 0
MW 150.8 125.5 150.8 25.3 o
TD 84.8 70.2 84.8 14.6 o
EK 106.7 86.7 106.7 20.0 o
RO 105.5 85.5 105.5 19.9 0
MEAN 106.3 87.6 106.3 18.7 o
±S.D. ±18.2 ±15.6 ±18.2 ±4.1
Matched pair p<.001 p<.001 p<.oi p<.ooi
t-test
APPENDIX 2.3. Individual protein turnover rates, expressed in millimoles 
of Leucine per Hour, for the 10 obese patients on 'Normal' Diet ('Diurnal'
and 'Diet O-Diurnal' groups), measured for diurnal changes with 
14(1- C) leucine infusion over 24 hours.
A. FEEDING 12 HOURS
NAME Q Zmillimoles
B
Leucine
E
per Hour
I
FB 9.94 6.13 3.91 2.81 5.03
SH 8.06 5.54 3.63 2.52 4.43
DH 8.68 6.47 4. 34 2.21 4.34
MH 8.79 5.92 4. 35 2.87 4.44
ML 7.67 5.45 3. 35 2.22 4.32
MT 9.36 6.68 4.46 2.68 4.90
MW 8.88 7.14 4. 51 1.74 4.37
TD 8.37 5.95 4. 36 2.42 4.01
EK 9.16 6.81 4. 78 2.35 4.38
RO 6.46 4.59 2.00 1.87 4.46
Mean 8.44 6.07 3.97 2.37 4.47
± S.D. ±0.86 ±0.75 ±0.82 ±0. 37 ±0.29
FASTING 12 HOURS
NAME C Z B E Imillimoles Leucine per Hour
FB 5.13 4.16 5.13 0.97 O
SH 4.32 3.59 4.32 O. 73 o
DH 5.49 4.57 5.49 0.92 o
MH 5.34 4.08 5.34 1.26 o
ML 5.27 4.59 5.27 0.68 o
MT 5.73 4.86 5.73 0.87 o
MW 7.67 6.38 7.67 1.29 o
TD 4.31 3.57 4.31 0.74 o
EK 5.42 4.41 5.42 1.01 o
RO 5.36 4.35 5.36 1.01 o
Mean 5.40 4.45 5.40 0.95 o
± S.D. ±0.93 ±0.79 ±0.93 ±0.21
APPENDIX 2.4. Control Group of Subjects. Dietary and Anthropometric Data
NAME SEX DAILY DIETARY INTAKE 
Kcal/Protein
AGE
(yrs)
HEIGHT
(cm)
WEIGHT
(Kg)
% of
IDEAL WEIGHT 
(%)
MG F 1327/65.6 43 170 54.0 80.6 %
JS F 1327/65.6 58 167 55.0 84.6 %
JCW M 2103/65.8 61 170 80.0 115.0 %
RWS M 2250/72.3 53 173 80.0 112.7 %
JKG M 1977/66.7 67 178 66.0 88.0 %
MEAN 2F 1797/67.2 56.4 172 67.0 96.2 %
± S.D. 3M +440/+2.9 +9 ±4.2 ±12.8 ±16
APPENDIX 2.5 'Control' group individual protein turnover rates
expressed in grams of protein per 12 hours, for both feeding 12 hour:
and fasting 12 hour s.
A. FEEDING 12 HOURS
NAME Q z B E I
g Protein per 12 Hours
MG 133.2 82.5 53.3 50.7 65.6
JS 149.5 100.8 69.4 48.7 65.6
JCW 180.5 148.9 104.7 31.7 65.8
RWS 161.9 118.6 75.9 43.4 72.3
JKG 151.2 110.4 72.3 40.8 66.7
MEAN 155. 3 112.2 75.1 43.1 67.2
±S.D. ±17 ±24.5 ±19 ±7.5 ±2.9
B. FASTING 12 HOURS
Q z B E I
g Protein per 12 Hours
MG 75.8 59.0 75.8 16.8 O
JS 106.7 81.7 106.7 25.0 o
JCW 111.7 95.6 111.7 16.1 oRWS 112.7 95.5 112.7 17.2 o
JKG 95.7 76.1 95.7 19.6 o
MEAN lOO. 5 81.6 100.5 18.9 o
±S.D. ±15 ±15 ±15 ±4
Q Z B E
Matched pair p<.OOl p< .Ol P<.Ol p< .Ol
t-test
APPENDIX 2.6
of 5 non-obese patients, expressed as millimoles of Leucine per Hour,
14and measured over 24 hours, using (1- C) leucine infusion.
. Individual protein turnover rates for the 'Control Group'
A. FEEDING 12 HOURS
NAME Q Zmillimoles
B
of Leucine
E
per Hour
Z
MG 6.78 4.20 2.71 2.58 4.07
JS 7.60 5.12 3.53 2.48 4.07
JCW 9.17 7.56 5.32 1.61 3.86
RWS 8.23 6.02 3.86 2.21 4.37
JKG 7.68 5.61 3.67 2.07 4.01
Mean 7.89 5.70 3.82 2.19 4.07
± S.D. ±0.88 ±1.2 ±0.95 ±0.38 ±0.19
B. FASTING 12 HOURS
NAME Q Z B E Imillimoles of Leucine per Hour
MG 3.86 3.00 3.86 0.86 O
JS 5.42 4.15 5.42 1.27 o
JCW 5.68 4.86 5.68 0.82 o
RWS 5.72 4.85 5.72 0.87 o
JKG 4.86 3.87 4.86 0.99 o
Mean 5.11 4.15 5.11 0.96 o
± S.D. ±0.78 ±0.77 ±0.78 ±0.18
APPENDIX 2.7. Protein and leucine balances for obese (Diurnal and Diet O-Diurnal groups) and control subjects. 
Leucine excretion is calculated at dietary protein proportion until balance, and whole body protein proportion
(8%) for the excess.
NAME INTAKE 24-HOUR EXCRETION 24-HOUR BALANCE
g Protein mmol Leucine g Protein/d mmol Leu/d g Protein/d mmol Leu/d
A. OBESE (N x 6.25) (N x 6.25)
FB 80.9 60.4 89.7 65.8 - 8.8 - 5.4
SH 71.4 53.2 73.3 54.4 - 1.9 - 1.2
DH 69.9 52.1 84.5 61.0 -14.6 - 8.9
MB 71.4 53.3 85.4 61.8 -14.0 - 8.5
ML 73.8 51.8 - - “ “
MT 78.6 58.8 85.2 62.8 - 6.6 - 4.0
MW 72.3 52.4 85.3 60.3 -13.0 - 7.9
TD 66.9 48.1 88.9 61.5 -22.0 -13.4
EK 68.4 52.6 71.9 54.7 - 3.5 - 2.1
RO 72.3 53.5 74.3 54.7 - 2.0 - 1.2
MEAN 7 2 . 6 53 . 6 82.1 59.7 - 9.6 - 5.8
± S.D. ±4.3 ±3.5 ±6.9 ±4.1 + 6.8 + 4 . 2
B. CONTROL
MG 65.6 48.8 67.3 49.8 - 1.7 - 1.0
JS 65.6 48.8 84.6 60.4 -19.0 -11.6
JCW 65.8 46.3 92.9 62.8 -27.1 -16.5
RWS 72.3 52.4 101.3 70.1 -29.0 -17.7
JKG 66.7 48.1 76.0 53.8 - 9.3 - 5.7
MEAN 67.2 48.8 84.4 59.4 -17.2 -10.5
♦ S.D. ±2.9 ±2.2 ±13.4 ±7.9 ±11.7 ± 7.1
APPENDIX 3.1 Protein turnover in 4 non-obese 'Control' Group subjects
measured over 24 hours, by continuous intravenous infusion of 
(■^Niglycine, using urinary ammonia as end-product.
A. FEEDING 12 HOURS
NAME Q Z B E
g Protein per 12 Hours
MG 130.9 97.3 65. 3 33.6
JS 120.0 77.8 54.4 42.1
JCW 171.0 124.2 108.2 46.8
RWS 117.7 63.7 45 4 54.0
MEAN 134.9 90.8 68.3 44.1
± S.D. ±24.7 ±26 ±28 ±8.5
FASTING 12 HOURS
NAME Q Z B E
g Protein per 12 Hours
MG 58.0 24.5 58.0 33.6
JS 64.7 22.6 64.7 42.1
JCW 94.7 47.8 94.7 46.8
RWS 85.1 31.2 85.1 54.0
MEAN 75.6 31.5 75.6 44.1
± S.D. ±17 ±11 ±17 ±8.6
APPENDIX 3.2. Oral single dose (15N)glycine/NH^ end-product method 
measurements of protein turnover, in 6 obese patients on 'Normal' 
Diet, and 3 of these patients on 'Diet O'. Measurements were made 
in Feeding Phase only.
A. NORMAL DIET (Feeding 12 Hours)
NAME Q Z B E
g Protein per 12 Hours
MK 277.7 243.7 210.7 34.0
MW 116.8 80.8 44.8 36.0
RP 131.8 95.9 59.8 36.0
ES 203.9 163.2 128.9 40.7
TD 146.3 106.0 79.3 40.3
DH 139.4 102.0 66.3 37.5
MEAN 169.3 131.9 98.3 37.4
± S.D. ±60.9 ±61.5 ±62 ±3
B. DIET 0 (Feeding 12 Hours)
NAME Q Z
g Protein
B
per 12 Hours
E
MK 69.9 58.1 69.9 11.8
TD 74.8 67.3 74.8 7.5
DR 67.2 57.1 67.2 10.1
MEAN 70.6 60.8 70.6 9.8
± S.D ±3.9 ±5.6 ±3.9 ±2.2
14GROUP), measured over 24 hours by (1- C)leucine infusion, initially 
on 'Normal' Diet, and then 3 weeks later on Diet O (see Appendix 4.2).
A. NORMAL DIET 
FEEDING PHASE
APPENDIX 4.1. Protein turnover rates in 4 obese women (DIET O—DIURNAL
NAME Q Z B E I
g Protein per 12 Hours
MW 174.7 140.5 88.7 34.2 72.3
TD 164.6 117.1 85.8 47.5 66.9
EK 180.2 134.1 94.1 46.2 68.4
RO 127.1 90.3 39.4 36.9 72.3
MEAN 161.7 120.5 77.0 41.2 70.0
± S.D. ±24 ±22 ±25 ±7 ±2.8
FASTING PHASE
NAME Q Z B E I
g Protein per 12 Hours
MW 150.8 125.5 150.8 25.3 O
TD 84.8 70.2 84.8 14.6 o
EK 106.7 86.7 106.7 20.0 o
RO 105.5 85.5 105.5 19.9 o
MEAN 112.0 92.0 112.0 20.0 o
± S.D. ±28 ±24 ±28 ±4
APPENDIX 4.2. Protein turnover rates measured by (1- C)leucine infusion 
over 36 hours, in 4 obese women (DIET O—DIURNAL GROUP) after 3 weeks 
on Diet O. After the Feeding and Fasting Phases of Diet 0, Diet P 
(500 Kcal/50 g Protein) was introduced (3 patients).
A. DIET O 
FEEDING PHASE
NAME Q Z
g Pro
E
Hours
I
MW 82.0 76.1 .O 5.9 O
TD 83.4 79.6 88.4 8.8 O
EK 82.5 73.8 82.5 8.7 o
RO 63.9 57.9 63.9 6.0 o
MEAN 79.2 71.9 79.2 7.4 o
± S.D. ±11 ±io ±11 ±2
FASTING PHASE
NAME Q Z B 
g Protein per 12
E
Hours
I
MW 79.2 73.1 79.2 6.2 o
TD 88.1 81.3 88.1 6.8 o
EK 74.9 68.2 74.9 6.7 o
RO 64.5 58.8 64.5 5.7 o
MEAN 76.7 70.4 76.7 6.4 o
± S.D. ±io ±9 ±io ±0.5
B. DIET P (PROTEIN REFEEDING)
FEEDING PHASE
NAME Q Z B E I
g Protein per 12 Hours
MW 111.1 89.2 50.7 21.9 48.1
EK 93.5 68.1 33.1 25.4 48.1
RO 89.1 65.0 28.7 24.1 48.1
MEAN 97.9 74.1 37.5 23.8 48.1
± S.D. ±12 ±13 ±11 ±2
APPENDIX 5.1. Amino Acid composition of milk used to compute 0 2 uptakes and CO^ outputs
oxidation.
mg/g N (in milk) nmoles AA/q N
Leu C6H13N°2 640
4.9
Pro C 5H9N02 590 5.1
Lys C H N O  510 V l 4  2U 2
3.5
Val C 5H11N02 460
3.9
g i u / < ; i u - n h 2 C 5H9N04/C5H10N 2°3 144° 9.8
Asp/Asp-NHj C 4H7N04/C4H8N 2°3 53°
4.0
Ser C 3H7N03 370
3.5
lieu C6H13N02 350
2.7
Phe C9H11N02 340
2.1
Thr C4H9N°3 310
2.6
Tyr CgHn N03 280 1.5
Arg r h N O 250 © i4W4 *
1.4
Ala C 3H7N02 240 2.7
His C6H9N 3°2 ' 190
1.2
Met C 5H11N02S 180
1.2
Gly C j H g N O j  140 1.9
Trp C 11H12N2°2 90
0.4
Cys C6H12N2°4S2 60
O. 5
Thus for each g of N in milk:
C 270.8H 530.0N70.8°135.1S2.2
285.96 02 236.4 C 0 2
millimoles * millimolee
35.4 urea ♦ 2.2 SOj + 194.2 HjO
» - 8 - -
for amino a
(In milk)
0.823
A P P E N D I X  5 .2. Fatty Acid composition and Glycerol in milk-based diets 
used to compute C>2 uptake and CC>2 outputs tor oxidation. It is 
assumed for calculation purposes that milk fat is only in triglyceride 
form.
Oleate 27.5 % C18H34°2
Palmitate 25.5 % C16H32°2
Stearate 11.0 % C18H36°2
Myristete 11.0 % C14H28°2
Glycerol 25.0 % C3 »8 °3
Thus for 1 mole of 'Mean Triglyceride's
C h O + 18.81 0, -*• 12.3 CO, + 13.28 H O13.3 26.55 2.25 2 2 2
R - 8 - - 0.707
APPENDIX 5.3. Conversion of the carbohydrate content of Diet O inot 
available monosaccharide. The factors are calculated by allowing for 
hydration of the bonds linking sugar units.
1 g Starch ---1.1 g Glucose
1 g Disaccharide (eg. lactose) --v 1.05 g Glucose
DIET O 'HYCA-L1 - Contains 106.24 g mixed carbohydrate/bottle.
Carbohydrate
(g)
Conversion
Factor
Glucose Equivalents
(g)
Glucose 20.57 1 20.57
Maltose 15.11 1.053 15.91
Trisaccharides 12.54 1.071 13.43
Tetrasaccharides 10.56 1.081 11.42
Pentasaccharides 8.88 1.087 9.65
Polysaccharides 38.58 1.1 42.44
TOTAL 106.24 g CHO 113.42 g Glucose
APPENDIX 5.4. The Stoichiometry of fuel metabolism in Table 8.4.
1 0 C 6H1 2 °6
+  6 0  0 2 60  C0 2  +  60  H2 0
» W i
8 7 .9 0  C0 2  .  1 5 .9 5  *  8 8 .3 3
1 0  C3 .8 2 H7 .4 9 N1 °1 .9 1 S0 .0 3  +
4 0 .3 9  0 2 3 3 .2 5  C0 2  + 5 CN2 H40  + 2 7 .4 3  t^O  + 0 .3 1  SO
5  C3 .8 2 H7 .4 9 N1 °1 .9 1 S 0 .0 3  + 3 .5 7  0 2 +  2 .9 1 H20  *  2 .5  CN2 H40  + 2 .7 7  CgH ^O g + 0 .1 6
1 0 0  C3 .8 2 H7 .4 9 N1 °1 .9 1 S 0 .0 3  +
1 5 .5 9  0 2 5 8 .1 0  C02  + 50 C N ^ O  + 2 0 .6 6  3 8 ^  5 5 ° .
5  C1 3 .3 H2 6 .5 5 °2 .2 5  +
9 4 .0 6  0 2 6 6 .5  C02  + 6 6 .4  H2 0
57.71 Glucose + 115 'Amino Acid1 + 216.51 C>2 - 308.65 C02 + 31.61 Fat + 57.5 Urea + 242.2 1^0 +
3.1 S03
3.57 S03
